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Abstract
Dietary intake of a glucosinolate-rich Daikon extract (glucoraphasatin and 
glucoraphenin) elevated rat hepatic dealkylations o f methoxy-, ethoxy-, 
pentoxyresorufin and benzyloxyquinoline, accompanied by increased expression of 
C Y Pl and CYP3A2 apoprotein levels. A marked induction o f glutathione S- 
transferase and quinone reductase activities in liver was evident, as well as o f 
glucuronosyl transferase and epoxide hydrolase activities and expression, but only at 
higher doses. Lung enzymes were not altered by the same treatment.
In precision-cut rat liver slices glucoraphasatin caused a marked increase in epoxide 
hydrolase activity. Addition o f myrosinase to form the isothiocyanate led to a marked 
rise in glutathione ^'-transferase, quinone reductase and epoxide hydrolase activities 
and expression.
Incubation o f precision-cut rat liver slices with intact glucosinolates (glucoerucin and 
glucoraphanin) enhanced the 0 -dealkylations o f methoxy- and ethoxyresorufin and 
elevated CYPl apoprotein levels; similar effects were observed in lung slices. Both 
glucosinolates increased hepatic epoxide hydrolase, glutathione Ytransferase and 
quinone reductase activities.
Studies on the temporal induction o f carcinogen-metabolising enzyme systems by 
glucosinolates and isothiocyanates in precision-cut rat liver slices indicated that a six- 
hour tissue exposure was required for induction o f all enzymes to be manifested.
The potential o f the naturally-occurring i?-sulforaphane to up-regulate carcinogen- 
metabolising enzyme in precision-cut rat liver slices and FAO cells was compared to 
that o f  5'-sulforaphane; i?-sulforaphane was superior in modulating these enzyme 
systems in both systems.
Using the CALUX assay it was established that phenethyl isothiocyanate, erucin and 
sulforaphane were poor ligands to the Ah receptor. However, they effectively 
antagonised, in a non-competitive manner, the activation of the receptor by 
benzo[a]pyrene. Further studies revealed that sulforaphane could prevent and reverse 
the activation of the Ah receptor by benzo[a]pyrene.
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1.1 Diet and Cancer
It was estimated that in Europe in 2008 there were 3.2 million new cases of cancer with 1.7 
million deaths. The most frequent cancers were colorectal, breast, lung and prostate; 
meanwhile the most common reasons of death from cancer were lung cancer, colorectal 
cancer, breast cancer and stomach cancer (Ferlay et al., 2010). Since some 90-95% of all 
cancer cases are caused by lifestyle factors such as diet, smoking habits, physical inactivity, 
alcohol, obesity and exposure to the sun, there is enormous potential for cancer prevention 
(Anand et al., 2008). To date, it was observed from the European Prospective Investigation 
into Cancer and Nutrition (EPIC) study that among the various lifestyle factors diet plays a 
critical role in cancer incidence, being one of the most important risk factors along with 
tobacco smoking (Gonzalez and Riboli, 2010). A relationship between diet and health 
attracted attention for centuries; but, an association between diet and cancer has been 
reported only in recent decades (DeMarini, 1998). The consumption of diet-containing 
mutagens and carcinogens, including polycyclic aromatic hydrocarbons (PAHs), 
heterocyclic amines (HAs), nitrosamines and mycotoxin (Ames, 1983; Ames et al., 1990; 
Rogers et al., 1993; Ames et al., 1995) is most closely correlated with increasing cancer risk. 
It was recently reported that, acrylamide, which is present in carbohydrate-rich foods, such 
as potatoes, when cooked at high temperatures, e.g. frying, is a potent carcinogen in humans 
indicating the importance of cooking in the generation of food carcinogens (Medeiros Vinci 
et al., 2 0 1 1 ).
fri contrast, epidemiological evidence strongly suggests that consumption of vegetables and 
fruit can decrease cancer incidence (Soerjomataram et al., 2010). A myriad of substances
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present in fruit and vegetables are believed to contribute to cancer prevention, including 
isothiocyanates, indole-3-carbinol, flavonoids, carotenoids, allium compounds, isoflavones, 
vitamin E and dietary fibre (Steinmetz and Potter, 1996). Among the various vegetables 
consumption of broccoli and other cruciferous vegetables is the most closely associated with 
reduced cancer risk such as colorectal, lung, prostate and breast (Voorrips et al., 2000; 
Seow et al., 2002; Lam et al., 2009; Traka and Mithen, 2008; Li et al., 2010). The protecting 
effect o f these vegetables against cancer risk has been attributed, at least partly, due to their 
comparatively high amounts of glucosinolates, which differentiate them from other 
vegetables. Glucosinolates, a class of sulphur-containing glycosides, present at substantial 
amounts in cruciferous vegetables and their breakdown products such as the isothiocyanates, 
are believed to be responsible for their health benefits (Latte et al., 2011). The underlying 
mechanisms responsible for the chemopreventive effect of these compounds are likely to be 
manifold, possibly coneeming very complex interactions, and thus difficult to fully 
understand (Myzak et al., 2004). Amongst isothiocyanates, phenethyl isothiocyanate and 
sulforaphane have attracted much interest ever since their outstanding ability to hamper 
carcinogenesis at various stages of the cancer process has been clearly shown in animal 
studies (Soit et al., 2003; Priya et al., 2011).
1.2 Carcinogenesis
Carcinogenesis is a multi-stage, multistep process of cancer development that involves 
several molecular and cellular occurrences, resulting in the transformation of a normal cell 
to a malignant neoplastie cell (Figure 1.1).
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Figure 1.1: Multi-stage carcinogenesis. Initiation stage involves DNA mutation that 
generates cell alteration followed by DNA synthesis to “fix” the genetic damage generated 
via the initiation stage. The promotion stage is exemplified by the clonal expansion of 
initiated cells by the stimulation of cell proliferation and/or prevention of apoptosis, causing 
development of a focal lesion. Progression stage is the last stage in the process of 
carcinogenesis, and is exemplified by accumulation of further genetic damage, brings about 
the transformation of cells from benign to maglignant, and is regarded as an irreversible 
process. Adapted from Klaunig and Kamendulis (2004).
The development of cancer is believed to occur in three steps, namely initiation, promotion 
and progression (Klaunig et al., 2011). In the initiation step, noiinal cells experience non­
repaired DNA damage and DNA synthesis to generate a mutated, initiated cell. The initiated 
cell is generated via interaction with endogenous and exogenous chemical carcinogens that 
have DNA mutagenic properties. The inactive parent carcinogenic chemicals may be 
metabolised in the organism to form reactive intermediates that bind to DNA triggering 
mutations, or generate free radical species that bring about damage to macromolecules 
leading to cancer development (loannides et al., 2010). Meanwhile, tumour promotion is the 
proliferation of the initiated cell to a focal lesion which is not a direct DNA-destructive
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process; however it involves regulation of gene expression that causes a rise in cell numbers 
via cell division and/or a reduction in apoptosis. Subsequent to cell proliferation, mutations 
may occur in the preneoplastic cells which then produce neoplasms. The final step, 
progression, involves further damage of the genome, and in contrast to the promotion step, it 
is an irreversible process (Klaunig and Kamendulis, 2004). Impairment of the carcinogenesis 
process at the early stage (initiation step) by increasing elimination of carcinogenic 
substances that lead to DNA damage is considered as a possible site of chemoprevention, 
and thus an essential attribute of chemopreventive agents.
1.2.1 Bioactivation o f  chemical carcinogens
The metabolism of xenobiotics is primarily known as biotransformation and occurs in 
diverse tissues, causing a transformation in the structure of the xenobiotic converting it fi*om 
lipophilic to hydrophilic, which facilitates its elimination through excretion (Plant, 2003). 
This process can be either beneficial or harmful, in the latter case producing metabolic 
intermediates that interact with DNA, resulting in DNA damage leading to cancer (Castell et 
al., 2005). The rate of deactivation and bioactivation reactions will determine, to a large 
extent, the toxicity and carcinogenicity of a compound (loannides and Lewis, 2004).
In theory, the potential carcinogenicity of such chemicals may be increased via stimulation 
of bioactivation pathways and/or decrease in detoxification potential. In contrast, anti- 
carcinogenic potential may be increased through enhancing detoxification and suppressing 
bioactivation. It is widely accepted that the stimulation of phase II enzymes is a signal of 
health benefit (van lersel et al., 1999). Enzymes involved in biotransformation can be
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divided into phase I and phase II. In phase I, a xenobiotic experiences a transition, via 
oxidation, reduction or hydrolysis, while in the phase II, either the xenobiotic or its reactive 
metabolites, form conjugates with endogenous substances, rendering them more hydrophilic 
and easily excretable in urine or faeces. For the phase I metabolism, the main reaction is 
oxidation, and is most frequently catalysed by cytochrome P450, whereas the phase II, may 
be classified into conjugations of electrophiles, catalysed by for example the glutathione S- 
transferases and epoxide hydrolase, and conjugations of nucleophiles, catalysed by 
sulphotransferases and glucuronyltransferases (Wolf, 1990; van lersel et al., 1999) (Table 
1.1).
Table 1.1: Phase I and Phase II enzymes involved in biotransformation system.
Phase Enzymes Type of reactions Reside in
1 Cytochrome P450s oxidation of earbon, nitrogen and sulphur atoms microsomes
Flavin-containing 
monooxygenase (FMO)
oxygenation of nucleophilic nitrogen, sulphur, 
phosphorus and selenium atoms
mierosomes
11 Quinone reductase reduction of quinones cytosol
Glutathione iS-transferase glutathione conjugation of electrophiles cytosol and microsomes
Epoxide hydrolase hydration of epoxides cytosol and microsomes
Glucuronyltransferases conjugation of glucuronic acid with -OH, -NH2 mierosomes
Sulphotransferase conjugation of SO3" to -OH, -NH2 cytosol
A-acetyltransferases acétylation of -NH2, -OH cytosol
Adapted from Wolf (1990); van lersel et al. (1999).
1.3 Glucosinolates and isothiocyanates
Cruciferous vegetables, including all types of cabbage, kale, broccoli, cauliflower, Brussels 
sprouts, kohlrabi, rapeseed, rutabaga and turnip, in which 15-20 glucosinolates have been 
discovered, are classified within the family of Cruciferae. Recently, studies focused on the 
chemopreventive effects of cruciferous vegetables which have been ascribed to their high
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levels o f glucosinolates (Figure 1.2) and their degradation products, such as isothiocyanates 
and indoles (Latte et a l, 2011). Around 120 different naturally-occurring glucosinolates 
have been recognised so far; however their content varies among different cruciferous 
vegetables (Fahey et a l, 2001). Common glucosinolates include glucoraphanin in broccoli, 
glucoerucin in rocket salad, glucoraphasatin in radish as well as gluconasturtiin in 
watercress (Table 1.2).
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Figure 1.2: Glucosinolate structure. The R group is an amino acid derivative, i.e. aliphatic 
(for example alkyl and alkenyl), aromatic (for example benzyl and phenyl) or heterocyclic 
(for example indolyl) compounds (Holst and Williamson, 2004).
Table 1.2: Glucosinolates and isothiocyanates in cruciferous vegetables.
Typical name Scientific name Glucosinolates Isothiocyanates
Rocket salad Eruca sativa Glucoerucin Erucin
Broccoli Brassica oleracea Glucoraphanin Sulforaphane
Cabbage Brassica oleracea Sinigrin Allyl isothiocyanate
Radish Raphanus sativus Glucoraphasatin Sulforaphene
Watercress Nasturtium-aquaticum Gluconasturtiin Phenethyl isothiocyanate
Horseradish Armoracia rusticana Sinigrin Allyl isothiocyanate
Adapted from Kristal and Lampe (2002); Barillari et al., (2007).
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When cruciferous vegetables are disturbed, for example during chopping or chewing, the 
enzyme myrosinase (p-thioglucosidase glucohydrolase, EC 3.2.3.1) comes into contact with 
the glucosinolate leading to the formation of the isothiocyanate (Figure 1.3); furthermore, 
intestinal microbial myrosinase can contribute to the generation of isothiocyanates from 
their glucosinolate precursors (Getahun and Chung, 1999; Brown and Hampton, 2011).
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Figure 1.3: Formation of isothiocyanates from glucosinolates. Myrosinase ruptures the p- 
thioglucoside bond of the glucosinolate molecule to generate a highly unstable agylcone 
intermediate, followed by non-enzymic intramolecular (Lossen) rearrangement to form 
isothiocyanate, nitriles, or thiocyanates, depending on the structure of the aglycone, 
temperature and pH. Adapted from Getahun and Chung (1999); Brown and Hampton 
(2011).
1.4 Human dietary exposure to glucosinolates
Eating cruciferous vegetables fully accounts for human dietary exposure to glucosinolates 
(McGregor et al., 1983). The average intake of glucosinolates is difficult to ascertain 
because of the variation in plants from diverse cultivars of cruciferous vegetables 
(Steinbrecher et al., 2009). The consumption of cruciferous vegetables varies between 
populations. In UK, it was estimated that the average daily intake of total glucosinolates was 
14 mg/person/day for a 70 kg individual or 0.2 mg/kg/day (Sones et al., 1984), in contrast to 
US and Canada, where the average intake was lower (Krul et al., 2002), bearing in mind that 
some people dislike Brassica vegetables whereas others consume large amounts (Holst and
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Williamson, 2004). As isothiocyanates are most important due to their chemoprevention 
potential, appreciation of daily intake is valuable for assessing their chemopreventive 
activity according to dietary guidelines which so far have not been defined.
1.4.1 Absorption and metabolism o f  isothiocyanates
In the gastrointestinal tract, isothiocyanates, derived from either plant or bacterial-mediated 
hydrolysis of glucosinolates, are absorbed via passive diffusion into the epithelial cells of 
either small or large intestine, and subsequently metabolised primarily by conjugation with 
glutathione (Figure 1.4), followed by transport of the conjugate to the systemic circulation 
through transporters such as the multidrug resistance associated protein-1 (MDR-1) (Zhang 
and Callaway, 2002).
The conjugation rate with glutathione and subsequent interaction with transporters depends 
on the isothiocyanate structure (Tseng et al., 2002). This conjugate is then metabolised 
through the mercapfuric acid pathway, where it undergoes additional enzymic changes 
including cleavage of glutamine, generating the cysteine-glycine conjugate, cleavage of 
glycine, producing the cysteine-conjugate, and lastly W-acetylation of cysteine to generate 
the A-acetylcysteine (NAC)-conjugate which is secreted into urine or bile (Brusewitz et al., 
1977). In an intervention study which utilised broccoli, it was observed that in the plasma 
45% of consumed sulforaphane occurs as the free isothiocyanate rather than the thiol 
conjugate (Gasper et al., 2005). It was contemplated that the isothiocyanate-glutathione 
conjugate more likely dissociates either in the plasma, or is possibly cleaved enzymically by
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the glutathione S-transferases (Meyer et ah, 1995; Thornalley, 2002) to liberate the free and 
biologically active isothiocyanate.
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Figure 1.4: Absorption and metabolism of isothiocyanates. Glucosinolates are transformed 
into the corresponding isothiocyanates, for example sulforaphane, through plant or bacterial 
myrosinase in the human intestine. Isothiocyanates are absorbed across the intestinal cells’ 
membranes via passive diffusion and directly form conjugates with glutathione. This conjugate 
is exported into the systemic circulation and subsequently metabolically proceeds to the 
mercapturic acid metabolism resulting in urinary excretion; or alternatively it disassociates to 
liberate biologically active isothiocyanates, probably mediated by glutathione ^'-transferases. 
The free isothiocyanate possibly stimulates biological action to prevent carcinogenesis. Adapted 
from Traka and Mithen (2009).
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1.5 Epidemiological studies on glucosinolate intake and cancer risk
Numerous epidemiological and experimental studies propose that genetic polymorphisms 
may affect the chemopreventive activity of isothiocyanates. Polymorphisms in the GSTMl 
and GSTTl genes predominantly bring about a decrease in transcription leading to a decline 
of the glutathione ^'-transferases (GSTs) which is active in the metabolism of 
isothiocyanates. Subsequently the isothiocyanates are not eliminated and reside in the body 
for a longer time resulting into a higher exposure of the tissues (Higdon et ah, 2007). 
Epidemiological studies that looked at the GST genotype, demonstrated that GSTMl and/or 
GSTTl-null individuals had a lower risk of lung cancer than the wild-type when consuming 
isothiocyanates (Zhang, 2004).
It was reported that consumption of cruciferous vegetables led to a reduced risk of lung 
cancer among Chinese women. Weekly consumption of more than 53.0 pmol 
isothiocyanates caused a significant decrease in the risk of lung cancer as evaluated by 
GSTMl and GSTTl polymorphisms among 420 smoking and non-smoking subjects (Zhao 
et al., 2001). Similarly, a study was carried out in 63,257 middle-aged subjects with 
colorectal cancer in which cancer occurrence between subjects having both GSTMl and T1 
null genotypes and consuming high and low levels isothiocyanates was evaluated. There was 
a 57% decrease in colorectal cancer incidence in high isothiocyanate-consuming individuals 
(Seow et ah, 2002). Epidemiological data from a population-based study established a 
reverse association in the consumption of cruciferous vegetables and prevalence of lung 
cancer in a mixed population (Le Marchand et al., 1989). Furthermore, in a subsequent study 
in Iowa women showed that high consumption of broccoli caused an odds ratio of 0.72,
11
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implying health benefit of biologically active molecules in lung cancer prevention 
(Steinmetz et ah, 1993). Prospective studies performed in 29,361 subjects (1338 were 
positive for prostate cancer) suggested that only cruciferous vegetables are competent in 
preventing prostate cancer and its symptoms in contrast to other finits and vegetables. 
Among cruciferous vegetables, broccoli and cauliflower were reported to be more efficient 
with relative risk of 0.55 and 0.48 between >1 serving/week and <1 serving/month, 
respectively (Kirsh et ah, 2007). Comparison of numerous studies relating to cruciferous 
vegetables consumption showed that high intake of these vegetables resulted in 2 2 % lower 
occurrence of lung cancer as detected in a case-control study, and in cohort studies 17% 
lower in contrast to those with lowest intake. Subjects with GSTMl and GSTTl double null 
genotypes showed a very marked inverse relationship between consumption of these 
vegetables with lung cancer incidence (Lam et ah, 2009; Manchali et ah, 2011).
Numerous laboratory studies in animal models support the epidemiological evidence. It was 
revealed that isothiocyanates decreased the incidence and development o f cancer in animal 
models following exposure to chemical carcinogens. Chemopreventive potential of 
isothiocyanates was apparent in animals exposed to the tobacco carcinogens 
4-methylnitrosamino-1 -butanone (NNK) and N-nitrosomethylbenzylamine (NMBA). In 
particular, phenethyl isothiocyanate prevented tumour development in the lung of A/J mice 
exposed to NNK (Zhang, 2004). In addition, this isothiocyanate diminished the generation 
of DNA adducts in the colon, liver and prostate of rats exposed with PhIP, a food carcinogen 
(Dingley et ah, 2003). It was reported that sulforaphane prevented the development of breast 
tumours when rats were exposed to 7,12-dimethylbenz(a)anthracene (DMBA) (Talaley and
1 2
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Fahey, 2001). Meanwhile, in the Ames test, sulforaphane appears to inhibit the metabolic 
conversion of the heterocyclic amine 2-amino-3-methylimidazo[4,5-/]quinoline (IQ) to 
genotoxic reactive intermediates (Yoxall et ah, 2005).
1.6 Cancer prevention by glucosinolates and isothiocyanates: possible mechanisms
Epidemiological studies indicate that consumption of cruciferous vegetables decreases the 
cancer incidence being in line with anti-mutagenic data (Latte et ah, 2011). Dietary 
carcinogens such as polycyclic aromatic hydrocarbons, heterocyclic amines and 
nitrosamines rely on metabolic bioactivation to generate intermediates capable of causing 
DNA damage and possibly cancer. Metabolic bioactivation is attained via Phase I enzymes 
such as cytochromes P450 (Steinkellner et ah, 2001). Interaction of DNA with the 
electrophilic metabolites of carcinogens or mutagens leads to the genetic modification, and 
subsequently preneoplastic and neoplastic cells are formed followed by métastasés (Murillo 
and Mehta, 2001). The reactive intermediates also will bind to other macro components such 
as protein resulting in the generation of free radical species leading to the initiation of 
carcinogenesis (loannides et ah, 2010). Modulation of the metabolism of mutagens and 
carcinogens involving phase I and phase II enzymes may preclude the generation of 
electrophilic intermediates. Phase I enzymes, such as the CYPl family, catalyse the 
bioactivation of carcinogens, predominantly polycyclic aromatic hydrocarbons and 
heterocyclic amines (Vistisen et ah, 1992; Nugon-Baudon and Rabot, 1994). In animal 
studies, down-regulation of cytochrome P450 enzymes engaged in the bioactivation of 
carcinogens inhibited carcinogenesis (Higdon et ah, 2007). Meanwhile, phase II enzyme 
systems, such as glutathione ^-transferase and UDP-glucuronyltransferase, bring about the
13
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detoxification of reactive intennediates by creating conjugates (Pool-Zobel et al., 2005; Van 
Poppel, 1999) resulting into their removal prior to eliciting their detrimental effects 
(loannides et ah, 2010) (Figure 1.5). Lastly, isothiocyanates, the breakdown product of 
glucosinolates, also react with efflux transporters such as ATP-binding cassette (ABC), 
hence affecting the pharmacokinetic behavior of other chemicals (discussed below).
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Figure 1.5: Isothiocyanates intervention in the bioactivation and deactivation pathways 
of chemical carcinogen. Adapted from loannides et ah (2010).
Isothiocyanates and indoles, the breakdown products of glucosinolates, are capable of 
modulating the activities of enzymes involved in the biotransformation of xenobiotics via 
induction (Zhang, 2004). Monofunctional inducers such as isothiocyanates may influence
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phase I enzymes, but generally stimulate phase II enzymes and react with the antioxidant 
response element (ARE), which is known as an electrophilic response element. In contrast, 
bifunctional inducers such as indoles influence both phase I and phase II enzyme activities. 
A number of indoles, such as indole-3-carbinol (13C) and 5,ll-dihydroindolo[3,2-b]- 
carbazole (ICZ) react with the aryl hydrocarbon receptor (AhR) and activate the xenobiotic 
response element (XRE), also referred to a aryl hydrocarbon response element (Steinkellner 
et ah, 2001; Bonnesen et al., 2001; Latte et al., 2011) resulting in the rise of specific phase I 
and II enzymes activities. The basic mechanisms underpinning the chemopreventive effect 
of isothiocyanates seem to encompass modulation of various pathways that regulate 
development of cancer. The pathways may involve: (i) defence against exogenous factors 
via targeting metabolism of xenobiotics, (ii) enhancement of the antioxidant capability, and 
(iii) targeting growth of tumour cells (Traka and Mithen, 2009).
1.6.1 Modulation o f  enzyme activities by glucosinolates and isothiocyanates
1.6.1.1 Effect o f  glucosinolates and isothiocyanates on phase I  enzymes
The first in vivo studies showed that cytochrome P450 activities in the liver were elevated in 
dose-dependent manner following exposure of rats to broccoli (Aspry and Bjeldanes, 1983). 
In rodents, studies demonstrated that consumption of broccoli for few days tended to 
enhance rat CY PlA l, 1A2, 2B1/2 and 2E1 apoprotein levels, whereas CYP2C1 was not 
influenced. The elevation of CYPlA l, 1A2, 2B1/2, 2E1 and 3A1/2 activities was also 
observed in the liver of rats while CYPlAl and 2B1/2 were up-regulated in the colon to a 
lesser extent as compared to the liver (Vang et ah, 2001a; 2001b). Cytochrome P450 levels 
in the colon of rats are much lower than in liver, indicating that in rodents, the protecting
15
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effect of broccoli on chemically-mediated tumours is more likely due to the broccoli- 
mediated changes in CYPl A and CYP2B activities (Vang et ah, 1991; Latte et ah, 2011).
Studies conducted in humans fed fresh broccoli demonstrated that CYP1A2 and CYP2E1 
were also stimulated (Kail et ah, 1997; Vistisen et ah, 1992). Regulation of cytochrome 
P450 activities depends on the amount of broccoli consumed, thus also contributing to 
individual-variation in biological response to broccoli consumption (Vang et ah, 2001a). 
Stimulation of CYPIA enzymes by cruciferous vegetables is primarily associated with the 
amount of glucosinolates consumed (Vang et al., 2001a). In an in vitro study involving 
several indole glucosinolate-hydrolysed products, such as 3,3-diindolylmethan (DIM), 
indole-3-carbinol (13C) and 5,ll-dihydroindolo-[3,2-b]carbazole (ICZ), in human colon 
adenocarcinoma cell lines, a rise in CYPlA l activity was observed, while no similar effect 
was evident in the case of sulforaphane or phenethyl isothiocyanate (Bonnesen et al., 2001). 
Similarly in rats, broccoli extracts elevated CYPIA activity, but not sulforaphane alone 
(Keck et ah, 2003), comparable with other in vivo studies where sulphoraphane administered 
at dietary doses did not influence CYPIA or CYP2B activities in rat liver or lung (Hanlon et 
ah, 2008a; Yoxall et ah, 2005). Both erucin and sulforaphane enhanced CYPIA apoprotein 
levels however; the lack of change in activity was attributed to mechanism-based inhibition. 
Experimental studies conducted in both rat and human precision-cut liver slices confirmed 
the in vivo observations in which these isothiocyanates elevated CYPIA apoprotein 
expression but not the activity (Hanlon et ah, 2008a), indicating that the chemopreventive 
effects of these two aliphatic isothiocyanates does not involve modulation of CYP enzymes. 
In contrast, phenethyl isothiocyanate, an isothiocyanate with aromatic side-chain, decreased
16
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CYP1A2 activity in the rat liver following exposure at dietary doses (Konsue and loannides, 
2010a). It appears that the increase in CYPl seen with broccoli does not involve 
isothiocyanates but indole glucosinolates which are effective inducers of this enzyme 
(Staack et ah, 1998; Bonnesen et ah, 1999; Latte et ah, 2011). It has been reported that I3C 
and ICZ, the hydrolysed-products of glucobrassicin, activated the aryl hydrocarbon receptor 
resulting in the stimulation of CYP1A1/A2 gene expression in vitro and in vivo (Liu et ah, 
1994).
On the other hand, sulforaphane suppressed CYP2E1 and CYP1A2 competitively in 
microsomal preparations of rat liver and in human liver cells (T5-2E1-expressing human 
CYP2E1 and T5-lA2-expressing human CYP1A2) in vitro (Barcelo et ah, 1996; 1998). In 
human hepatocytes, CYP1A2 roRNA expression was not influenced by sulforaphane, while 
CYPIA and 2B1/2 activities were impaired dose-dependently in rat hepatocytes. 
Nevertheless, sulforaphane diminished the expression of CYP3A4 mRNA (Mahéo et ah, 
1997) and, in addition, of CYPlAl and CYP1A2 activities following induction of these 
enzymes in Mcf7 cells, but not HepG2 cells, with benzo(a)pyrene (Skupinska et ah, 2009).
1.6.1.2 Effect o f  glucosinolates and isothiocyanates on phase II  enzymes 
Stimulation of phase II enzymes such as glutathione iS-transferase and quinone reductase is 
dependent on the intracellular concentration or bioavailability of individual isothiocyanates, 
while the intracellular concentration of isothiocyanate is in turn dependent on the 
temperature, the isothiocyanate structure, as well as the concentration of glutathione (Zhang 
and Talalay, 1998). Thus, accumulation of the intracellular glucosinolate-hydrolysed
17
Chapter 1: Introduction
products determines their potential in stimulating cellular detoxification (Ye and Zhang, 
2001; Latte et ah, 2011).
Glutathione 5-transferase (GST), a superfamily of phase II enzymes that are classified into 
diverse subclasses, where GSTAl, GSTMl, GSTTl and GSTPl are the most important 
enzymes in humans. This enzyme plays a vital function in xenobiotic metabolism, including 
carcinogens and isothiocyanates (Lam et ah, 2009; Latte et ah, 2011). Numerous genetic 
variants of each glutathione 5-transferase have been identified ranging from GST-present to 
GST-null genotypes. The GST genotype has repeatedly been explored in studies 
investigating dietary consumption of isothiocyanates and cancer risk (Lam et ah, 2009). Due 
to the activated carcinogens not being disposed by GST, the GST-null genotypes are at high 
risk of cancer. In contrast, because of the fact that isothiocyanates are metabolised by GST, 
they may circulate in human body of GST-null genotypes for a longer period leading to a 
more potent chemoprotective effect (Porrini, 2008). Isothiocyanates are recognised as 
inducers as well as substrates of GST (Spitz et ah, 2000; Latte et ah, 2011).
Stimulation of GST isoenzymes is related to the antioxidant-responsive element (ARE) and 
the transcription factor, nuclear factor-erythroid 2 p45-related factor 2 (Nrf2), which bind to 
the Kelch-like ECH associated protein (Keapl) in the cytoplasm (Figure 1.6). Such inducers 
disturb the Nrf2-Keapl complex, resulting in Nrf2 migration to the nucleus and increased 
phase II enzyme expression through interaction with ARE (Talalay, 2005; Lii et ah, 2010).
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Figure 1.6: Phase II gene regulation by Nrf2-Keapl complex. An inducer will bind to 
Nrf2-Keapl complex to release Nrf2 that translocates to the nucleus and interacts with ARE 
to elevate the expression of phase II enzymes. Adapted from Talalay (2005).
Sulphotransferases are phase II enzymes that are engaged in the bioactivation of 
carcinogens, such as 2-amino-l-methyl-6 -phenylimidazo [4,5-b]pyridine (PhIP), which is 
generated in cooked meat. Inhibition of this enzyme by glucosinolate-derived compounds 
was attained with Brussels sprouts in peripheral human lymphocytes, indicating that down- 
regulation of sulphotransferases may be also responsible for the protection from DNA 
damage caused by aromatic amine (Hoelzl et al., 2008).
Sulforaphane and erucin stimulated quinone reductase activity in the liver and lung of rats, 
whereas GST activity was not affected by these two aliphatic isothiocyanates (Hanlon et al.,
2008). In precision cut-lung slices, however; these isothiocyanates induced quinone 
reductase and GST activities as well as elevated glutathione levels (Hanlon et ah, 2009).
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Phenethyl isothiocyanate, at dietary doses of exposure, up-regulated quinone reductase and 
GST activities in rats (Konsue and loannides, 2008); in precision-cut rat liver slices it 
stimulated of quinone reductase and GST activities as well as protein levels (Konsue and 
loannides, 2010b). Recently it was reported that, sulforaphane significantly enhanced 
quinone reductase also in HepG2 cells, whereas glucoraphanin was inactive (Haack et al., 
2010). Similarly, myrosinase-hydrolysed products of neoglucobrassicin significantly 
decreased quinone reductase activity. Simultaneous exposure to glucoraphanin and 
neoglucobrassicin in the presence of myrosinase caused a significant decrease in quinone 
reductase activity (Haack et al., 2010). In rats, administration of broccoli rich in intact 
glucosinolates and myrosinase displayed more potent inducibility of quinone reductase in 
comparison with broccoli hydrolysed prior to administration (Keck et ah, 2003).
1.6.1.3 Effect o f  isothiocyanates on phase III transporters
ATP-derived energy is used by ATP binding cassette (ABC) transporters to carry molecules 
across a concentration gradient via cellullar membranes (Latte et al., 2011). Several 
isothiocyanates were tested with respect to their ability to interact with ABC transporters 
consisting of multidrug resistance protein 1 (MRPl), multidrug resistance protein 2 (MRP2), 
P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). Among these 
transporters, MRPl and MRP2 have comparable substrate specificity, carrying negatively 
charged compounds for example glutathione, glucuronide as well as sulphate conjugates of 
many compounds such as the glutathione conjugates of isothiocyanates (Telang and Morris, 
2009). Intracellular accumulation of sulforaphane was elevated by MRPl and P-gp 
inhibitors in overexpressing cell lines, indicating that sulforaphane on its own or its
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glutathione conjugate are substrates for these transporters. Furthermore, it has been reported 
that isothiocyanates enhanced the accumulation of P-gp and MRPl substrates in cells 
overexpressing these transporters. For instance, the concurrent exposure of cytostatics drug 
such as daunomycin and vinblastine, as well as synthetic isothiocyanates caused a rise in the 
cellular accumulation of these drugs (Telang and Morris, 2009). Finally, transcellular 
transport studies showed that reduction of intracellular levels of GSH decreased the mean 
ratio o f basal-to-apical transport to apical-to-basal transport of phenethyl isothiocyanate in 
the kidney epithelial MDCKII/MRP2 cells (transfected with human MRP2), indicating that 
the interaction between MRP2 transporter and phenethyl isothiocyanate is dependent on the 
intracellular levels of GSH (Ji and Morris, 2005).
1.6.2 Protection against oxidative stress
Oxidative stress occurs when there is an imbalance of cellular formation and elimination of 
reactive oxygen species (ROS). It is believed that this species may trigger the pathogenesis 
of several diseases, such as cancer, cardiovascular disease and diabetes. Defence against 
ROS can be direct via scavenging or by elevating protective mechanisms, which 
consequently increase protection from ROS. Isothiocyanates may enhance antioxidant 
capacity of animal cells through stimulation of phase II detoxifying enzyme activity as 
aforementioned (section 1.6.1.2) or through elevation of glutathione levels (Traka and 
Mithen, 2009). Glutathione is an essential tripeptide that helps to maintain the redox balance 
within cells and to protect them from the damaging effects of reactive oxygen species. 
Feeding of male F344 rats with phenethyl isothiocyanate for a week resulted in a 1.6-fold 
rise in hepatic glutathione content (Staack et al., 1998), and sulforaphane elevated GSH
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levels in human HepG2 cells by 4.3-fold (Ye and Zhang, 2001). Administration of Brussels 
sprouts to humans decreased the rate of oxidative damage, as detected by quantifying the 
levels o f 8-oxo-7,8-dihydro-2'-deoxyguanosine (8 -oxodG) secreted in the human urine as a 
result o f the DNA repair process impaired by ROS (Verhagen et ah, 1995). Moreover, 
methylthioalkyl-isothiocyanates e.g. raphasatin, suppressed free radical levels like 
superoxide in a number of studies (reviewed by Valgimigli and lori, 2009).
In spite of the strong proof that isothiocyanates induce cellular antioxidant proteins that 
defend the cells from chemical carcinogens, there is evidence that isothiocyanates also 
stimulate cellular stress (Traka and Mithen, 2009); for example sulforaphane is able to 
generate oxidative stress by stimulating phase I enzymes (Paolini et ah, 2004). Following 
diffusion into the cells, isothiocyanates conjugate directly with intracellular GSH followed 
by a rapid decrease in the cellular glutathione concentration (Zhang and Callaway, 2002). 
Early depletion in GSH levels is probably recognised by the cell as critical stress, and as a 
response elevates GSH levels. Thus numerous isothiocyanates stimulate the glutamate- 
cysteine ligase (GCL), the rate limiting enzyme in glutathione biosynthesis (Traka et ah, 
2005; Traka and Mithen, 2009), which is controlled transcriptionally via Nrf2 over ARE 
elements, in order to eliminate reactive species (Dickinson et al., 2004). Rise in glutathione 
levels, associated with elevated intracellular levels of isothiocyanates, is of benefit to the cell 
by elevating its antioxidant protections.
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1.6.3 Tumourgrowth inhibition
Isothiocyanates may also regulate cell growth, which is very important in chemoprevention, 
when uncontrolled cell proliferation may possibly tend to atypical growth and consequently 
lead to malignancy transformation. The mechanisms of isothiocyanates as cytostatic and 
cytotoxic agents comprise: induction of apoptosis, inhibition of cell-cycle progression and 
inhibition of angiogenesis (Traka and Mithen, 2009).
1.6.3.1 Induction o f apoptosis
Apoptosis, or programmed cell death, is a controlled phenomenon that occurs in a range of 
pathophysiological situations. Apoptosis performs vital functions in the expansion and 
preservation of homeostasis as well as in the removal of damaged cells that are no longer 
essential for the organism (Traka and Mithen, 2009). Isothiocyanates regulate apoptosis 
generally via mitochondrial liberation of cytochrome c, MAPK signalling, Bcl-2 family 
regulation and activation of caspases, a family of cysteine proteases active in the stimulation 
and implementation of apoptosis (Traka and Mithen, 2009).
Phenethyl isothiocyanate stimulated apoptosis through p53-dependent and independent 
pathways in mouse epidermal and human prostate cancer cells respectively (Huang et ah, 
1998; Xiao and Singh, 2002). In HT29 colon cells, this was related to the initiation of three 
signalling kinases namely, c-Jun N-terminal kinases (INK), extracellular signal-regulated 
protein kinase (ERK) and p38 kinase, resulting in the release of cytochrome c from 
mitochondria and caspase-3 activation (Hu et al. 2003; Traka and Mithen, 2009). Similarly, 
phenethyl isothiocyanate stimulated apoptosis in human prostate cancer PC-3 cells, which
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was associated with the formation of ROS (Xiao et a l, 2006). Allyl- and benzyl- 
isothiocyanates, both effective in stimulating apoptosis, initiated JNK and suppressed anti- 
apoptotic proteins such as Bcl-2 and Bcl-XL in human prostate, colon and leukaemia cancer 
cells (Xiao et a l, 2003). Sulforaphane also stimulated apoptosis in a series of cell lines such 
as colon, prostate, leukaemia and medulloblastoma cells (Gamet-Payrastre et a l, 2000; 
Bonnesen et a l, 2001; Chiao et a l, 2002; Fimognari et a l, 2002; Gingras et a l , 2004; Singh 
et a l, 2004). In a study comparing the effects of various isothiocyanates, exposure of human 
bladder cancer cells to benzyl- and phenethyl isothiocyanates resulted in significant loss of 
mitochondrial potential, albeit only at high concentrations, in comparison to allyl 
isothiocyanate and sulforaphane, which showed no effect (Tang and Zhang, 2005). Similar 
mechanisms were also observed in in vivo models, where isothiocyanates or their iV-acetyl 
cysteine (NAC) conjugates decreased growth of cancer cell xenograft and inhibited 
tumourigenesis after administration of a carcinogen, which was linked to enhanced 
apoptosis (Khor et a l, 2006; 2007).
1.6.3.2 Inhibition o f cell cycle
The capability of isothiocyanates to control cell cycle and impede cell proliferation 
contribute to their chemoprotective ability, and is facilitated by indirectly modulating 
cyclins, proteins liable for cell cycle progression, cyclin-dependent kinase (CDK) molecules 
and their inhibitors. Cell cycle at the G2 phase of Caco-2 colon cells was arrested by 
phenethyl- and benzyl isothiocyanates via stimulation of the expression of the CDK 
inhibitor (Visanji et ah, 2004). In human pancreatic cancer cells, benzyl
isothiocyanate-induced G2/M arrest and was linked with the initiation of checkpoint kinase
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2, while the expressions of other G2/M modulatory proteins, such as CyclinBl, Cdc2, as 
well as cell division cycle 25C (Cdc25C) were inhibited (Zhang et ah, 2006; Traka and 
Mithen, 2009). Cyclin-dependent kinase 1 (Cdkl) and Cdc25C protein levels in PC-3 
prostate cells were also decreased by phenethyl isothiocyanate (Xiao et ah, 2004). 
Moreover, allyl isothiocyanate treatment caused an accumulation of prostate cancer cells in 
the G2/M phase through down-regulation of the Cdkl, Cdc25B and Cdc25C proteins (Tang 
et ah, 2006; Traka and Mithen, 2009). Meanwhile, sulforaphane has been demonstrated to 
inhibit the cell cycle in all phases i.e. Gi, G2/M and S phase. Exposure to sulforaphane 
resulted in the accumulation of prostate cancer cells in the Gi phase, through decreasing 
phosphorylation/initiation of cdk4 as well as elevating simultaneously, and
reducing protein levels of cyclin D1 (Chiao et ah, 2002; Wang et ah, 2004a), resulting in a 
decrease of retinoblastoma tumour suppressor protein (Rb) phosphorylation that initiates the 
transformation from Gi to S phase. In PC-3 prostate cells, exposure to sulforaphane 
stimulated the checkpoint kinase 2 (Chk2) and Cdc25C phosphorylation, resulting in the 
suppression of G2/M phase (Singh et ah, 2004b). Similarly, the suppression of G2/M phase 
in colon cancer cells was related to a rise in protein levels of cyclin B 1 and 
(Gamet-Payrastre et ah, 2000; Pamaud et ah, 2004; Traka and Mithen, 2009). Recently, it 
was reported that sulforaphane suppressed the growth of human oral carcinoma cell lines as 
well as the movement and intrusion of the YDIOB oral carcinoma cell line (Jee et ah, 2011).
Remarkably, it appears that the NAC conjugates of isothiocyanates are also effective in 
stimulating cell cycle arrest through similar mechanisms. Supplementation of diet with 
phenethyl isothiocyanate-NAC in immunodeficiency mice xenografted with tumours of
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human prostate cancer PC-3 cells led to induction of the cell cycle inhibitors and
p27^^P\ and a decline in cyclins D and E expression (Chiao et ah, 2004; Traka and Mithen, 
2009). The stimulation of by isothiocyanates was the consequence of reduced
histone deacetylase (HDAC) activity and subsequent rise in the binding of acetylated histone 
H4 with the gene promoter (Myzak et ah, 2004; 2006; Traka and Mithen, 2009). Moreover, 
epigenetic modifications were also detected in response to phenethyl isothiocyanate 
exposure, which retriggered the méthylation of GSTti, a tumour suppressor gene in prostate 
cancer cells, through inhibition of HD AC and déméthylation of the GSTtt promoter (Wang 
et ah, 2007).
Moreover, in monitoring proteins involved in cell cycle progression, isothiocyanates may 
possibly disturb microtubule structure through preventing tubulin polymerisation. This 
appeared after exposure of human colon cells to allyl isothiocyanate (Smith et ah, 2004) as 
well as sulforaphane in mouse mammary carcinoma cells, bovine endothelial cells and 
human breast adenocarcinoma Mcf7 cells (Jackson and Singletary, 2004a; 2004b; Jackson et 
ah, 2006), in which the prevention of tubulin polymerisation was established by 
sulforaphane. Erucin, an aliphatic isothiocyanate recently displayed anti-proliferative effects 
via induction of the p53 and p21 proteins in human lung carcinoma A549 cells (Melchini et 
ah, 2009).
1.6.3.3 Angiogenesis inhibition
Angiogenesis performs a vital function in preserving tumour growth and increasing tumour 
size. Inability to develop new blood vessels to sustain the growth of intra-tumoural capillary
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linkages, the tumour development growth is restricted to 0.5 mm in diameter, the maximum 
tumour thickness in which oxygen and nutrients can diffuse (Juge et a l, 2007). 
Isothiocyanates at concentrations in pM have potential in inhibiting angiogenesis in in vitro 
and in vivo models. Employing human umbilical vein endothelial cells (HUVECs) as a 
model for angiogenesis, sulforaphane caused a dose-dependent reduction in cell proliferation 
(Asakage et al., 2006). Phenethyl isothiocyanate interfered with the development and 
movement of HUVECs capillary-like tube structures leading to the inhibition of vascular 
endothelial growth factor (VEGF) expression and excretion, suppression of VEGF receptor 
2 protein levels, as well as non-activation of Akt (Xu et al., 2005; Bertl et al., 2006; Xiao 
and Singh, 2007; Traka and Mithen, 2009).
1.7 The aryl hydrocarbon receptor: relevance to chemical carcinogenesis
The aryl hydrocarbon (Ah) receptor is a ligand-dependent transcription factor which is 
abundantly expressed in mammalian tissues and plays a vital role to the metabolism of 
xenobiotics. High affinity ligands, for example PAHs, halogenated aromatic hydrocarbons 
(HAH), as well as polychlorinated dibenzofurans and dibenzo-p-dioxins, particularly the 
toxin 2,3,7,8 -tetrachlorodibenzo-p-dioxin (TODD), compete for binding to the Ah receptor 
site. The Ah receptor is considered as an orphan receptor since no endogenous ligand has 
firmly been identified. Up to now, the very toxic dibenzo-p-dioxin TCDD is the most avid 
ligand of this receptor known (Bock and Kohle, 2009).
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1.7.1 Ah receptor pathway
Ah receptor and its related proteins are members of a small family identified as a basic 
helix-loop-helix transcription factors. It resides in the cytosol, adjacent to the plasma 
membranes, where in the absence of ligand, the Ah receptor appears as a multi-protein 
complex associated with two 90 kDa heat shock proteins (HSP90) that prevent dimérisation 
with the Ah receptor nuclear translocator protein (ARNT), the X-associated protein 2 
(XAP2), which is important for HSP90 and Ah receptor binding, as well as 23 kDa co­
chaperone protein, p23 (Denison et al., 2002; Petrulis and Perdew, 2002; Denison and Nagy, 
2003). When the ligand binds to the receptor, HSP90 and related proteins disassociate from 
Ah receptor, and the Ah receptor translocates into the nucleus (Barouki et al., 2007).
Following ligand binding, the Ah receptor may experience a modification in the 
conformation, revealing nuclear localisation sequence(s), stimulating nuclear translocation 
of the multi-protein complex, which then detaches from the HSP90, XAP2 and p23 protein 
complex upon interaction with ARNT (Denison et al., 2002; Petmlis and Perdew, 2002; 
Denison and Nagy, 2003). Nonetheless, following several extensive studies, debate on 
whether dissociation of the Ah receptor from the protein complex takes place either in the 
cytosol or nucleus still remains controversial (Petmlis and Perdew, 2002). So far, the 
common observation is that, when in the nucleus, the liganded Ah receptor disassociates 
from the protein complex and then binds to ARNT, creating the heterodimer transformed Ah 
receptor complex (AhRC). In this DNA-binding form, the complex binds to xenobiotic 
responsive elements (XRE) of particular target genes, where it activates the transcription of 
CYPlAl and other target genes (Figure 1.7). The liganded receptors which failed to
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dimerise with ARNT, are secreted out into the cytosol through a nuclear export pump 
(Denison et ah, 2002; Denison and Nagy, 2003).
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Figure 1.7: Activation of target gene expression by the Ah receptor. AhR, Ah receptor; 
ARNT, Ah receptor nuclear translocator protein; CY PlA l, cytochrome P450 isoenzyme 
lA l; hsp90, 90 kDa heat shock proteins; mRNA, messenger ribonucleic acid; XAP2, X- 
associated protein 2, XRE, xenobiotic response elements. Adapted from Denison and Nagy 
(2003).
Furthermore, the liganded Ah receptor complex regulates the expression of diverse genes, 
exhibiting pleiotropic biological effects; the binding of TCDD to the Ah receptor mediates
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its hepatotoxic effects as a result of immunotoxicity, porphyria, developmental and 
reproductive toxicity, as well as a number of genes encompassed in cell differentiation and 
proliferation (Table 1.3) (Hankinson, 1995; Sogawa and Fujii-Kuriyama, 1997; Safe, 2001). 
Thus, the Ah receptor seems to act as an environmental sensor at the cellular level, 
committing exposed cells to toxicants to cell cycle arrest before DNA replication. For 
example, the Ah receptor is apparently a potent inhibitor of cell cycle progression through 
formation of protein complexes with the retinoblastoma protein, which is capable of 
inhibiting Gi phase of cell cycle progression, and leading to cellular apoptosis (Elferink et 
al., 2001; Puga et al., 2002).
Table 1.3: Regulation of genes by the Ah receptor.
Gene Function
CYPlAl
CYP1A2
CYPIBI Phase I drug metabolising enzymes
NQOl
GSTa Phase II detoxifying enzymes: NADP(H) oxidoreductase, GST & UGT
UGT 1*06
PAI-2
IL-ip
TGFa Proteins involved in the regulation o f cells proliferation and
TGFp differentiation
c-fos
c-jun
Jun-B
Jun-D
IL-ip, interleukin-Ip; PAI-2, plasminogen activator inhibitor-2; TGF, transforming growth
factor.
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1.7.2 Genetic variation in the Ah receptor
The aryl hydrocarbon receptor has a variety of polymorphic forms characterised by diverse 
ligand-binding activities and displaying different biological responses such as cancer 
vulnerability. It is feasible to estimate ligand-binding affinities of the Ah receptor via 
measuring the expression of these polymorphic forms of Ah receptor in cell-free systems, 
cultured cells through DNA transfection or gene knock-out mice. As reported, the DBA/2 
mouse strain has low inducibility in the CYPlAl gene expression in response to inducers 
like TCDD whereas high inducibility is seen in the C57BL/6 strain (Shimada et al., 2002).
It is contemplated that Ah receptor polymorphism in the inbred mouse strains and human 
population is caused by a difference in the amino acid sequence of the Ah receptor protein 
(Nebert, 1991). About 9 mutations have been reported in the human Ah receptor gene, while 
for murine Ah receptor gene almost 2200 mutations have been recognised in 13 inbred 
strains (Thomas et al., 2002). The significance of gene variation in Ah receptor in the human 
remains unclear, though it may be hypothesised that there are sensitive individuals who, 
following exposure to low doses of the inducer will display increased Ah receptor- 
dependent enzymatic activity, in contrast to very resistant individuals where the inducer will 
show the effect only at high doses.
1.7.3 Potential o f  glucosinolates/isothiocyanates as Ah receptor activators 
Indole-3-carbinol formed from various tryptophan-derived glucosinolates, for example 
glucobrassicin from broccoli (Wattenberg and Loub, 1978) or brassinin from Chinese 
cabbage (Mehta et ah, 1995), is very sensitive to acidic conditions and forms several
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oligomeric products such as 3,3’-diindolylmethane (DIM), a most stable biologically active 
oligomer but weak AhR agonist, which is likely to be responsible for the pharmacological 
effects of indole-3-carbinol; moreover, indolo[3,2-b]carbazole is an effective AhR agonist 
(Denison and Nagy, 2003; Waard et ah, 2008). It was reported that indole-3-carbinol and 
DIM stimulate phase I and phase II carcinogen-metabolising enzyme systems in hepatocyte 
cultures of rat and monkey (Wortelboer et ah, 1992). Furthermore, comparable reactive 
tryptophan-derived compounds will be enzymically produced in the normal intermediary 
metabolism of mammalian cells, and may be transformed to powerful endogenous AhR 
agonists (Bittinger et ah, 2003; Bock and Kohle, 2006).
Isothiocyanates, e.g. watercress-derived phenethyl isothiocyanate and broccoli-derived 
sulforaphane, are selective Nrf2 activators but not agonists to AhR (Miao et ah, 2004). The 
modestly toxic sulforaphane is converted to an ITC-GSH conjugate in the human intestinal 
epithelium (Petri et ah, 2003), accumulates in the cells and initiates multiple Nrf2 target 
genes of phase II enzymes such as quinone reductase and glutathione transferases (Zhang, 
2000). It was reported that sulforaphane effectively initiated AhR transformation and its 
subsequent binding to the xenobiotic responsive element (XRE), situated in the promoter 
region o f AhR-regulated genes such as CYPlAl (Anwar-Mohamed and El-Kadi, 2009).
1.8 Toxicity of glucosinolates and isothiocyanates
Up to now, only a single case has been reported of hepatic toxicity following consumption 
of broccoli juice, taken for 4 weeks for the treatment of obesity (800 ml/day). Levels of 
transaminases, aspartate aminotransferase and y-glutamyltranspeptidase were increased in
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the female subjects. Once the consumption was terminated, transaminase levels fell to 
normal values within 15 days; however no hepatic histological assessments were carried out 
(Ekiz et ah, 2010; Latte et ah, 2011). Administration of isolated glucosinolates (5 mg/g dry 
substances), such as pure gluconapin or sinigrin, resulted in hepatic hypertrophy in rats. 
Furthermore, in rats, progoitrin clearly stimulated inflammation in the liver, kidneys and 
thyroid (Nugon-Baudon and Rabot, 1994; Verhoeven et ah, 1997). Treatment of rats with a 
series of isothiocyanates for a week revealed that phenethyl- and benzyl isothiocyanates 
caused marked decrease in the pH of urine on day 1, followed by an increased in the 
thickness of the urinary bladder epithelium and transient inflammation in conjunction with 
hyperplasia (Akagi et ah, 2003; Latte et ah, 2011).
The existence of epithiospecifier protein (ESP), a myrosinase cofactor identified from 
Arabidopsis thaliana, may also influence the breakdown products of indole glucosinolates 
forming indole-3-acetonitriles as a substitute of indole-3-carbinols. Some indole nitriles 
were shown to possess toxicity (Agerbirk et ah, 2009). Three nitriles, consisting of indole-3- 
acetonitrile, p-hydroxyphenylacetonitrile and 1 -cyano-3-methyl-sulphinylpropane increase 
the foetal weights in rats. When examined on days 8  and 9 of pregnancy, only 1 from 87 
embryos demonstrated skeletal abnormality at an exposure level of 200 mg/kg. In an in vitro 
study concerned with the toxicity of 2-propenyl and 3-butenyl glucosinolate, i.e. the 
breakdown products of sinigrin and gluconapin, caused a marginal cytotoxic effect in MCL- 
5 cells, which is a human B-lymphoblastoid cell line having metabolic activity (Kadir et ah,
2009). No toxicity was reported in humans following consumption of cruciferous vegetables
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and their breakdown products, bearing in mind that the dosages administered in the animal
studies surpass the normal human dietary intake (Verhoeven et ah, 1997).
1.9 Project objectives
1. The ability of isothiocyanates to modulate cytochrome P450 enzymes and phase II 
enzymes such as quinone reductase and glutathione ^'-transferase, has been extensively 
studied. However their effects on other enzyme systems, such as 
glucuronosyltransferase and epoxide hydrolase, which are also important in the 
metabolism of chemical carcinogens, have not received much attention, and this 
deficiency is addressed in the present study.
2. Studies using sulforaphane invariably utilised the commercially available racemate 
rather than the naturally-occurring R-isomer. The ability of R- and ^'-sulforaphane to 
modulate carcinogen- metabolising enzymes is compared in rat hepatoma FAO cells 
and in precision-cut rat liver slices.
3. The ability of intact glucosiuolates to influence carcinogen-metabolising enzyme 
systems will be assessed.
4. Glucoraphasatin is a glucosinolate found primarily in Daikon, a radish extensively 
consumed in Japan. Its potential chemopreventive activity through modulation of 
carcinogen-metabolising enzyme systems will be investigated both in vivo and in vitro.
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5. The Ah receptor is increasingly linked with cancer, so that agonists are considered 
potentially toxic whereas antagonists are believed to be potentially beneficial. The 
ability of isothiocyanates to act as agonists and antagonists of the Ah receptor will be 
evaluated.
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2.1 MATERIALS
Abeam, Cambridge, U.K
Rat anti-CYP3A primary antibody, rabbit monoclonal antibody to quinone reductase, goat 
polyclonal antibody to lactate dehydrogenase, goat polyclonal antibody to p-actin
ABGene, Epsom, Surrey, U.K
Absolute™ QPCR ROX MIX, absolute QPCR seal and Thermo-fast 96 detection plates
Alabama Research and Development Corporation, Munsford, Alabama, U.S.A
Krumdieck Tissue Slicer
Agricultural Research Council, Industrial Crop Research Center (CRA-CIN), 
Bologna, Italy (Dr Renato lori and colleagues)
Glucoraphanin and glucoerucin (were isolated according to Visentin et al., 1992; purity 95- 
99%), glucoraphasatin (was isolated according to Barillari et al., 2005; purity 95%), R- 
sulforaphane (was generated in situ from natural glucoraphaniu by myrosinase-catalysed 
hydrolysis), myrosinase (was isolated as described by Pessina et al., 1990; one unit of 
enzyme was defined as the amount of enzyme able to hydrolyse 1 pmol sinigrin per minute 
at pH 6,5 and 37°C) and Daikon extract (was prepared as described by Barillari et al., 2005; 
two glucosinolates are present in this extract, glucoraphasatin (253±9 pmol/g; 11.6±0.4% 
w/w) and glucoraphenin (116±10 pmol/g; 5.5±0.5% w/w).
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Ambion, Warrington, U.K
RNA later®-ICE
Amersham Life Sciences, Bucks, U.K
ECL Plus western blotting detection system, ECL advance detection system, Hybond-P 
polyvinylidene fluoride (PVDF) membrane and mini camera
BD Biochemicals, Oxford, U K
7-Benzyloxyquinoline (7-BQ), 7-hydroxyquinoline (7-HQ), rat anti-CYPlBl primary 
antibody
BDH Chemicals Ltd, Poole, U.K
Ethylenediaminetetra-acetic acid disodium salt
Bio-Rad, Hertfordshire, U.K
Bio-Rad dye reagent, acrylamide (40%), 6fx-acrylamide (2%)
Calbiochem, Lutterworth, U.K
Rat anti-CYPlAl, anti-CYPlA2, anti-GSTAl-1, anti-GSTMl-1 and anti-GSTPl-1 primary 
antibodies
Cambrex Bio Science Rockland, Rockland, U.S
Low melting point agarose
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Fisher Scientific UK Ltd, Loughborough, U.K
Acetonitrile, Tris base, dimethyl sulphoxide, potassium chloride, sodium chloride, sodium 
sulphate anhydrous, x-ray film
Fluka, Buchs SG, Switzerland
4-Chloro-7-nitrobenzofuran (NBD-Cl)
Gib CO- Invitrogen Life Sciences, Paisley, U K
Dithiothreitol, dNTP mix (dATP, dCTP, dGTP, and dTTP), Earle's Balanced Salt Solution 
(EBSS) (IX), Minimum Essential Medium Alpha (MEM-a), Dulbecco’s Modified Eagle 
medium (DMEM), Pen Strep Penicillin Streptomycin, Geniticin G-148 sulphate, foetal 
bovine serum, gentamicin, random hexamers, RNase-firee water, RNase OUT, RPMI 1640 
culture medium, RT buffer and Superscript II reverse transcriptase
Greiner bio-one, Frickenhausen, Germany
Cell scrapper
Helena Biosciences, Sunderland, U.K
12-Well Plates
LKT Laboratories Inc., Minnesota, U.S
Phenethyl isothiocyanate, i?,5'-sulforaphane, «S'-Sulforaphane, erucin
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Lonza, Verviers, Belgium
Non-Essential Amino Acid (NEAA) lOOX
Maeherey-nagel GmbH & Co. KG., Dtiren, Germany
Nucleospin® RNA II
Melford Laboratories Ltd., Ipswich, Suffolk, U.K
P-Nicotinamide adenine dinucleotide phoshate (NADP), p-nicotinamide adenine 
dinucleotide phoshate reduced (NADPH)
Midwest Research Institute, Kansas, U.S.A
Benzo[a]pyrene-4,5-epoxide, benzo[a]pyrene-4,5-dihydrodiol
MWG, Ebersberg, Germany
Rat CYPlAl, CYP1A2, NQOl, GST, IS S rRNA primers and probes
Nunc™, Roskilde, Denmark
6-Well plates, 24-well plates, 96-well plates, T-25 flask, T-50 flask, T-75 flask
Oxoid Limited Basingstoke, Hampshire, U.K
Phosphate buffered saline (Dulbecco’s A)
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Premier Beverages, U.K
Marvel dried skimmed milk powder
Promega, Southampton, U.K
DNase buffer, DNase stop solution, RNase-free DNase, Luciferase assay reagent, cell 
culture lysis reagent 5X
Roche Diagnostics, Mannheim, Germany
Cytotoxicity detection kit (LDH)
Santa Cruz Biotechnology, CA, U.S.A
Goat polyclonal antibody to the Ah Receptor, goat polyclonal antibody to UGT1A6, rabbit 
polyclonal antibody to mEH, goat polyclonal antibody to SULTl, goat polyclonal antibody 
to NAT-1/2, mouse monoclonal antibody to CYPlAl, rabbit polyclonal antibody to 
CYPIBI, goat polyclonal antibody to Amtl, donkey anti-goat IgG-HRP
Sarstedt, North Carolina, U.S.A
96-Well plates
Sigma-Aldrich, Dorset, U.K
P-Naphthol, a-Naphthol, alamethicin, 4-(Dimethyl-amino) benzaldehyde (DMAB), p- 
aminobenzoic acid (PABA), penicillin-streptomycin-neomycin solution stabilised, 
ammonium persulphate, HRP-conjugated anti-mouse, anti-rabbit and anti-goat secondary
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antibodies, bovine serum albumin, l-chloro-2,4-dinitrobenzene (CDNB), 3, 4- 
dichloronitrobenzene (DCNB), 5, 5'- dithio-bis(2-nitro)-benzoic acid (DTNB),
ethoxyresorufin, D-glucose anhydrous, glucose-6-phosphate, glucose-6-phosphate
dehydrogenase, glutathione reductase, L-glutathione reduced, L-glutathione oxidised, 
glycerol, hydrocortisone 21-hemisuccinate sodium salt, insulin, P-mercaptoethanol, 
methoxyresorufin, 2-methyl-1,4-naphthoquinone (menadione), L-methionine, 3-(N- 
morpholino) propanesulforic acid (MOPS), Tween 20, thiazoyl blue tétrazolium bromide 
(MTT), 7-pentoxyresorufm, 3'- phosphoadenosine 5'-phosphosulfate (PAPS), polaroid film, 
pyronin Y, resorufm, sodium dodecyl sulphate (SDS), N,N,N',N'- 
tetramethylethylenediamine (TEMED)
Thermo Scientific, Rockford, IL, U.S.A
Restore™ PLUS western blot stripping buffer
2.2 METHODS
2.2.1 Rat husbandry
Male Wistar albino rats (200-250 g) were purchased from B&K Universal Ltd. (Hull, East 
Yorkshire, U.K) or Charles River (Margate, Kent, U.K), and housed in the Experimental 
Biology Unit under a 12-h light-dark cycle, 30-40% humidity, and with temperatures 
maintained at 22°C ± 2°C. The animals were allowed to acclimatise to the above conditions 
for at least 24 h prior to use. A minimum of two rats and a maximum of four rats were 
housed per cage; water and standard dry rodent food, RMl (E) SQC EG (Special Diets 
Services, Witham, Essex, England) in powder form, were provided ad libitum.
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2,2.2 Preparation and maintenance o f  precision-cut tissue slices
Precision-cut tissue slices were prepared from the rat liver and lung. These slices with 
uniform diameter and thickness were maintained under controlled conditions.
2.2.2.1 Preparation o f liver slices
Rats were sacrificed by cervical dislocation and the liver was immediately removed and 
placed in ice-cold oxygenated EBSS solution containing 25 mM D-glucose. The whole rat 
liver was cut into 3 lobes. A hand-held core maker (Vitron, Tuscan, U.S.A) was used to 
prepare tissue cylinders, having a diameter of 8 mm, from the rat lobes. Liver slices (200- 
300 pm) were produced using a Krumdieck tissue slicer (Alabama Research and 
Development Corporation, Alabama, U.S.A) as illustrated in Figure 2.1. This slicer was pre­
chilled to 4°C and filled with chilled oxygenated EBSS. Prior to use, all parts of the slicer 
were swabbed with 70% IMS.
2.2.2.2 Preparation o f lung slices
The procedure for the preparation of lung slices is basically similar to that of the liver, but 
with important differences (Umachandran et al., 2004) (Figure 2.2). Firstly, the lungs were 
solidified by slow infusion with 0.75% solution of warm (37°C) low-melting point agarose 
using a catheterised trachea. The trachea was clipped and the lungs were kept submerged in 
ice-cold oxygenated EBSS until the agarose solidified. The lung was cut into 2 lobes and 
tissue cylinders were prepared as described for the liver; lung slices (400-600 pm) were cut 
using the Krumdieck tissue slicer.
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(iii) (iv)
(v) (vi)
Figure 2.1: Preparation of precision-cut rat liver slices. The slicer (i) was pre-chilled to 
4°C for at least 24 h prior to use. All parts of the slicer were swabbed with 70% IMS before 
assemblying, and filled with ice-cold oxygenated EBSS. Rat liver (ii) was immersed into 
ice-cold oxygenated EBSS and cores were created using a hand-held core maker (iii) having 
a diameter of 8 mm (iv). Precision-cut rat liver slices were incubated in 12-well culture 
plates containing 1.5 ml medium (v). Finally, the plates were placed in a humidified 
incubator at 37°C equipped with an orbital shaker (105 rpm) (vi).
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»
(i) (ii)
(iii) (iv)
(v) (vi)
Figure 2.2: Preparation of precision-cut rat lung slices. The lung (i) was removed 
immediately after rat was sacrificed and immersed into ice-cold oxygenated EBSS. Rat lung 
(ii) was solidified by slow infusion with 0.75 % solution of warm (37°C) low-melting point 
agarose using a catheterised trachea. The trachea was clipped and the lung was kept 
submerged in ice-cold oxygenated EBSS until the agarose solidified and cores were created 
using a hand-held core maker (iii) having a diameter of 8 mm (iv). Precision-cut rat lung 
slices were incubated in 12-well culture plates containing 1.5 ml medium (v). Finally, the 
plates were placed in a humidified incubator at 37°C equipped with an orbital shaker (105 
rpm) (vi).
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2.2.23 Preparation o f culture medium
All the tissue slices were pre-incubated in the medium prepared as described by Lake et al. 
(1993). RPMI 1640 was supplemented with 1 pM insulin, 0.1 mM hydrocortisone 21- 
hemisuccinate sodium salt, 0.5 mM L-methionine, 50 pg/mL gentamicin and 5% foetal calf 
serum (PCS). During incubation, a series of concentrations of the test compounds was 
prepared in DMSO or Milli Q water. DMSO, at a final concentration not exceeding 0.5% 
(v/v), was added equally into all incubations when it was used as the test compound solvent.
2.2.2.4 Incubation o f  tissue slices
Tissue slices were incubated in 12-well culture plates, with each slice being placed in a 
separate well containing 1.5 ml of medium (see section 2.2.2.3). The plates were placed in 
an incubator equipped with an orbital shaker (105 rpm) (Stuart, Barloworld Scientific Ltd, 
Staffordshire, U.K), and were maintained at 37°C under an atmosphere of 95% air/5 % CO2 
(Galaxy B CO2 Incubator, Scientific Laboratory Supplies Ltd, Nottingham, U.K).
Liver slices were initially pre-incubated for 0.5 h, 1 h in the case of lung slices, under these 
conditions in order to allow the viable tissue to slough the damaged cells. The tissue slices 
were then briefly washed with 0.154 M KCl containing 50 mM Tris-HCl buffer, pH 7.4, 
before being transferred to a fresh culture medium containing test compound(s), and were 
incubated for a further 24 h. At the end of the incubation period, the slices were removed 
firom the culture medium, washed again briefly with the buffer as described above, and 
homogenised using an electrically-driven glass Potter Elvehjem type homogeniser fitted 
with a Teflon pestle powered by a NLD710HD drill, (Performance Power Tool, Chandlers 
Ford, U.K) in the same buffer (10 slices in 1.0 ml buffer).
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2.2.3 Lactate dehydrogenase (LDH) leakage
Lactate dehydrogenase (LDH) is an enzyme located on the cellular plasma membrane. 
Release of LDH from tissue slices into the incubation medium was used as an indicator of 
cytotoxicity (Decker and Lohmann-Matthes, 1988). LDH concentration was measured using
a cytotoxicity detection kit (Roche Diagnostics, Mannheim, Germany) according to the 
manufacturer’s instructions. Three tissue slices were used per each concentration studied of 
the test compound. Following a 24 h incubation, the culture medium was removed and the 
tissue slices were each homogenised in 1.5 ml of phosphate buffered saline (PBS), pH 7.4. 
Both media and homogenates were centrifuged at 2000 x g for 5 min at 4°C using a 
benchtop centrifuge. Aliquots (0.1 ml) of either medium or homogenate supernatants were 
mixed with 0.1 ml of a freshly prepared reaction mixture containing 11.25 ml of dye 
solution [lodotetrazolium chloride (INT) and sodium lactate] and 0.25 ml of catalyst 
(diaphorase/NAD^ mixture) in a 96-well plate. The plate was then incubated at room 
temperature for 15 min and the reaction was terminated by addition of 50 pi of stop solution. 
Using an ELISA reader, the absorbance was read at 492 nm, and leakage of LDH was 
expressed as percentage of total slice LDH released into the culture media.
LDH medium
% LDH released =  — —-----   , ..— r------------ — X 100
LDH medium +  LDH slice homogenate
2.2.4 Preparation o f  subcellular fractions
For the preparation of the homogenate, 10 slices were pooled in 1 ml of 0.154 M KCl 
containing 50 mM Tris-HCl buffer, pH 7.4, the homogenising buffer. The microsomal 
supernatant (S9) was prepared by differential centrifugation at 9000 x g (Eppendorf,
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Hamburg, Germany) for 20 min at 4°C. Subsequently, the supernatant was decanted, divided 
into several aliquots and stored at -80°C until required. Completely thawed S9 was further 
centrifuged at 105,000 x g for 45 min at 4°C using Beckman L7-65 ultracentrifuge with a 
fixed angle 70 ITI type rotor (Beckman Coulter Ltd, Bedfordshire, U.K). The supernatant, 
i.e. cytosolic fraction, was removed and stored at -80°C; the microsomal pellet was 
resuspended in the same volume of original S9 in homogenising buffer. The microsomal 
fractions were immediately used in enzyme assays.
The preparation of whole tissue fractions, like whole rat liver and lung, were similar as 
above, the difference being only in the homogenate preparation procedure. Fresh or fully 
thawed whole tissue was briefly washed in homogenising buffer and subsequently, ice cold 
homogenising buffer was added to achieve the desired concentration: 25% (w/v) for liver S9 
or 50% (w/v) for lung S9. The tissues were scissor-minced prior to homogenisation, and 
microsomal and cytosolic fractions were prepared by differential centrifugation as described 
for tissue slices.
2.2.5 Cell culture
2.2.5.1 Rat hepatoma FAO cells
The rat hepatoma FAO cell line was used to ascertain the effect of sulforaphane isomers on 
carcinogen-metabolising enzymes in a different in vitro system to precision-cut tissue slices, 
was kindly donated by Dr. Kate Plant (University of Surrey). Cells were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% FBS, Ix non- 
essential amino acids (NEAA), 100 U/ml penicillin and 100 pg/ml streptomycin, and were 
grown until 70-80% confluent. At a density of 4 x 10"* cells/ml, the cells were seeded (3
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ml/well) into 6-well plates using the same medium, and cultured for 24 h. Solutions of the 
test compounds were prepared in DMSO and subsequently diluted in serum-free media so 
that the final concentration of the solvent was 0.1% (v/v). Cells were incubated at 37°C 
under an atmosphere of 95% air/5 % CO2 in a humidified incubator for 24 h. At the end of 
the incubation period, the cells were washed with ice-cold PBS and harvested in buffer 
containing 25 mM Tris-HCl, pH 7.4, and 125 mM sucrose (1 ml/well) using cell scrapers, 
and the lysates were resuspended and collected using a 21G needle and an 1 ml syringe. 
Cells were then sonicated for 5 seconds and centrifuged at 13,000 x g for 20 minutes at 4°C, 
to prepare the post-mitochondrial supernatant (S9). The supernatant was kept at -80°C until 
use. Completely thawed S9 was further centrifuged at 105,000 x g for 45 min at 4°C using a 
Beckman L7-65 ultracentrifuge with a fixed angle 70 ITI type rotor (Beckman Coulter Ltd, 
Bedfordshire, U.K). The supernatant i.e. cytosolic fraction was removed and kept on ice; the 
microsomal pellet was resuspended in the same volume of S9 in 0.154 M KCl containing 50 
mM Tris-HCl buffer, pH 7.4. The cytosolic and microsomal fractions were immediately 
used for carrying out enzyme assays.
2.2.5.2 Mouse hepatoma H lL l.lc2  cells
Activation of the Ah receptor was investigated using the chemically-activated luciferase 
gene expression (CALUX) assay. This assay employs the recombinant mouse hepatoma cell 
line (H lL l.lc2) expressing a firefly luciferase reporter gene plasmid, under control of the 
MMTV LTR viral promoter (Garrison et al., 1996), was kindly donated by Prof. Aide Roda 
(University of Bologna, Italy). Cells with low passage number were removed from liquid 
nitrogen and revived in 25cm^ flasks until they reached 80% confluency in a-MEM media
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supplemented with 10% FBS and G418 antibiotic solution (100 pg/ml). These cells were 
maintained under standard condition of 37°C and 95% air/5% CO2 in a humidified 
incubator. To passage the cells, old medium was aspirated, the flasks were washed with 
PBS, and trypsin-EDTA (0.25% trypsin, 1 mM EDTA) was added (3 ml); flasks were 
incubated at 37°C for 5 minutes, until cells had detached from the flask surface. The trypsin- 
EDTA was neutralised by addition of 7 ml of medium, and the cells were then split into a 
final volume of 20 ml in T75 cm^ flasks. Cell numbers and viability were calculated in 10 pi 
aliquots of cell suspension mixed with an equal volume of trypan blue (4%) in a Modified 
Fuch’s Rosenthal counting chamber, under phase contrast light microscopy. Blue-coloured 
cells were considered as dead/non-viable, whereas non-coloured cells were considered as 
live/viable cells.
2.2.5.2.1 CALUX assay
H lL l.lc2  cells, at a density of 7 x 10"^  cells/ml, were seeded in 24-well plates using a-MEM 
media supplemented with 10% FBS and 50 units penicillin-50 pg/ml streptomycin-100 
pg/ml neomycin antibiotic solution and cultured for 24 h until they were 50-70% confluent. 
Solutions of the test compounds were initially prepared in DMSO/Milli Q water and 
subsequently diluted in fresh antibiotic-free- a-MEM media containing 10% FBS. Prior to 
the addition of the compounds, the H lL l.lc2  cells were gently washed in PBS and 
incubated under standard conditions of 37°C and 95% air/5% CO2 in a humidified incubator 
for 24 h. At the end of the incubation period, the cells were lysed by the addition of 100 pi 
of cell culture lysis reagent (IX) and incubated for 15 minutes at room temperature. The cell 
lysates were collected by scraping and transferred to eppendorf tubes. The cells were
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vortexed for 15 seconds and then centrifuged at 13,000 x g for 2 minutes at 4°C in order to 
pellet out any remaining cell debris.
The luciferase activity of cleared cell lysates was determined using the Promega stabilised 
luciferase assay system. Lysates (20 pi) were added to a white 96-well microtitre plate, 
using every third well in order to avoid cross-talk, followed by the addition of luciferase 
assay reagent (100 pi). Subsequently, the microtitre plate was shaken for 90 seconds in a 
Packard Lumicount microplate luminometer with PlateReader software (Packard Instrument 
Company), and reading of the luminescence was taken 2 minutes after luciferase assay 
reagent was added. Finally, the fluoresced light was quantified as relative light units (RLU), 
corrected for gain and normalised for cell number. Luciferase activity was expressed as 
percentage of binding of the ligands to the Ah receptor, where TCDD (10'^ M) served as a 
positive control, achieving 100% binding.
2.2.6 Determination o f microsomal CYP450 activities
2.2.6.1 Ethoxy-, methoxy- andpentoxyresorufin 0-dealkylases
The 0-deethylation of ethoxyresorufin to resorufin was performed as a biomarker for 
CYPlAl activity (Burke and Mayer, 1974), whilst, CYP1A2 and CYP2B activities were 
monitored using methoxyresorufin 0-demethylase (MROD) (Nerurkar et al., 1993) and 
pentoxyresorufin 0-depentylase (PROD) (Lubet et al., 1985) respectively. Using a Perkin- 
Elmer LS-5 luminescence spectrophotometer, generation of resorufin was determined at 
excitation and emission wavelengths of 571 and 585 nm and slit widths at 10 nm and 2.5 nm 
respectively.
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The following reagents were added into a cuvette:
0.1 M Tris-HCl buffer, pH 7.8 1.85 ml
Microsomal suspension^ 0.10 ml
0.1 mMEthoxyresomfin^ 0.01 ml
^For liver and lung slices, 10 slices were pooled in 1 ml homogenising buffer, whereas for 
whole tissues 25% (w/v) for liver or 50% (w/v) for lung microsomal preparations were used. 
^0.1 mM Methoxyresorufin or 0.1 mM pentoxyresorufin were also used, with all the 
substrates being dissolved in 70% ethanol.
The reaction was initiated by the addition of 0.01 ml of 50 mM NADPH dissolved in 1% 
NaHCOs. The mixture was immediately mixed well by gentle inversion of the cuvette before 
being placed into the cell holder, and the reaction was monitored for 10 min at 37 °C. The 
enzyme activities were calculated using a standard curve constructed by plotting 
fluorescence against known concentrations of resorufm (0-250 pmole), and expressed in 
units of pmol per minute per mg of microsomal protein.
2.2.6.2 Determination o f  microsomal CYP3A activity
7-Benzyloxyquinoline (7-BQ) was used as a model substrate for CYP3A activity because it 
showed the highest degree of selectivity among CYP subfamily (Stresser et al., 2002). 7-BQ 
is demethylated predominantly by CYP3A to the fluorescent product 7-hydroxyquinoline (7- 
HQ). Fluorimetric determination of the production of 7-HQ was performed as described by 
Stresser et al (2000). Using a Perkin-Elmer LS-5 luminescence spectrophotometer, 
excitation and emission wavelengths were set at 410 nm and 538 nm respectively, and both 
slit widths at 5 nm.
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The following reagents were added into a fluorimetric cuvette:
0.1 M Tris-HCl buffer, pH 7.8 1.75 ml
3.3 mM glucose-6-phosphate (G-6-P) 0.05 ml
0.4 U/ml G-6-P dehydrogenase 0.10 ml
Microsomal suspension* 0.10 ml
40 pM 7-BQ 0.01 ml
*For liver and lung slices, 10 slices were pooled in 1 ml homogenising buffer, whereas for 
whole tissue a 25% (w/v) liver microsomal preparation was used.
Each analysis was performed in triplicate, and the reaction was initiated by addition of 0.01 
ml of 1.3 mM NADP^, and the rate of 7-HQ formation was monitored for up to 5 min at 
37°C. The enzyme activities were calculated using a standard curve created by plotting 
fluorescence against known concentrations of 7-HQ (0 to 0.5 nmole), and is expressed in 
units of pmol per minute per mg of microsomal protein.
2.2.7 Determination o f  phase II  activities
2.2.7.1 Quinone reductase
Determination of NQOl activity was based on a method described by Prohaska and 
Santamaria (1988). Menadiol reduced a yellow dye 3-(4, 5-dimethylthiazol-2-yl)-2,5- 
diphenyl tétrazolium bromide (MTT) to a blue formazan, in the presence of the electron 
acceptor menadione, which can be measured over a broad range of wavelengths at 550-640 
nm.
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The following were added to both spectrophotometer cuvettes:
Test cuvette Reference cuvette 
25 mM Tris-HCl containing 0.083% Tween 20 0.800 ml 0.850 ml
100 mM MTT in 70% ethanol 0.006 ml 0.006 ml
50 mM NADPH in 1% NaHCOs 0.006 ml 0.006 ml
Cytosolic fraction* 0.050 ml
*For liver and lung slices, 10 slices were pooled in 1 ml homogenising buffer, whereas for 
whole tissues 25% (w/v) for liver or 50% (w/v) for lung cytosolic preparation were used.
Reaction was initiated by the addition of 6.0 pi of 10 mM menadione to both cuvettes, and 
production of blue formazan was determined at 610 nm for 1 min using a dual beam UV/Vis 
spectrophotometer. NQOl activity was calculated using a molar extinction coefficient of
11.3 mM cm (Prohaska and Santamaria, 1988), and was expressed in units of nmol per 
minute per mg of cytosolic protein.
2.2.7.2 Glutathione-S-transferase
The glutathione-S-transferases (GSTs) are a family of cytosolic enzymes catalysing the 
detoxification of highly electrophilic chemicals by conjugation to glutathione. The assays 
were performed using 1 -chloro-2,4-dinitrobenzene (CDNB), 1,2-dichloronitrobenzene 
(DCNB) and 4-chloro-7-nitrobenzofuran (NBD-Cl) as accepting substrates using the 
method described by Habig et al. (1974). The change in absorbance against time due to the 
conjugation of substrate with glutathione was monitored at room temperature for 1 min in a 
dual beam UV/Vis spectrophotometer at wavelengths of 340 nm for CDNB, 345 nm for 
DCNB and 419 nm for NBD-Cl.
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For the determination of GST activity using CDNB and DCNB as substrates, the following 
were added into both cuvettes:
Reference cuvette Test cuvette
0.1 M Potassium phosphate buffer, pH 7.5 1.00 ml 0.95 ml
25 mM CDNB or DCNB in 70% ethanol 0.05 ml 0.05 ml
25 mM Reduced glutathione 0.25 ml 0.25 ml
Cytosolic fraction* — 0.05 ml
*For liver and lung slices, 10 slices were pooled in 1 ml homogenising buffer, whereas for 
whole tissues 25% (w/v) for liver or 50% (w/v) for lung cytosolic preparations were used.
For the determination of GST activity using NBD-Cl as substrate, the following were added 
into both cuvettes:
Reference cuvette Test cuvette
0.1 M Sodium phosphate buffer, pH 7.5 1.235 ml 1.225 ml
(containing 5 mM reduced glutathione)
4 mM NBD-Cl in 70% ethanol 0.075 ml 0.075 ml
Cytosolic fraction* — 0.100 ml
*For liver and lung slices, 10 slices were pooled in 1 ml homogenising buffer, whereas for 
whole tissues 25% (w/v) for liver or 50% (w/v) for lung cytosolic preparations were used.
Each assay was carried out in triplicate. The buffer was maintained at 37°C and the reaction 
mixture was mixed by gentle inversion of the cuvette before placing into the cell holder. The
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enzyme activities were calculated using molar extinction coefficients of 8.5, 9.6 and 14.5 
mM cm (Habig et al., 1974) for CDNB, DCNB and NBD-Cl, respectively, and were 
expressed as nmol per minute per mg of total protein.
2.2.73 Epoxide hydrolase
Epoxide hydrolase is an important microsomal enzyme involved in the detoxification of 
carcinogens that converts epoxides to dihydrodiols. In this study, activity was determined by 
monitoring the hydrolysis of benzo(a)pyrene 4,5-epoxide to the corresponding dihydrodiol 
as described by Dansette et al. (1979). Using a Perkin-Elmer LS-5 luminescence 
spectrophotometer, the reaction was measured fiuorimetrically with excitation and emission 
wavelengths set at 310 and 385 nm, with slit widths at 5 and 2.5 nm, respectively.
Into a quartz crystal cuvette, the following were added:
0.015 M Tris-HCl buffer, pH 8.7 1.90 ml
Microsomal suspension* 0.10 ml
2 mM Benzo(a)pyrene 4,5-epoxide in acetonitrile 0.01 ml
*For liver and lung slices, 10 slices were pooled in 1 ml homogenising buffer, whereas for 
whole tissues 25% (w/v) for liver or 50% (w/v) for lung microsomal preparations were used.
The reaction was immediately commenced by the addition of benzo(a)pyrene 4,5-epoxide 
and monitored for 4 min at 37°C, with the slope of the kinetic reaction being recorded. A 
calibration curve was constructed using 2 pi of 2 mM benzo(a)pyrene 4,5,-trans 
dihydrodiol, dissolved in acetonitrile, to 2 ml of 0.015 M Tris-HCl buffer, pH 8.7. Each 
analysis was conducted in triplicate.
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2.2.7.4 UDP-Glucuronosyl transferase
The ability of UDP-GT to convert 1-naphthol to 1-naphthyl p-glucuronide is used to 
determine the activity of the membrane-bound microsomal enzymes. The enzyme, liable for 
the glucuronidation of 1-naphthol, can be measured by incubating the microsomal fraction in 
the presence of the substrate and UDP-glucuronic acid (UDP glue A). Activity was measured 
fiuorimetrically at alkaline pH using 1-naphthol as substrate (Bock and White, 1974).
UDP- glucuronic acid + ROH <->UDP + R-O-glucuronic acid
The following were added in chloroform-resistant test tubes:
50 mM Potassium phosphate buffer, pH 7.25 with 5 mM EDTA 0.696 ml
100 mM Magnesium chloride 0.050 ml
0.5 mM 1-Naphthol 0.100 ml
Microsomal suspension* 0.100 ml
0.1 mg/ml Alamethicin 0.004 ml
*For liver and lung slices, 10 slices were pooled in 1 ml homogenising buffer, whereas for
whole tissues 25% (w/v) for liver or 50% (w/v) for lung microsomal preparations were used.
The mixtures were vortex-mixed and pre-incubated for 5 min at 37°C. The reaction was 
started by the addition of 50 pi of freshly prepared 20 mM UDP-glucuronic acid, which had 
also been pre-incubated at 37°C. All samples were then incubated for 15 min in a shaking 
water bath at 37°C. Following incubation, 1 ml of 0.4 M trichloroacetic acid/0.6 M glycine 
was added to stop the reaction. Samples were vortex-mixed and incubated on ice for an 
additional 5 min, after which chloroform (10 ml) was added to each tube and allowed to mix
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for 10 min on a rotary mixer. Layers were separated by centrifugation for 5 min at 2000 x g 
in Beckman J-6 centrifuge. The product, 1-naphthyl (3-glucuronide, was measured 
fiuorimetrically in a quartz cuvette by mixing 1 ml of the aqueous phase to 2 ml of 0.45 M 
NaOH. Using a Perkin-Elmer LS-5 luminescence spectrophotometer, the reaction was 
monitored at excitation and emission wavelengths of 293 and 335 nm respectively, and with 
both slit widths at 5 nm. Blanks were conducted using the same procedure as the samples 
except that 50 pi potassium phosphate buffer replaced UDP-glucuronic acid. The enzyme 
activities were calculated using a standard curve created by plotting fluorescence against 
known concentrations of 1-naphthyl glucuronide (0-20 nmol/ml), and expressed as nmol per 
minute per mg of total microsomal protein.
2.2.7.5 Sulphotransferases
The conjugation of 2-naphthol in the presence of PAPS, the sulphate donor, to form 2- 
naphthyl sulphate was used to determine sulphotransferases activity (Sekura et al., 1979). 
The end product is naphthyl sulphate, which was extracted as an ion pair with methylene 
blue that can be detected spectrometrically.
The incubation mixture was prepared as follows in chloroform-resistant test tubes:
0.5 M Sodium phosphate buffer, pH 7.4 0.200 ml
5 mM 2-Naphthol prepared in 5% acetone^ 0.020 ml
0.1 M 2-Mercaptoethanol 0.030 ml
(prepared in 0.5 M sodium phosphate buffer, pH 7.4)
4 mM PAPS 0.020 ml
(prepared in 0.5 M sodium phosphate buffer, pH 7.4)
Water 0.130 ml
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(^2-naphthol was dissolved in absolute acetone followed by dilution with water to 5% in 
order to obtain the required concentration).
The incubation mixture was pre-incubated in a water bath with agitation at 37°C for 10 min. 
An aliquot of 100 pi cytosol (for liver slices, 10 slices were pooled in 1 ml homogenising 
buffer, whereas for whole tissues 25% (w/v) for liver or 50% (w/v) for lung cytosolic 
preparations were used) was added to begin the reaction and incubated for 30 min. 
Following incubation, 0.5 ml methylene blue (250 mg in IL water containing 50 g 
anhydrous sodium sulphate and 10 ml concentrated sulphuric acid) was added to stop the 
reaction. Chloroform (2 ml) was then added to the mixture and allowed to mix on a rotary 
shaker for 10 min. The mixture was centrifuged at 2000 x g for 10 minutes, using a 
Beckman J-6 centrifuge, to separate the layers. The chloroform layer (lower layer) was 
decanted and placed in glass test tubes containing approximately 50-100 mg anhydrous 
sodium sulphate to remove excess water. Using UV/Vis spectrophotometer, absorbance was 
measured at 651 nm in the samples placed in a quartz cuvette. Enzyme activity was 
calculated based on the assumption that 1 pmol of 1-naphthol sulphate yields an absorbance 
of 30 units (Sekura et al., 1979).
2.2.7.6 N-acetyltransferases
iV-acetyltransferases (NATs) are a soluble enzymes residing in the cytosolic fraction, and 
play a significant role in the detoxification and bioactivation of a variety of aromatic 
xenobiotics, including numerous carcinogens (Dairou et al., 2004). NAT activity was 
measured using 4-aminobenzoic acid (PABA) as substrate, as reflected by the inability of 
the acetylated arylamine to form a Schiff s base with dimethylaminobenzaldehyde (DMAB),
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Test Blank
0.200 ml 0.400 ml
0.200 ml 0.200 ml
0.200 ml _ _ _
according to a published procedure (Mattano and Weber, 1987). The disappearance of p- 
aminobenzoic acid was determined spectrophotometrically at an absorbance o f450 nm.
Acetyl-CoA + R=NH2 (aromatic amine) -------> CoA + R-NH-COCH3
The following were added into an Eppendorf tube:
25 mM Tris-HCl buffer, pH 7.5 
1 mM PABA 
Cytosolic fraction*
*For liver and lung slices, 10 slices were pooled in 1 ml homogenising buffer, whereas for 
whole tissues 25% (w/v) for liver or 50% (w/v) for lung cytosolic preparations were used.
Eppendorf tubes were mixed well and then pre-incubated in a water bath with agitation at 
37°C for 5 min. The reaction was initiated by the addition of acetyl-CoA to a final 
concentration of 400 pM, and further incubated for 30 min in a shaking water bath at 37°C. 
Following incubation, 100 pi of 20% (w/v) ice-cold TCA was added to stop the reaction. 
The mixture was centrifuged at 15,300 x g for 5 min, using a bench top centrifuge, to 
remove the protein. The supernatant (200 pi) was decanted and added to 800 pi of 5% (w/v) 
DMAB prepared in ACN: water (9:1). Using a UV/Vis spectrophotometer, absorbance was 
measured at 450 nm. Enzyme activity was calculated using a standard curve constructed by 
plotting absorbance against known concentrations of PABA (0-200 nmol) and expressed as 
nmol/min/mg of total cytosolic protein.
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2.2.7.7 Determination o f  total glutathione content
Total glutathione content was determined according to the method described by Akerboom 
and Sies (1981). This is a kinetic assay which measures the sum of reduced (GSH) and 
oxidised (GSSG) forms of glutathione in the cytosolic fraction. The reaction is as follows:
non-enzymic
2GSH + *DTNB ------------------> GSSG + 2TNB
GSSG reductase
GSSG + NADPH+ H+ ------------------#>2GSH + NADP+
(*DTNB: 5, 5’-dithiobis (2-nitrobenzoic acid)
Cytosolic fractions from whole tissue (25% w/v for liver), or tissue slices (10 slices per 1 ml 
cytosol) were prepared. An aliquot (0.1 ml) of cytosolic fraction was mixed with an equal 
volume of 2 M perchloric acid containing 4 mM EDTA to precipitate the proteins. The pH 
of the mixture was then neutralised with 2 M potassium hydroxyde containing 0.3 M MOPS. 
Glutathione standards were put through the same procedure. All standards and samples were 
centrifuged at 2,000 rpm for 10 min. The supernatant was decanted and used in the assay.
The following were added into a spectrophotometer cuvette:
0.1 M Potassium phosphate buffer, pH 7.0 containing 25 mM EDTA 0.85 ml 
4 mg/ml NADPH in 0.1% NaHCOs 0.05 ml
6U/ml Glutathione reductase 0.02 ml
Sample or standard 0.10 ml
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Reaction was initiated by addition of 0.10 ml of 3.8 mM 5, 5’-dithiobis (2-nitrobenzoic 
acid), (DTNB). The contents of the cuvette were mixed by gentle inversion and the reaction 
was followed at 412 nm for up to 2 min using a UVWis spectrophotometer. Enzyme activity 
was calculated using a standard curve created by plotting glutathione reductase activity 
against glutathione concentration (0-0.1 mM), and expressed as nmol per slice.
2.2.8 Determination o f sample total protein content
Protein concentration in both microsomes and cytosol was determined by the method of 
Bradford (1976). An aliquot of tissue sample was diluted with sodium hydroxide (0.5 M), in 
the case of microsomal fractions 30-fold for slices and 50-fold for whole tissue, whereas for 
cytosolic fractions 50-fold for slices and 80-fold for whole tissue. Triplicate aliquots (10 pi) 
of either sample or standard were mixed in 96-well plates with 0.2 ml of Bio-Rad dye 
reagent (diluted 5-fold with Milli Q water). The mixture was incubated at room temperature 
for 5 minutes until blue colour developed, and the absorbance was read at 595 nm using an 
iEMS spectrometer plate reader. A range of bovine serum albumin (BSA) standards (0 -500  
pg/ml) was taken through the same process. The amount of protein was extrapolated from 
the standard curve. Results were expressed as mg of protein per ml of subcellular fraction 
preparation.
2.2.9 Quantification o f  apoprotein levels by Western blot analysis
The blotting technique was initially introduced in 1975 by Southern, who elaborated transfer 
of DNA from agarose gel to nitrocellulose membranes. After 4 years, Towbin and his 
colleagues (1979) improved the efficiency of protein elution from polyacrylamide gels.
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Western blot is commonly used to determine the presence of proteins in complex mixtures, 
and the relative abundance of protein individually. Polyacrylamide gel is used to separate a 
mixture of proteins based on their molecular weight by electrophoresis using a Bio-Rad 
Mini Protean III kit (Bio-Rad, Hertfordshire, U.K). The separated polypeptides on the gel 
are then transferred to a polyvinylidene fluoride (PVDF) membrane with a pore size of 0.2 
pm. Non-specific binding is blocked with excess protein, followed by incubation with a 
specific primary antibody to detect the desirable protein and finally with a secondary 
antibody directed against first antibody. Protein(s) of interest are eventually detected using a 
peroxidase reaction product, an existing chemiluminescent detection reagents, such as 
ECL™ western blotting detection reagents; an improved non-radioactive method for the 
detection of immobilised specific antigens conjugated to horseradish peroxidase (HRP) 
labelled antibodies; molecular weight markers are used to delineate the proteins of interest 
according to size.
2.2.9.1 Preparation o f SDS-polyacrylamide gels
All Western blot equipment were cleaned with reverse osmosis (RO) water and wiped with 
70% IMS prior to use to remove residual impurities. Using a gel sandwich kit, a pair of gels 
was prepared in glass cassettes, each assembled from a spacer plate with permanently 
bonded spacers, having a thickness of 1.5 mm, and a short plate aligned together and 
secured in a gel casting frame. This frame was then clipped upright onto the casting stand, 
securing the gel cassette perpendicular to the bench surface and sealing it off by pushing 
down against the grey rubber gasket to avoid any leaking during the running of the gel. A 
resolving gel solution was prepared comprising 5.43 ml Milli Q water, 4.50 ml of resolving
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gel buffer [Tris-HCl (1.5M) containing SDS (0.4% w/v), pH 8.8], 5.62 ml of acrylamide 
(40% w/v), 2.95 ml of bis-acrylamide (2% w/v), 0.18 ml of freshly prepared ammonium 
persulphate (10% w/v) and 0.018 ml of N,N,N',N'-tetramethylethylenediamine (TEMED). 
The resolving gel solution was poured up to 1 cm below the teeth of the completely inserted 
comb, and was immediately overlayed with 1 ml Milli Q water to avoid gel dehydration. 
This solution was allowed to polymerise for 20 min and the excess water was drained off 
using a filter paper.
A stacking gel solution comprising of 7.15 ml of Milli Q water, 2.5 ml of stacking gel buffer 
[Tris-HCl (0.5M) containing SDS (0.4% w/v), pH 6.8], 0.7 ml of acrylamide (40% w/v), 0.4 
ml of bis-acrylamide (2% w/v), 0.05 ml of freshly prepared ammonium persulphate (10% 
w/v) and 0.01 ml of N,N,N',N'-tetramethylethylenediamine (TEMED) was prepared. Once 
this solution was well mixed, it was poured between the glass plates above the resolving gel 
until the top of the short plate was reached. The 10-well comb was gently inserted into the 
glass cassette and the gel was allowed to polymerise for 30 to 45 min. The comb was 
removed, and the gel cassette was released from the casting frame and transferred to the 
electrode mount, which was inserted into an electrode assembly tank filled with diluted (5- 
fold) running buffer. The 5x concentrated running buffer was prepared by dissolving 15.15 g 
Tris base, 72 g glycine and 5 g SDS in up to IL of Milli Q water, with pH adjusted to 8.3.
2.2.9.2 Sample preparation and loading
Protein content from triplicate cytosolic or microsomal preparations isolated by differential 
centrifrigation of homogenised liver or lung tissues was determined, and equalised with
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phosphate buffered saline (PBS), pH 7.5. The samples with equal total protein concentration 
were diluted (1:1) with sample loading buffer consisting of 4.80 ml of Milli Q water, 1.20 
ml of Tris buffer (0.5M), pH 6.8, 0.96 ml of glycerol, 0.92 ml of SDS (10% w/v), 0.48 ml of 
p-mercaptoethanol and 0.60 ml of pyronin Y (0.05% w/v). To unfold the polypeptide 
structure, samples in loading buffer were heated in a heating block at 100°C for 5 min, 
cooled and centrifuged at 3000 x g for 1 min. Depending on the enzyme studied, equal 
volumes of each sample (20-30 pi) were loaded into the corresponding wells, with one well 
in each gel reserved for a molecular marker mixture (0.003 ml) to aid in the identification of 
protein of interest. The gels were mn for 75 to 90 min at a constant current of 40 mA and 
voltage of 120 V, until the band of pink dye reached the base of the plate. At this stage, the 
power supply switched off, and the electrode assembly was taken out of the buffer tank.
2.2.93 Transfer o f  polypeptides to PVDF membrane
The proteins need to be transferred from gel to the membrane so as so make them accessible 
to the antibody. The gel cassette was removed from the electrode assembly and the glass 
plates were separated using a gel releaser. Transfer buffer, consisting of 16 mM Tris-HCl, 
120 mM glycine and 20% (v/v) methanol, pH 8.3, was prepared up to 1 litre and was poured 
into the electrophoresis tank. The gels were floated off in a tray filled with transfer buffer. 
The PVDF membrane, which had been pre-wetted in 100% methanol, scotch brite, blotting 
paper and the gels were immersed and equilibrated in the same buffer for 5 min. A PVDF 
membrane and the gel were sandwiched between two single pieces of blotting paper and 
secured between two pieces of scotch brite in the transfer cassette. The gel was facing the 
black side (negative electrode) of the transfer cassette, and these cassettes were then inserted
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into the transfer module placed in the electrophoresis tank filled with transfer buffer. The 
proteins from the gel were transferred onto the membrane at a constant current of 400 mA 
and a voltage of 100 V for 1 h in the cold room (4-8°C).
2.2.9.4 Detection and visualisation o f  proteins
Upon completion of the transfer, the membrane was placed into 50 ml Falcon tubes 
containing 7.5% (w/v) Marvel Milk powder dissolved in washing buffer (Tris-buffered 
saline (TBS), pH 7.6, containing 0.1% Tween-20). The detection of proteins bound to the 
membrane was achieved in three steps, each lasting for 1 h and executed at room 
temperature. Firstly, to prevent any non-specific binding of primary and secondary 
antibodies, each membrane is blocked with 7.5% (w/v) Marvel Milk, followed by incubation 
with the primary antibody and, finally, with secondary antibody conjugated with horseradish 
peroxidase (HRP). The membrane was washed 3 times for 10 min in washing buffer at the 
end of each of these three steps. The protein bands were visualised using an ECL advance 
detection system for the less detectable proteins (sensitivity ~ 1 pg) and/or ECL Plus 
Western blotting detection system for the most detectable protein (sensitivity ~ 5 pg). At this 
point, the membrane was transferred to a flat glass plate, with the protein side facing 
upwards. Detecting reagents were mixed and poured over the entire membrane prior to 
incubation for 5 min. Following incubation, the membrane was wrapped with saran wrap 
with the protein facing upwards and placed in a film cassette. The development and 
exposure of the membrane to x-ray film were performed in a dark room. The density o f the 
protein bands developed on x-ray film was quantified using the GeneTool software 
(Syngene Corporation, Cambridge, U.K). The band representing the control was assigned a
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value of 100%, while the bands representing treatment(s) were expressed as percentage of 
the control. Finally, the blots were stripped using a Restore™ PLUS western blot stripping 
buffer and re-probed with anti p-actin and LDH antibodies to normalise for differences in 
protein loading of microsomal and cytosolic proteins respectively.
2.2.10 Determination o f mRNA levels in rat liver slices
Using reverse transcription (RT) real time-PCR (RT-PCR), mRNA levels in rat liver slices 
were quantified. mRNA was converted into complementary DNA (cDNA) followed by 
DNA amplification by real-time PCR. This technique has advantages over the traditional 
PCR which is inaccurate and less sensitive, and also more laborious. An amplification of 
small nucleic acid segments to a huge number of exact copies of DNA is achieved by RT- 
PCR and detected by fluorescence.
2.2.10.1 RNA Extraction
Rat liver slices were prepared as described in Section 2.2.2.1. Optimum incubation time was 
established and later applied to study the effect of isothiocyanates on the mRNA levels of 
the genes of interest; three slices per replication were used. To avoid the possibility of inter­
individual variation, all slices were taken from the same animal. On completion of the 
incubation, the slices were washed briefly in 0.154 M KCl containing 50 mM Tris-HCl 
buffer, pH 7.4, and immediately frozen in liquid nitrogen and stored at -80°C. The RNA 
Later ice solution was added into the slices, 0.3 ml per three slices in order to protect RNA 
from degradation during long-term storage. Prior to homogenisation, the slices were cooled 
down for 24 hr at -20°C and then left at room temperature to thaw. Homogenisation was
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performed using UVed hand-held micropestles, followed by RNA extraction using 
NucleoSpin® RNA II, Total RNA Isolation System. Throughout this procedure, it was 
ensured that all solutions and equipment were free from DNase and RNase, to avoid the 
possible contamination and to minimise the RNA degradation. Lastly, total RNA was eluted 
using RNase-free water and kept at -20°C prior to quantification.
2.2.10.2 RNA quality determination
To study gene expression, the purity of RNA was essentially determined using Nanodrop 
(Lab, East Sussex, U.K). A ratio of absorbance readings at 260 to 280 nm greater than 1.8 
denoted acceptable RNA purity. In addition, an electrophoresis analysis was also performed 
to confirm purity. At this stage, aliquots (2 pi) of RNA were mixed with Orange G dye (5 
pi) and loaded onto 1% agarose containing 5 pg/ml ethidium bromide in Ix TAE buffer, a 
mixture of 40 mM Tris base, 40 mM glacial acetic acid and 1 mM EDTA. Two ribosomal 
bands at 286' and 186 were observed using GeneTool software (Syngene Corporation, 
Cambridge, UK) showing that the eluted RNA is pure, and a ratio of 286:186 greater than
2.0 was considered to indicate high quality intact RNA (Vendrely et al., 1968). 
Concentration of RNA (ng/ml) was determined using Nanodrop (Lab, East Sussex, U.K).
2.2.10.3 DNase I  treatment
As a result of the sensitivity of the method and in order to avoid amplification of 
contaminating genomic DNA, the elimination of DNA is critical. At this point, 5 pg/ml of 
RNA was treated with DNase I prior to cDNA synthesis. In 0.2 ml tubes, the reaction 
mixture consisted of 2 pi of RNase-free DNase I. To make the total volume to 20 pi, RNase-
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free water was added that included 2 pi of DNase stop solution (20mM EOT A, pH 8.0), 
which was added at the end of the incubation at 37°C for 30 min. Following addition of the 
DNase stop solution, the mixture was farther incubated at 65 °C for 10 min in a Peltier 
Thermal Cycler (MJ Research PCT-225) to inactivate the DNase.
2.2.10.4 cDNA synthesis
Synthesis of cDNA was carried out by mixing 1 pg (4 pi) of DNased RNA to 5 pi of RNase- 
free water, 1.5 pi of mM dNTPs, and 1.5 pi of 150 ng/pl random hexamers. The reaction 
mixtures were then incubated at 65°C for 5 min in a Peltier Thermal Cycler and then cooled 
down on ice for at least 2 min. Meanwhile, a bulk mix for RT (RT+) was prepared which 
comprised, for one sample, 0.75 pi RNase-free water, 4 pi of 5x RT buffer, 2 pi of 0.1 M 
DTT, 1 pi of 40 U/pl RNase OUT RNase inhibitor, and 0.25 pi of 200 U/pl Superscript II 
reverse transcriptase. Moreover, a bulk mix for control RT (RT-) was also prepared as 
described above by excluding addition of RNase OUT and Superscript II reverse 
transcriptase. Any amplification of this control would indicate the existence of 
contaminating genomic DNA during the RNA sample preparation. An 8 pi of the mixture 
(RT+ or RT-mix) was added to 12 pi of DNased-RNA, and this new mixture was then 
incubated at 25°C for 10 min followed by 50 min at 42°C, and finally 15 min at 70°C in 
PCR machine. The samples were kept at -20°C and were mixed well with 80 pi of RNase- 
free water prior to use.
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2.2.10.5 Quantitative PCR
Using Primer Express® version 2 software (Applied Biosystems, Warrington, U.K), primers 
and probes for rat CYPlAl and NQOl genes were designed. To normalise gene 
quantification, 186 rRNA, a housekeeping gene, was used as an internal standard. Dual label 
probes were used which had been labelled with reporter dye (6-FAM) at the 5 '-end, while 
the 3 '-end was labelled with TAMRA quencher. The oligonucleotide sequences of the 
primers and probes are as follows:
CYPlAl
5' primer: GCCTTCACATCAGCCACAGA 
3' primer: TTGTGACTCTAACCACCCAGAATC 
Probe: TGGCCGTCACCACATTCTGCCTT
NQOl
5 'primer: GAGGTTCAAGAGGAGCAGAAAAAG
3 'primer: GTTGTCGGCTGGAATGGACTT 
Probe: TTTGGCCTTTCTGTGGGCCATCA
766
5' primer: CGGCTACCACATCCAAGGAA 
3' primer: GCTGGAATTACCGCGGCT 
Probe: TGCTGGACACAGACTTGCCCTC
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The primers and probes were diluted to the appropriate concentrations using O.lx TAE 
buffer. Typically, to avoid cross contamination because of multiple pipetting, a bulk mix for 
a number of genomic standards and cDNA of RNA samples (form RT+) was prepared 
together with its individual control (form RT-).
The following were used for one RNA sample:
Forward primer (10 pmol/pl stock) 1.0 pi
Reverse primer (10 pmol/pi stock) 1.0 pi
Probe (5 pmol/pl stock) 0.5 pi
RNase-free water 5.0 pi
Taqman® Universal PCR MasterMix 12.5 pi
Using 96-well plates, 5 pi of cDNA or genomic standard and 20 pi of bulk mix were added 
into each well. Genomic standards were assayed in duplicate, while samples were analysed 
in triplicate. The reaction plate was then sealed with an optical adhesive cover, followed by 
spinning at 1000 x g for 2 min using a centrifuge (Eppendorf, Centrifuge 5810, Hamburg, 
Germany) before loading onto the ABI Prism 7000 sequence detection system (Applied 
Biosystem, Warrington, U.K.). Gene expression and its number of copies were determined 
by using real-time PCR (RT-PCR). The fluorescent detection of accumulated PCR product 
was carried out under the thermo cycler settings shown in Table 2.1.
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Table 2.1; Thermal cycler settings for quantitative PCR.
Stage Tem perature (°C) Time Cycles
1 50 2 min 1
2 95 10 min 1
95 15 s
3 40
60 1 min
To get the precise number of copies from DNA amplification, a threshold cycle (Ct) was 
then set in the exponential phase of the amplification plots. Quantity of DNA present in each 
sample was determined based on the rate at which the cycle number reached the threshold, 
the earlier this threshold was attained indicates the more DNA.
2.2.10.6 Genomic DNA standard
Using a standard curve created by amplifying known amounts of target DNA, an absolute 
PCR quantification can be achieved. Rat genomic DNA standard was set up and serial 
dilutions were carried out to provide a stock solution of 0 to 10  ^single strand DNA per 5 pi 
using O.lx TAE, which stored at -20°C.
2.2.11 Statistical evaluation
The results are presented as mean ± standard deviation. Statistical evaluation was carried out 
by one-way ANOVA followed by the Dunnett’s test. The statistical significance is expressed 
as follows:
P<0.05 significant (*) or (t)
P<0.01 very significant (**) or (tt)
P<0.001 highly significant (***) or ( f t t )
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CHAPTER 3
A comparison of the potential of sulforaphane isomers 
to modulate carcinogen-metabolising enzymes in 
precision-cut rat liver and lung slices
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3.1 Introduction
Sulforaphane is one of the most promising chemopreventive phytochemicals belonging to 
the isothiocyanate class (Fimognari and Hrelia, 2007). In animal models of cancer, 
sulforaphane afforded protection against the carcinogenicity induced by chemicals, such 
as polycyclic aromatic hydrocarbons, in a number of tissues as well as against UV-light 
induced skin carcinogenesis (Zhang, 2004; Chung et al., 2000; Fahey at al., 2002; 
Dinkova-Kostova et al., 2006; Shen et al., 2007). The chemopreventive activity of 
sulforaphane appears to involve a multitude of mechanisms, acting both at the initiation 
and post-initiation stages of cancer (Fimognari and Hrelia, 2007). One of its principal 
mechanisms o f action is to protect against DNA damage by limiting the availability o f the 
metabolically-generated genotoxic metabolites of carcinogenic compounds. This can be 
achieved either by suppressing the cytochrome P450-mediated generation and/or 
facilitating the detoxification of the genotoxic intermediates.
Numerous examples have been documented where compounds that differ in chirality 
show varying biological activities. Epipolythiopiperazine-2,5-diones (ETPs), an 
important class of biologically active fungal metabolites, have a R,R configuration that 
presented antiviral properties, whereas the S,S configuration was devoid of antiviral 
activity (Hume et al., 1997). Cefozopran, the 4^^-generation of cephalosporins, exists in 
the two forms, cw-isomer and trans-isomer; the antibacterial activity of the cw-isomer is 
more potent than that of the ?ram-isomer (Liu et al., 2010). Furthermore, astaxanthin, 
typically known as aW-trans astaxanthin, is a red-orange carotenoid pigment that is 
readily isomerised to cis-trans, especially 9-cis and 13-cis isomers; these isomers showed 
higher antioxidant potency than the trans-isomer (Liu and Osawa, 2007).
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Most studies using sulforaphane, including chemopreventive studies in animal models, 
employed racemic sulforaphane because it was the only form commercially available. As 
humans are exposed exclusively to i?-sulforaphane through the diet, it was considered 
prudent to investigate the potential of this isomer, in comparison to 6-sulforaphane, to 
modulate carcinogen-metabolising enzyme (Figure 3.1). These studies were conducted in 
the liver, the principal site of carcinogen metabolism, and the lung, this being a target 
tissue for sulforaphane and other isothiocyanates.
V ?
—C—S ^ ^
i?-sulforaphane 6-sulforaphane
Figure 3.1: Structure of R- aud 6-sulforaphaue
3.2 Methods
3.2.1 Effect o f R- and S-sulforaphane on carcinogen-metabolising enzymes in rat liver 
and lung slices
Rat liver and lung slices were prepared using a Krumdieck tissue sheer as already 
described (sections 2.2.2.1 and 2.2.2.2). Tissue slices were incubated in culture medium 
supplemented with either R- or 6-sulforaphane (0-25 pM) for 24 h (see section 2.2.2.4); 
the isomers were dissolved in DMSO so that the final concentration was 1.5 pl/ml of 
incubation medium. Following incubation, slices were removed and microsomal and 
cytosolic fractions were prepared by differential centrifugation (see section 2.2.4). 
Epoxide hydrolase and UDP-glucuronosyltransferase activities were determined in the
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microsomal fractions as described in sections 2.2.7.3 and 2.2.7.4. The following 
determinations were carried out in the cytosolic fractions: quinone reductase (NQOl) 
using menadione as substrate, glutathione 6-transferase activity monitored using CDNB 
as accepting substrate and total glutathione levels (see sections 2.2.7.1, 22.1.2  and 
2.2.7.7). Protein concentration in both fractions was determined using bovine serum 
albumin as standard (section 2.2.8). Finally, in order to monitor whether increase in 
enzyme activities involves a rise in enzyme availability. Western immunoblotting was 
performed as described in section 2.2.9. LDH release from liver and lung slices into the 
incubation medium was used as an index of cytotoxicity of R- and 6-sulforaphane in the 
culture medium (section 2.2.3).
3.2.2 Modulation o f  carcinogen-metabolising enzymes in rat hepatoma F  AO cells by R- 
and S-sulforaphane
Similar studies were conducted in the rat hepatoma FAQ cell line. Cells were maintained 
and grown as described in section 2.2.5.1. At a density of 4 x 10"^  cells/ml, the cells were 
seeded and cultured for 24 h (section 2.2.5.1). R- and 6-sulforaphane (0-25 pM) were 
prepared in DMSO and subsequently diluted in serum-free media so that the final 
concentration of the solvent was 0.1% (v/v). Cells were incubated and the lysates were 
collected to prepare the post-mitochondrial supernatant (S9) and finally cytosolic and 
microsomal fractions (section 2.2.5.1). Quinone reductase (NQOl) and glutathione 6- 
transferase activities, total protein concentration and Western immunoblotting were 
performed as described above.
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3.2.3 MTT cytotoxicity assay on rat hepatoma FAO cells
Cytotoxicity in FAO cells was assessed using MTT, the method established by Mosmann, 
(1983). FAO cells, at a density of 4 x 10"^  eells/ml, were seeded (200 p, 1/well) into 96-well 
plates using Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% 
foetal bovine serum, Ix non-essential amino acids (NEAA), 100 U/ml penicillin and 100 
pg/ml streptomycin, and cultured for 24 h. Test compound solutions and incubation were 
similar as in section 3.2.2; MTT (5 mg/ml in PBS), was added into the wells (10 pi) 2.3 
hours before eompletion of the incubation. At the end of the incubation, medium 
containing MTT was removed, DMSO (100 pi) was added into the wells, and absorbance 
was read at 540 nm using an ELISA plate reader.
3.2.4 Activation o f  the Ah receptor
Activation of the Ah receptor by R- and 5"-sulfbraphane was assessed using the 
ehemically-activated luciferase expression (CALUX) assay (seetion 2.2.5.2.1). After 
reached 50-70% confluency in 24-well plates, the cells were then incubated with R- or S- 
sulforaphane and/or benzo[a]pyrene (10'^^ to 10'  ^ M), dissolved in DMSO, for 24 h at 
37°C and 5% CO2 in a humid environment, and subsequently washed with PBS; 100 pi 
of lysis reagent was added into each well and further incubated for 15 minutes at room 
temperature. Cell lysates were colleeted and centrifuged at 13000 x g for 2 minutes, and 
luciferase activity in the supernatant was determined (seetion 2.2.5.2.1).
3.3 Results
3.3.1 LDH and MTT cytotoxicity assays
The toxicity of both isomers, as exemplified by the leakage of laetate dehydrogenase, was 
investigated in both rat liver and lung slices. In both tissues, a small but statistieally
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significant increase in leakage was seen at the highest concentration of sulforaphane 
employed (25 pM); no difference could be discerned between the two isomers (Figure 
3.2).
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Figure 3.2: Leakage of LDH following incubation of ra t liver and lung slices with R- 
or S'-sulforaphane. LDH leakage was measured in rat liver and lung slices incubated 
with R- or ^'-sulforaphane (0-25 pM) for 24 h. Results are presented as mean ± SD of 
three slices, each analysed in duplicate. *, P<0.05; **, P<0.01; ***, P<0.001.
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Similarly, a statistically significant decrease in FAO cell viability was observed at the 
highest concentration of both sulforaphane isomers (Figure 3.3).
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Figure 3.3: Cytotoxicity assay of the sulforaphane isomers in ra t hepatom a FAO 
cells. FAO cells (4 x 10"^  cells/ml) were incubated with R- or ^'-sulforaphane (0-25 pM) 
for 24 h; 10 pi MTT (5 mg/ml in PBS), was added into the wells 2.3 hours before 
completion of the incubation. At the end of the incubation, the medium containing MTT 
was removed, DMSO (100 pi) was added into the wells, and absorbance was read at 540 
nm using an ELISA plate reader. Results are expressed as mean ± SD of triplicate 
determinations. *, P<0.05; **, P<0.01; ***, P<0.001 when compared to the zero 
concentration.
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3.3.2 Effect o f  R- and S-sulforaphane on carcinogen-metahoUsing enzymes in rat liver 
slices
The effect of exposure of rat liver precision-cut slices to the two sulforaphane isomers on 
the three members of the CYPl family was determined immunologically (Figure 3.4). 
CYPlAl and CYP1A2 were the most sensitive proteins to induction by the sulforaphane 
isomers, but i?-sulforaphane was the more potent, especially in the case of CYP1A2. 
Although the levels of CYPIBI also rose, the effect was more modest and no clear 
difference could be discerned between the two isomers, ^-sulforaphane stimulated 
hepatic quinone reductase and glutathione 5-transferase activities, but no rise in either 
activity was observed in the case of the 5-isomer (Figures 3.5 and 3.6); at the highest 
concentrations, both compounds suppressed quinone reductase activity and, in the case of 
the 5-isomer, glutathione 5-transferase. Only the ^-isomer was effective in up-regulating 
glutathione 5-transferase activity, whereas 5-sulforaphane suppressed the activity at the 
highest concentration. In rat liver slices, both isomers up-regulated the enzyme 
expression of quinone reductase, with the i?-isomer being more effective (Figure 3.5). R- 
sulforaphane increased the expression of GSTa whereas the effect of the 5-isomer was 
marginal; to a lesser extent R-sulforaphane elevated the levels of GSTp whereas no such 
effect was evident in the case of the 5-isomer (Figure 3.6).
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Figure 3.4: Up-regulation of CYPl apoprotein levels by R- and 5-sulforaphane in 
precision-cut liver slices. Precision-cut rat liver slices were incubated with either R- or 
5-sulforaphane (0-25 pM) for 24 h; slices were pooled and microsomes isolated. The 
immunoblot analysis was carried out by exposure to mouse anti-rat CY PlA l, mouse anti­
rat CYP1A2 or rabbit anti-rat CYPIBI primary antibodies followed by the appropriate 
peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg of total 
protein. The blots were stripped and re-probed with anti-|3-actin antibody to normalise for 
differences in protein loading.
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Figure 3.5: Modulation of quinone reductase activity and expression in precision-cut 
liver slices by R- and 5-sulforaphane. Precision-cut rat liver slices were incubated with 
R- or 5-sulforaphane (0-25 pM) for 24 h; slices were pooled and the cytosolic fraction 
was isolated and quinone reductase determined. Results are presented as mean ± SD of 
three replicates, each comprising 10 slices/ml. The immunoblot analysis was carried out 
by exposure to rabbit anti-rat NQOl primary antibody followed by the appropriate 
peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg of total 
protein. The blots were stripped and re-probed with anti-LDH antibody to nomialise for 
differences in protein loading. *, P<0.05; **, P<0.01; ***, P<0.001 when compared to 
the 0 concentration. P<0.05; P<0.01; ttt>  P<0.001 when compared to the 5-isomer.
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Figure 3.6: Modulation of glutathione 5-transferase activity and expression in 
precision-cut liver slices by R- and 5-sulforaphane. Precision-cut rat liver slices were 
incubated with R- or 5-sulforaphane (0-25 pM) for 24 h; slices were pooled and the 
cytosolic fraction was isolated and glutathione 5-transferase deteiinined. Results are 
presented as mean ± SD o f three replicates, each comprising 10 slices/ml. The 
immunoblot analysis was carried out by exposure to rabbit anti-rat GSTAl-1 or GSTMl- 
1 primary antibodies followed by the appropriate peroxidase-labelled secondary antibody. 
Each lane was loaded with 30 pg o f total protein. The blots were stripped and re-probed 
with anti-LDH antibody to noimalise for differences in protein loading. *, P<0.05; **, 
P<0.01; ***, P<0.001 when compared to the 0 concentration, f , P<0.05; j^", P<0.01; ttt^  
P<0.001 when compared to the 5-isomer.
When the rat liver slices were exposed to the isomers of sulforaphane, the i?-isomer 
doubled glucuronyl transferase activity whereas the 5-isomer, under the same conditions, 
impaired the activity (Figure 3.7). In concordance, i?-sulforaphane elevated protein levels 
by about 40% whereas the 5-isomer decreased the levels at concentrations o f 2.5 pM and 
above (Figure 3.7).
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Figure 3.7: Modulation of UDP-glucuronosyl transferase activity and expression in 
precision-cut ra t liver slices by R- and 5-sulforaphane. Precision-cut rat liver slices 
were incubated with R- and 5-sulforaphane (0-25 pM), for 24 h; slices were pooled and 
microsomes isolated, and UDP-glucuronosyl activity was determined. Results are 
presented as mean ± SD for three pools o f slices, each comprising 10 slices/ml. The 
immunoblot analysis was carried out by exposure to goat anti-rabbit glucuronosyl 
transferase (UGT1A6) primary antibody followed by the appropriate peroxidase-labelled 
secondaiy antibody. Each lane was loaded with 30 pg of total protein. The blots were 
stripped and re-probed with anti-^-actin antibody to noimalise for differences in protein 
loading. *, P<0.05; **, P<0.01; *»*, P<0.001.
Although both isomers enhanced epoxide hydrolase activity, in the case o f the i^-isomer a 
maximal 65% rise was achieved at the 2.5 pM concentration, whereas a 50% maximal
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rise was noted following incubation of the slices with 5-sulforaphane, but at the 10 pM 
concentration; this is also reflected in the protein levels monitored immunologically 
(Figure 3.8).
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Figure 3.8: Modulation of epoxide hydrolase activity and expression in precision-cut 
rat liver slices by R- and 5-sulforaphane. Precision-cut rat liver slices were incubated 
with R- and 5-sulforaphane (0-25 pM), for 24 h; slices were pooled and microsomes 
isolated, and epoxide hydrolase activity was determined. Results are presented as mean ± 
SD for three pools of slices, each comprising 10 slices/ml. The immunoblot analysis was 
canied out by exposure to rabbit anti-rat epoxide hydrolase primary antibody followed by 
the appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg 
of total protein. The blots were stripped and re-probed with anti-|3-actin antibody to 
normalise for differences in protein loading. *, P<0.05; **, P<0.01; ***, P<0.001.
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i^-sulforaphane increased hepatic total glutathione levels but in the case o f 5-sulforaphane 
a rise was seen only at the lowest concentration studied, and decreased below control 
levels at all higher concentrations (Figure 3.9).
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Figure 3.9: Modulation of total glutathione levels in precision-cut liver slices by R~ 
and 5-sulforaphane. Precision-cut rat liver slices were incubated with R- or 5- 
sulforaphane (0-25 pM) for 24 h; slices were pooled and the cytosolic fraction was 
isolated and total glutathione levels determined. Results are presented as mean ± SD of 
three replicates, each comprising 10 slices/ml. *, P<0.05; **, P<0.01; ***, P<0.001 when 
compared to the 0 concentration, f, P<0.05; ft? P<0.01; ftt^ P<0.001 when compared to 
the 5-isomer.
3.3.3 Effect o f  R- and S-sulforaphane on carcinogenic-metabolising enzymes in rat 
lung slices
C Y PlAl and CYPIBI, at the protein level, were also inducible in the lung, with the R- 
isomer being clearly the more potent of the two isomers (Figure 3.10).
In the lung, both isomers elevated quinone reductase activity, with ^^-sulforaphane being 
more potent, giving rise to a statistically significant rise at 1.0 pM whereas a 10-fold 
higher concentration was required in the case o f 5-sulforaphane (Figure 3.11). Only the
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R-isomer was effective in up-regulating glutathione 5-transferase activity; whereas 5- 
sulforaphane, as observed in the liver, suppressed the activity at the highest concentration 
(Figure 3.12). In the lung, /^-sulforaphane was more effective than the 5-isomer in up- 
regulating the expression of quinone reductase (Figure 3.11), whereas GSTa expression 
was moderately increased only by/^-sulforaphane (Figure 3.12).
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Figure 3.10: Up-regulation of CY Pl apoprotein levels by R -  and 5-sulforaphane in 
precision-cut lung slices. Precision-cut rat lung slices were incubated with either R- or 5- 
sulforaphane (0-25 pM) for 24 h; slices were pooled and microsomes isolated. The immunoblot 
analysis was carried out by exposure to mouse anti-rat CYPlAl or rabbit anti-rat CYPIBI 
primary antibodies followed by the appropriate peroxidase-labelled secondary antibody. Each 
lane was loaded with 30 pg of total protein. The blots were stripped and re-probed with anti-(3- 
actin antibody to normalise for differences in protein loading.
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Figure 3.11: Modulation of quinone reductase activity and expression in precision- 
cut lung slices by R- and 5-sulforaphane. Precision-cut rat lung slices were incubated 
with R- or 5-sulforaphane (0-25 pM) for 24 h; slices were pooled and the cytosolic 
fraction was isolated and quinone reductase detennined. Results are presented as mean ± 
SD of three replicates, each comprising 10 slices/ml. The immunoblot analysis was 
canied out by exposure to rabbit anti-rat NQOl primary antibody followed by the 
appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg of 
total protein. The blots were stripped and re-probed with anti-LDH antibody to normalise 
for differences in protein loading. *, P<0.05; **, P<0.01; ***, P<0.001 when compared 
to the 0 concentration, f , P<0.05; t'N P<0.01; ttt?  P<0.001 when compared to the 5- 
isomer.
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Figure 3.12: Modulation of glutathione 5-transferase activity and expression in 
precision-cut lung slices by R- and 5-sulforaphane. Precision-cut rat lung slices were 
incubated with R- or 5-sulforaphane (0-25 pM) for 24 h; slices were pooled and the 
cytosolic fraction was isolated and glutathione 5-transferase detennined. Results are 
presented as mean ± SD of three replicates, each comprising 10 slices/ml. The 
immunoblot analysis was carried out by exposure to rabbit anti-rat GSTAl-1 primary 
antibody followed by the appropriate peroxidase-labelled secondary antibody. Each lane 
was loaded with 30 pg o f total protein. The blots were stripped and re-probed with anti- 
LDH antibody to normalise for differences in protein loading. *, P<0.05; **, P<0.01; 
***, P<0.001 when compared to the 0 concentration, f , P<0.05; P<0.01; ttt?
P<0.001 when compared to the 5-isomer.
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Both isomers elevated pulmonary total glutathione levels with the R-isomer being 
markedly more potent than 5-isomer (Figure 3.13).
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Figure 3.13: Modulation of total glutathione levels in precision-cut lung slices by R- 
and 5-sulforaphane. Precision-cut rat lung slices were incubated with R- or 5- 
sulforaphane (0-25 pM) for 24 h; slices were pooled and the cytosolic fraction was 
isolated and total glutathione levels deteimined. Results are presented as mean ± SD of 
three replicates, each comprising 10 slices/ml. *, P<0.05; **, P<0.01; ***, P<0.001 when 
compared to the 0 concentration. P<0.05; If? P<0.01; ftt?  P<0.001 when compared to 
the 5-isomer.
3.3.4 Effect o f  R- and S-sulforaphane on carcinogen-metabolising enzymes in rat 
hepatoma FAO cells
In the rat hepatoma FAO cell line, /?-sulforaphane caused a very marked rise in quinone 
reductase activity, whereas the 5-isomer was far less effective; similarly, protein levels 
rose more markedly in the case o f the /^-isomer and only marginally in the case o f  the 5- 
isomer (Figure 3.14). Glutathione 5-transferase activity was elevated following exposure 
of the cells to /^-sulforaphane whereas no such effect was seen with 5-sulforaphane; only 
the /^-isomer increased GSTa protein levels (Figure 3.15).
91
Chapter 3: Modulation o f enzyme systems by sulforaphane isomers
ttt
I I  
s  s.
1  s  
= 1
Î1
12 1 
10
0 1 2.5 10 25
i?-sulforaphane (pM)
1 1
^ a  
% S
IIs
12 1 
10
8 
6 
4 
2
I  0 i  I il
0 1 2.5 10 25
5-suIforaphane (pM)
0 1 2 ,5  10 25
/^-sulforaphane (pM)
sQ
I
0
1 2 -J
1 2 .5  10 25
5-sulforaphane (pM)
Figure 3.14: Effect of R- and 5-sulforaphane on quinone reductase activity and 
expression in FAO cells. FAO cells (4 x 10“^ cells/ml) were incubated with R- or 5- 
sulforaphane (0-25 pM) for 24 h; activity is presented as mean ± SD of three replicates. 
*, P<0.05; **, P<0.01; ***, P<0.001 when compared to the 0 concentration, f  P<0.05; 
t t ,  P<0.01; t t t ,  P<0.001 when compared to the 5-isomer. The immunoblot analysis was 
carried out by exposure to rabbit anti-rat NQOl primary antibody followed by the 
appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 10 pg of 
total protein. The blots were stripped and re-probed with anti-LDH antibody to normalise 
for differences in protein loading.
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Figure 3.15: Effect of R- and ^'-sulforaphane on glutathione ^'-transferase activity 
and expression in FAO cells. FAO cells (4 x 10  ^cells/ml) were incubated with R- or S- 
sulforaphane (0-25 pM) for 24 h; activities are presented as mean ± SD of three 
replicates. *, P<0.05; **, P<0.01; ***, P<0.001 when compared to the 0 concentration, t ,  
P<0.05; t t ,  P<0.01; t t t ,  P<0-001 when compared to the S'-isomer. The immunoblot 
analysis was carried out by exposure to rabbit anti-rat GSTAl-1 primary antibody 
followed by the appropriate peroxidase-labelled secondary antibody. Each lane was 
loaded with 10 pg of total protein. The blots were stripped and re-probed with anti-LDH 
antibody to normalise for differences in protein loading.
3.3.5 Activation o f  the Ah receptor
In studies to determine the ability of R- and j"-sulforaphane to activate the Ah receptor, R- 
isomer was found to be relatively a better ligand than the 5'-isomer, attaining 10% and 4%
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of binding, respectively. However, when comparing to benzo[a]pyrene, both isomers 
were very weak agonists of the Ah receptor (Figures 3.16).
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Figure 3.16: Activation of the Ah receptor by benzo[a]pyrene, R- and S- 
sulforaphane. H lL l.lc2  cells (7 x 10"^  cells/ml) were incubated in culture medium 
supplemented with benzo[a]pyrene or R- and ^sulforaphane (10'^^ - lO'^M) for 24 h. a 
Benzo[a]pyrene, A i?-sulforaphane, ♦ ^'-sulforaphane. Activation of the receptor is 
expressed as % of that achieved by TCDD (10^ M). Results are presented as mean ±  SD 
of triplicate determinations.
3.4 Discussion
One of the principal mechanisms through which isothiocyanates elicit their 
chemopreventive activity is by suppressing the interaction of the reactive intermediates of 
carcinogenic chemicals with DNA. Indeed, sulforaphane suppressed the DNA binding of 
the polycyclic aromatic hydrocarbons benzo[a]pyrene and 1,6-dinitropyrene in human 
mammary epithelial cells (Singletary and MacDonald, 2000), and the formation of DNA 
adducts with the heterocyclic amine 2-amino-l-methyl-6-phenylimidazo[4,5-6]pyridine 
(PhIP) in human hepatocytes (Bacon et al., 2003). This can be achieved either through 
inhibition of the cytochrome P450-mediated bioactivation of chemical carcinogens to 
genotoxic metabolites and/or by increased detoxification of these by up-regulation of
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phase II enzymes. Sulforaphane is a mechanism-based inhibitor that can impair 
cytochrome P450 activity (Yoxall et al., 2005; Hanlon et al., 2008c). Moreover, 
sulforaphane up-regulates, in both rat liver and lung, detoxification enzymes such as the 
glutathione ^-transferase and quinone reductase (Hanlon et al., 2009b; 2009c; 2008c). 
However, these studies employed the commercially-available racemate i?,5'-sulforaphane 
whereas humans are exposed through the diet exclusively to the R-isomer. Consequently, 
the present study was undertaken to compare the ability of the R- and 5"-isomers to 
modulate carcinogen-metabolising enzymes in two in vitro systems, precision-cut rat 
liver and lung slices and rat hepatoma FAO cells.
3.4,1 Modulation o f  cytochrome P450 enzymes by sulforaphane isomers 
Studies with synthetic i?,5'-sulforaphane have shown that sulforaphane up-regulates CYPl 
enzymes in the liver and lung of rats, but since it is a mechanism-based inhibitor no 
commensurate increase in activity is observed (Hanlon et al., 2008b; 2009b; 2009c). For 
this reason changes in cytochrome P450 expression were monitored only at the protein 
level employing immunoblotting. In the liver, both isomers up-regulated CY PlAl, 
CYP1A2 and, to a lesser extent, CYPIBI but in all cases the effect tended to be more 
potent with R-sulforaphane, especially in the case of CYP1A2. The difference between 
the two isomers is more pronounced in the lung where the R-isomer was more effective 
in up-regulating CYPlAl and CYPIBI; CYP1A2 is not expressed in the lung (loannides 
and Lewis, 2004). The mechanism for this difference in the up-regulation of CYPl 
enzymes is not clear but may be related to the fact that, although both isomers are poor 
ligands to the Ah receptor that up-regulates CYPl expression, the R-isomer is relatively a 
better ligand than the S'-isomer.
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3.4.2 Modulation o f  phase II detoxification enzymes by sulforaphane isomers 
In rat liver slices the R-isomer increased quinone reductase activity but no such effect 
was manifested when the 6"-isomer was used; although both isomers stimulated this 
activity in the lung, once again the R-isomer was more effective. A similar picture 
emerges at the protein level, in both tissues, indicating that the difference in activity 
reflects differences in enzyme availability. It is noteworthy to point out that quinone 
reductase is an enzyme activity regulated by the Ah receptor (Tijet et al., 2005). 
Glutathione «S-transferase was monitored using CDNB, a substrate metabolised by a 
number of isoenzymes such as GSTa and p (Ricci et al., 1994). R-sulforaphane elevated 
this activity in both liver and lung slices but ^'-sulforaphane had no effect in the liver and 
was less effective in the lung. At the protein level, GSTa levels increased moderately in 
both lung and liver following exposure to R-sulforaphane whereas the 5'-isomer was 
devoid of such activity. Similarly, hepatic GSTp levels were up-regulated only by the R- 
isomer. The up-regulation of phase II enzymes by sulforaphane involves the antioxidant 
response element (ARE), the transcription of which is regulated by Nrf2 (Juge et al., 
2007). The marked difference in the ability of the two isomers to up-regulate these 
enzymes may reflect different potential in preventing the Keapl-mediated degradation of 
Nrf2.
This difference appears to extend to glucuronosyl transferase activity and expression in 
rat liver slices, which were up-regulated only by the R-isomer whereas, in contrast, S- 
isomer impaired the activity and decreased protein levels. UDP-glucuronyltransferases 
are a very important phase II biotransformation enzyme system participating in the 
metabolism of major classes of chemical carcinogens including polycyclic aromatic 
hydrocarbons and aromatic amines (Bock, 2006). A major isoform is UGTIA6, which
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was monitored in the present studies immunologically as it is the most important in 
carcinogen metabolism (Bock, 2006). The UGTIA6 level was elevated about 40% by R- 
sulforaphane, whereas the R-isomer decreased the levels at concentrations of 2.5 pM and 
higher. The rise in activity was the consequence of increased enzyme availability, as 
indicated in the Western blot studies. These findings are contradicted with in vivo studies 
where exposure of rats to R,6'-sulforaphane failed to increase the activity of this enzyme 
in the liver (Yoxall et al 2005). As in this study the racemate was used, a possible 
explanation of this discrepancy is that in the in vivo studies, represent the sum of the 
effects of the two isomers, the R-isomer that elevates activity and of the R-isomer that 
suppress activity. At the mRNA level, however, sulforaphane increased U GTlA l 
expression in HepG2 cells (Bacon et al., 2003). The present studies support previous 
findings where consumption of a cruciferous vegetable diet led to enhanced 
glucuronidation of the heterocyclic amine PhIP (2-amino-1 -methyl-6-phenylimidazo[4,5- 
èjpyridine) in human volunteers, although other components in the vegetables are likely 
to have also contributed to the up-regulation of this enzyme (Walters et al., 2004). 
Similarly, in recent studies consumption of diets supplemented with cruciferous 
vegetables lowered the levels of serum bilirubin, the glucuronidation of which is 
catalysed by UGTlAl (Navarro et al., 2009). U GTlA l is also regulated by the Ah 
receptor (Tijet et al., 2006; Waard et al., 2008) and it is possible that the mechanism for 
this difference between of two isomers in the up-regulation of this enzyme may be related 
to the fact that, although both isomers are poor ligands to the Ah receptor, the R-isomer is 
relatively a better ligand than the 6"-isomer.
Epoxide hydrolase detoxifies epoxides, which are the reactive intermediates of many 
structurally-diverse chemicals including polycyclic aromatic hydrocarbons, mycotoxins
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such as aflatoxin Bi, and halogenated aliphatic compounds such as vinyl chloride 
(Decker et al., 2009). In this study, both isomers increased epoxide hydrolase activity in 
rat liver slices, with the R-isomer being somewhat more potent with a maximal 65% rise 
was achieved at the 2.5 pM concentration, whereas a 50% maximal rise was noted 
following incubation of the slices with R-sulforaphane, but was observed at the 10 pM 
concentration; this is also reflected in the protein levels monitored immunologically. 
However, this finding contradicts in vivo studies where epoxide hydrolase activity and 
protein levels were unaffected by R,R-sulforaphane treatment (Yoxall et al 2005).
Although both isomers increased total glutathione levels at the 1 pM concentration, at the 
higher concentrations (2.5 and 10 pM) only R-sulforaphane caused a rise in glutathione 
levels, whereas the 5'-isomer gave rise to a decrease in rat liver; in the case of rat lung, 
both isomers elevated total glutathione levels with the R-isomer being more potent. 
Sulforaphane is primarily metabolised through conjugation with glutathione (Conaway et 
al., 2002), and it is conceivable that the decrease in glutathione levels at high 
concentrations of R-sulforaphane in rat liver might reflect, at least partly, a more rapid 
metabolism of the R-isomer utilising the tripeptide. Such difference in metabolism may 
also contribute to the lower potency of the R-isomer in modulating carcinogen- 
metabolising enzymes as it would decrease its effective concentration in the culture 
medium. However, at present there is no experimental evidence to support this 
hypothesis.
Further studies were conducted in rat hepatoma FAO cells to ascertain the effect of 
sulforaphane isomers on carcinogen-metabolising enzymes in a different in vitro system 
to liver slices. In these cells, R-sulforaphane up-regulated quinone reductase and
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glutathione R-transferase activities, whereas the R-isomer was far less effective; similar 
observations were made at the protein level. These findings are commensurate with in 
vitro and in vivo studies where sulforaphane induced quinone reductase and thioredoxin 
reductase activities both in Hepalclc? mouse hepatoma cell and in male Fisher 344 rats 
(Hintze et al., 2003).
A general observation in both systems was that at the highest isothiocyanate 
concentration used (25 pM), the increases in activity of the various enzymes observed at 
lower concentrations were no longer evident, and even dropped below control levels. It is 
likely that this may reflect isothiocyanate toxicity to the slices and rat hepatoma FAO 
cells, and this is supported by the observation that at this concentration both sulforaphane 
isomers increased leakage of lactate dehydrogenase and decreased cell viability.
3.4.3 Validity o f the in vitro precision-cut slice systems
Although this study has been conducted in vitro in two distinct systems, it is important to 
emphasise that the precision-cut slice system has been validated repeatedly with respect 
to modulation of cytochromes P450 as well as Phase II enzymes by xenobiotics, at the 
activity, protein and mRNA levels; effects in vivo could be reproduced in cultured slices, 
using established inducing agents, including TCDD, Aroclor 1254, phenobarbitone, |3- 
naphthoflavone, benzo[a]pyrene, ciprofibrate and dexamethasone (Drahushuk et al., 
1996; Lake et al., 1996; Pushparajah et al., 2007). Similar conclusions were reached in 
studies using precision-cut lung slices (Pushparajah et al., 2007; Lake et al., 2003). In 
recent studies in precision-cut rat liver slices it was demonstrated that phenethyl 
isothiocyanate impairs the 0-demethylation of methoxyresorufin (Konsue and loannides, 
2010a), whereas it up-regulates quinone reductase and glutathione R-transferase (Konsue
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and loannides, 2010b), commensurate with observations made in in vivo studies (Konsue 
and loannides, 2008).
3.4.4 In vitro-in vivo extrapolation
It is also pertinent to highlight that both isomers up-regulate the expression and activity 
of the phase II enzymes in precision-cut rat slices at concentrations as low as 1 pM, and 
such concentrations are likely be attained in human plasma after cruciferous vegetable 
intake. In studies conducted in rat, a single oral dose of phenethyl isothiocyanate, 
equivalent to the human dietary intake, achieved a Cmax of about 2 pM (Konsue et al., 
2010), but was much lower in the case of racemic sulforaphane following similar 
treatment (Hanlon et al,, 2008b). Rats generally metabolise xenobiotics at higher rates 
than larger body weight animals, so that plasma levels in human are likely to be higher. 
In a human study conducted by Hanlon et al. (2009b), a single oral dose of 300 ml of 
liquidised broccoli, obtained from a local supermarket and containing low levels of 
sulforaphane, achieved plasma levels of about 0.1 pM. This is most likely due to the fact 
that broccoli even when stored at 4°C (Howard et al., 1997), or refrigerated during 
transport and storage (Vallejo et al., 2003), is subject to loss of total glucosinolates 
(Smith et al., 2003). However, hepatic intracellular concentrations may be higher than 
those in the plasma; it has been demonstrated in in vitro studies that peak intracellular 
concentrations of isothiocyanates, as total of parent compound and glutathione 
metabolites, are attained within 3 h of exposure, and intracellular concentration may be as 
much as 200-fold higher than extracellular concentration (Ye and Zhang, 2001; Zhang et 
al., 2002).
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Such in vitro studies do not take into account pharmacokinetic behaviour when 
comparing the induction potential of two compounds. It is feasible that the isomers differ 
in their rate of metabolism and/or intracellular accumulation; this would be accounted for 
in this system, as the liver slices are metabolically competent, and liver is the principal 
tissue of xenobiotic metabolism. Clomiphene for example, an extensively used drug in 
the treatment of anovulation, consists of Z isomer (zuclomiphene), an oestrogenic agent, 
and the E  isomer (enclomiphene), an antioestrogenic property (Adashi, 1984). The 
plasma concentration of the E  isomer is higher than that of Z isomer following 
intravenous administration (Szutu et al., 1989). In contrast, the plasma concentration of Z 
isomer is higher than those of E  isomer after oral administration (Mikkelson et al., 1986). 
This is more likely due to differences in gut lumen or gut wall metabolism or in the 
extent of oral absorption between the two isomers (Szutu et al., 1989), not due to hepatic 
first-pass effect as systemic clearance is low (Walle & Walle, 1986). Thus isomers may 
display different pharmacokinetic characteristics.
3.5 Conclusion
Collectively, the above data indicate that the natural R-isomer of sulforaphane is more 
potent in modulating the detoxification enzymes in both liver and lung, and in rat 
hepatoma FAO cells, and is likely to be a far more effective chemopreventive agent than 
the R-isomer as it up-regulates quinone reductase, glutathione R-transferase, epoxide 
hydrolase, glucuronosyl transferase and elevates total glutathione levels. Since in 
carcinogenicity studies the racemate appears to have been invariably used, the present 
findings raise the possibility that such studies may have underestimated the 
chemopreventive potential of R-isomer to which the humans are exposed.
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CHAPTER 4
Intact glucosinolates modulate carcinogen-metabolising 
enzymes in precision-cut rat liver and lung slices
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4.1 Introduction
The chemopreventive activity of cruciferous vegetables has been attributed to glucosinolates, a 
class of sulphur-containing glycosides, which are present at substantial amounts in these 
vegetables (Hayes et a l, 2008; Steinbrecher and Linseisen, 2009). The accepted view is that 
glucosinolates are not directly responsible for the chemopreventive effects, but their breakdown- 
products such as the isothiocyanates.
It has always been assumed that intact glucosinolates, because of their hydrophilicity, would be 
unable to reach the bloodstream following oral intake. However, in recent studies it was 
demonstrated that, at least in rats and dogs, glucosinolates such as glucoraphanin (Figure 4.1), 
could be absorbed intact following oral intake (Bheemreddy and Jeffery, 2007; Cwik et al., 
2010). Administration of purified glucoraphanin to male F344 rats at 150 pmol/kg led to 5% of 
the oral dose being found intact in urine but not in the feces (Bheemreddy and Jeffery, 2007). 
Glucoraphanin in plasma was detectable in animals treated with glucoraphanin as compared to 
the control animals; in dog the levels were in the range of 2900-15,000 ng/mL after receiving 
oral dose at 200 mg/kg/day of body weight for 3 days, and in rats the mean concentrations 
determined after 13 days dosing at 10, 50,100, and 500 mg/kg/day were 49.9, 198, 416 and 1630 
ng/mL, respectively (Cwik et al., 2010). Moreover, in the rat glucoraphanin could be reduced to 
another glucosinolate, glucoerucin via the reduction of the alkylsulfinyl glucosinolate 
(Bheemreddy and Jeffery, 2007); glucoemcin differs from glucoraphanin only by the presence of 
oxygen on the sulphur atom (Barillari et al., 2005). Mikkelsen et al. (2010) have successfully 
engineered the glucoraphanin pathway into tobacco indicating the production of the highly value 
glucoraphanin in a plant that has vast potential in human health. Similarly, recently a high- 
glucoraphanin broccoli has been engineered, referred to as Beneforté and has been made 
commercially available in supermarkets (Mithen et al., 2010).
103
Chapter 4: Modulation o f  enzyme systems by intact glucosinolates
These findings prompted us to investigate whether intact glucosinolates have the potential to 
influence carcinogen-metabolising enzyme systems, and thus contribute to the chemopreventive 
activity of cruciferous vegetables. Studies have been conducted in the liver, the principal site of 
carcinogen metabolism and in the lung, a major target tissue for cruciferous vegetables and 
isothiocyanates.
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Figure 4.1: Structure of glucoerucin and glucoraphanin
4.2 Methods
4.2,1 Effect o f  intact glucosinolates on carcinogen-metabolising enzymes in rat liver and lung 
slices
Rat liver and lung slices were prepared from 8 mm cylindrical cores using a Krumdieck tissue 
slicer as previously described in sections 2,2.2.1 and 2.2.2.2. The multiwell plate procedure, 
using 12-well culture plates, was used to culture the slices in the presence of glucosinolate (0-25 
pM), isothiocyanate (0-25 pM), or glucosinolate (0-25 pM) plus myrosinase (0.018 U) for 24 h. 
Isothiocyanates were dissolved in DMSO so that the final concentration was 1.5 pl/ml of 
incubation medium. Following incubation, slices were removed from culture media, 
homogenised, and microsomal and cytosolic fractions were prepared by differential 
centrifiigation (see section 2.2.4). The dealkylations of ethoxy- and methoxyresorufin, epoxide 
hydrolase and UDP-glucuronosyltransferase activities were determined in the microsomal 
fraction as described in sections 2.2.6.1,22 .13  and 2.2.T.4. The following determinations were
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carried out in the cytosolic fraction: quinone reductase (NQOl) using menadione as substrate, 
glutathione ^'-transferase activity monitored using CDNB as the accepting substrate and total 
glutathione levels (see sections 2.2.7.1 and 2 2 .1 2  and 2.2.1.1). Protein concentration was 
determined in both cellular subfractions using bovine serum albumin as standard (section 2.2.8). 
Finally, in order to monitor whether increase in enzyme activities involves, at least partly, a rise 
in enzyme availability. Western blot analysis was performed as described in section 2.2.9. LDH 
release from liver and lung slices into the incubation medium was used as an index of 
cytotoxicity and was determined employing a cytotoxicity detection kit plus (Roche Diagnostics, 
Mannheim, Germany) (section 2.2.3).
4.2.2 Effect o f  intact glucosinolates and isothiocyanates on carcinogen-metabolising enzymes 
in rat liver slices; importance o f  duration o f  incubation
The multiwell plate procedure, using 12-well culture plates, was used to culture the slices in the 
presence of phenethyl isothiocyanate (1 pM), erucin (10 pM), R,5'-sulforaphane (10 pM), 
glucoraphanin (2.5 pM) or glucoerucin (2.5 pM). One slice was placed in each well, in 1.5 ml of 
culture medium. Slices were incubated with these isothiocyanates and glucosinolates under 
sterile conditions for 0, 0.5, 1, 2, 4, 6 and 24 h on a reciprocating plate shaker housed in a 
humidified incubator, at a temperature of 37°C and under an atmosphere of 95% air/5% 00%. 
Following incubation, slices were removed from culture media, homogenised, and microsomal 
and cytosolic fractions were prepared as described above. The dealkylations of methoxy- and 
ethoxyresorufin were measured in liver slices treated with the glucosinolates, whereas quinone 
reductase (NQOl) and glutathione ^'-transferase, were monitored using menadione and CDNB 
respectively, were determined in slices treated with the isothiocyanates; protein concentration 
was determined in both microsomal and cytosolic fractions, and Western blot analysis was 
performed to investigate changes in protein expression.
105
Chapter 4: Modulation o f enzyme systems by intact glucosinolates
4.2.3 Activation o f the Ah receptor
Activation of the Ah receptor by glucoraphanin or glucoerucin was assessed using the 
chemically-activated luciferase expression (CALUX) assay (section 2.2.5.2). When H lL l.lc2  
cells reached 50-70% confluency in 24-well plates, cells were then incubated with glucoraphanin 
or glucoerucin (10'^  ^ to 10'  ^ M) and/or benzo[a]pyrene (10'^^ to 10’^  M) dissolved in DMSO, at 
37°C and 5% CO2 in a humid environment for 24 h. Luciferase activity in the supernatant was 
determined as previously described (section 2.2.5.2.1).
4.3 Results
4.3.1 Toxicity o f  glucosinolates to tissue slices
Neither glucoerucin nor glucoraphanin elicited any toxicity in rat liver slices at the 
concentrations studied, as exemplified by lactate dehydrogenase leakage into the medium. 
Similarly, glucoraphanin at the concentrations studied, did not influence lung slice viability; but 
glucoerucin, caused a small (10%), but statistically significant increase in LDH leakage, but only 
at the highest concentration of 25 pM (Figure 4.2).
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Figure 4.2: Effect of glucoerucin and glucoraphanin on rat liver and lung slice viability.
LDH leakage was measured in rat liver and lung slices incubated with glucoraphanin or 
glucoerucin (0-25 pM) for 24 h. Results are presented as mean ± SD of three slices, each 
analysed in duplicate. *, P<0.05; **, P<0.01; ***, P<0.001.
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4.3.2 Effect o f  glucosinolates on CYPl activity and expression in rat liver slices
Incubation of rat liver slices with i?,5'-sulforaphane had no effect on the dealkylation of
ethoxyresorufin or methoxyresorufin but, in contrast, both activities were up-regulated when the
slices were exposed to glucoraphanin, the precursor of sulforaphane; however, this effect was
abolished when myrosinase was added to the incubation mixture with the glucosinolate (Figure
4.3).
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Figure 4.3: Effect of sulforaphane and glucoraphanin on the microsomal 0-dealkylations of 
ethoxy- and methoxyresorufin in precision-cut rat liver slices. Precision-cut rat liver slices 
were incubated with 7^,6'-sulfbraphane (0-25 pM), glucoraphanin (0-25 pM) or glucoraphanin (0- 
25 pM) plus myrosinase (0.018 U) for 24 h; slices were pooled and microsomes isolated, and the 
0-dealkylations of ethoxy- and methoxyresorufin determined. Results are presented as mean ± 
SD for three pools of slices, each comprising ten slices.*, P<0.05; **, P<0.01; ***, P<0.001.
At the apoprotein level, R^iS-sulforaphane and glucoraphanin up-regulated CYPlAl, CYP1A2 
and, to a lesser extent, CYPIBI; addition of myrosinase had no major impact on the 
glucoraphanin-induced changes (Figure 4.4).
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Figure 4.4: Up-regulation of CYPl apoprotein 
levels by sulforaphane and glucoraphanin in 
precision-cut rat liver slices. Precision-cut rat liver 
slices were incubated with i?,5'-sulforaphane (0-25 
pM), glucoraphanin (0-25 pM) or glucoraphanin (0-25 
pM) plus myrosinase (0.018 U) for 24 h; slices were 
pooled and microsomes were isolated. The immunoblot 
analysis was carried out by exposure of microsomal 
proteins to mouse anti-rat CY PlA l, mouse anti- 
CYP1A2 or rabbit anti-rat CYPIBI primary antibodies 
followed by the appropriate peroxidase-labelled 
secondary antibody. Each lane was loaded with 30 pg 
of total protein. The blots were stripped and re-probed 
with anti-P-actin antibody to normalise for differences 
in protein loading.
Similarly, erucin did not influence the O-deethylation of ethoxyresorufin and enhanced 
methoxyresorufin (9-demethylase at only one concentration; glucoerucin up-regulated both 
activities, the effect being more pronounced in the case of ethoxyresomfin; the effect, however, 
was not observed when the incubation system was supplemented with myrosinase (Figure 4.5). 
Both erucin and glucoerucin elevated the apoprotein levels of CYPlA l, CYP1A2 and CYPIBI 
(Figure 4.6). Supplementation of the incubation system with myrosinase had no major influence 
on the glucoemcin-mediated increase of CYPlAl and CYPIBI, but the effect on CYP1A2 was 
attenuated (Figure 4.6).
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Figure 4.5: Effect of erucin and glucoerucin on the microsomal 0-dealkylations of ethoxy- 
and methoxyresorufin in precision-cut rat liver slices. Precision-cut rat liver slices were 
incubated with erucin (0-25 pM), glucoerucin (0-25 pM) or glucoerucin (0-25 pM) plus 
myrosinase (0.018 U) for 24 h; slices were pooled and microsomes isolated, and the O- 
dealkylations of methoxy- and ethoxyresorufin determined. Results are presented as mean ± SD 
for three pools of slices, each comprising ten slices. *, P<0.05; **, P<0.01; ***, P<0.001.
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Figure 4.6: Up-regulation of CYPl apoprotein levels 
by erucin and glucoerucin in precision-cut rat liver 
slices. Precision-cut rat liver slices were incubated with 
erucin (0-25 pM), glucoerucin (0-25 pM) or glucoerucin 
(0-25 pM) plus myrosinase (0.018 U) for 24 h; slices 
were pooled and microsomes were isolated. The 
immunoblot analysis was carried out by exposure of the 
microsomes to mouse anti-rat CYPlAl, mouse anti-rat 
CYP1A2 or rabbit anti-rat CYPIBI primary antibodies 
followed by the appropriate peroxidase-labelled 
secondary antibody. Each lane was loaded with 30 pg of 
total protein. The blots were stripped and re-probed with 
anti-p-actin antibody to normalise for differences in
4.3.3 Effect o f glucosinolates on Phase II enzyme activity and expression, and on glutathione 
levels in rat liver slices
i. Quinone reductase
Quinone reductase activity was increased following exposure of the rat liver slices to 
sulforaphane and erucin. Their glucosinolate precursors also caused a rise in quinone reductase 
activity, but only at the highest concentrations. When myrosinase was added to the 
glucosinolate-containing incubations, the inductive potential was exacerbated, especially in the 
case of glucoerucin (Figures 4.7 and 4.8). When immunoblotting was conducted using antibodies 
to quinone reductase, increased expression was seen after treatment of the liver slices with the 
isothiocyanates. A rise was also seen at the highest concentrations of glucoraphanin and 
glucoerucin (Figures 4.7 and 4.8).
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Figure 4.7: Modulation of quinone reductase activity and expression in precision-cut ra t 
liver slices by sulforaphane and glucoraphanin. Precision-cut rat liver slices were incubated 
with sulforaphane (0-25 pM), glucoraphanin (0-25 pM) or glucoraphanin (0-25 pM) plus 
myrosinase (0.018 U) for 24 h; slices were pooled and cytosol isolated, and quinone reductase 
activity deteimined. Results are presented as mean ± SD for three pools o f slices, each 
comprising ten slices. The immunoblot analysis was earned out by exposure o f cytosolic proteins 
to rabbit anti-rat NQOl primary antibody followed by the appropriate peroxidase-labelled 
secondary antibody. Each lane was loaded with 30 pg o f total protein. The blots were stripped 
and re-probed with anti-LDH antibody to normalise for differences in protein loading.*, P<0.05; 
**, P<0.01; ***,P<0.001.
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Figure 4.8: Modulation of quinone reductase activity and expression in precision-cut ra t 
liver slices by erucin and glucoerucin. Precision-cut rat liver slices were incubated with erucin 
(0-25 pM), glucoerucin (0-25 pM) or glucoerucin (0-25 pM) plus myi'osinase (0.018 U) for 24 h; 
slices were pooled and cytosol isolated, and quinone reductase activity determined. Results are 
presented as mean ± SD for three pools o f slices, each comprising ten slices. The immunoblot 
analysis was carried out by exposure of the cytosol to rabbit anti-rat NQOl primary antibody 
followed by the appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 
30 pg of total protein. The blots were stripped and re-probed with anti-LDH antibody to 
normalise for differences in protein loading.*, P<0.05; **, P<0.01; ***, P<0.001.
ii. Glutathione S-transferase
Glutathione ^'-transferase activity was elevated after exposure o f rat liver slices to sulforaphane
and erucin, whereas only glucoraphanin stimulated glutathione ^-transferase activity
significantly, but only at the highest concentration; although an increase was seen in the case of
1 1 5
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glucoemcin, no statistical significance was attained (Figures 4.9 and 4.10). Marked induction 
was noted when myrosinase was added to the glueosinolate-containing incubation (Figures 4.9 
and 4.10). i?,5'-sulforaphane as well as emcin increased the expression of GSTa and GSTp 
(Figures 4.9 and 4.10). Glucoraphanin increased the expression of these proteins at the higher 
concentrations, but supplementation with myrosinase led to these increases being manifested at 
lower concentrations (Figure 4.9). In the case of glucoerucin, up-regulation of these proteins was 
more modest compared with glucoraphanin but, once again, it necessitated high levels of 
exposure; addition of myrosinase to glucoemcin led to a more pronounced rise in protein levels, 
which was now evident at much lower concentrations of the glucosinolate (Figure 4.10).
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Figure 4.9: Modulation of glutathione ^-transferase activity and expression in precision-cut 
ra t liver slices by sulforaphane and glucoraphanin. Precision-cut rat liver slices were 
incubated with R,5-sulforaphane (0-25 pM), glucoraphanin (0-25 pM) or glucoraphanin (0-25 
pM) plus myrosinase (0.018 U) for 24 h; slices were pooled and cytosol isolated, and glutathione 
iS-transferase activity determined. Results are presented as mean ± SD for three pools o f slices, 
each comprising ten slices. The iimuunoblot analysis was carried out by exposure o f the cytosol 
to rabbit anti-rat GSTAl-1 or GSTMl-1 primary antibodies followed by the appropriate 
peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg of total protein. The 
blots were stripped and re-probed with anti-LDH antibody to normalise for differences in protein 
loading.*, P<0.05; **, P<0.01; ***, P<O.OOL
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Figure 4.10: Modulation of glutathione S-transferase activity and expression in precision- 
cut ra t liver slices by erucin and glucoerucin. Precision-cut rat liver slices were incubated with 
emcin (0-25 pM), glucoemcin (0-25 pM) or glucoemcin (0-25 pM) plus myrosinase (0.018 U) 
for 24 h; slices were pooled and cytosol isolated, and glutathione S-transferase activity 
detemiined. Results are presented as mean ± SD for thi'ee pools o f slices, each comprising ten 
slices. The immunoblot analysis was canned out by exposure of the cytosol to rabbit anti-rat 
GSTAl-1 or GSTMl-1 primary antibodies followed by the appropriate peroxidase-labelled 
secondary antibody. Each lane was loaded with 30 pg of total protein. The blots were stripped 
and re-probed with anti-LDH antibody to normalise for differences in protein loading.*, P<0.05; 
**, P<0.01; ***,P<0.001.
Hi. UDP-ghicuronosyl transferase
Exposure of precision-cut rat liver slices to emcin and phenethyl isothiocyanate, but not 
sulforaphane, resulted in at least a doubling in the glucuronidation of 1-naphthol (Figure 4.11). 
Similarly, at the protein level, a modest rise in the expression of this enzyme was only seen in the 
case o f phenethyl isothiocyanate and emcin (Figure 4.11). In the case of glucoraphanin and 
glucoemcin, no statistically significant change were evident in glucuronosyl transferase activity 
but a very modest rise (< 20%) in protein levels was seen at the low levels of exposure (Figure 
4.12).
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Figure 4.11: Effect of isothiocyanates on the activity and expression of UDP-glucuronosyl 
transferase in precision-cut ra t liver slices. Precision-cut rat liver slices were incubated with 
isothiocyanates (0-25 pM), for 24 h; slices were pooled and microsomes isolated and UDP- 
glucuronosyl transferase activity determined. Results are presented as mean ± SD for three pools 
of slices, each comprising ten slices. The immunoblot analysis was carried out by exposure of  
microsomes to antibodies against glucuronosyl transferase (UGT1A6) followed by the 
appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg o f total 
protein. The blots were stripped and re-probed with anti-p-aetin antibody to nonualise for 
differences in protein loading. *, P<0.05; **, P<0.01; ***, P<0.001.
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Figure 4.12: Modulation of UDP-glucuronosyl transferase activity and expression in 
precision-cut ra t liver slices by glucoraphanin and glucoerucin. Precision-cut rat liver slices 
were incubated with glucoraphanin or glucoemcin (0-25 pM), for 24 h; slices were pooled and 
microsomes isolated, and UDP-glucuronosyl activity was determined. Results are presented as 
mean ± SD for three pools of slices, each comprising ten slices. The immunoblot analysis was 
carried out by exposure of microsomal proteins to antibody against glucuronosyl transferase 
(UGT1A6) followed by the appropriate peroxidase-labelled secondary antibody. Each lane was 
loaded with 30 pg of total protein. The blots were stripped and re-probed with anti-p-actin 
antibody to nonualise for differences in protein loading.
V. Epoxide hydrolase
Exposure of the liver slices to phenethyl isothiocyanate caused a very marked increase in 
microsomal epoxide activity; a much less pronounced, but statistically significant, increase was 
noted in the case of emcin, whereas J^,5'-sulfbraphane had no effect; a similar picture emerged at 
the protein level (Figure 4.13).
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Figure 4.13: Effect of isothiocyanates on the activity and expression of microsomal epoxide 
hydrolase in precision-cut rat liver slices. Precision-cut rat liver slices were incubated with 
isothiocyanates (0-25 pM), for 24 h; sliees were pooled and microsomes isolated and epoxide 
hydrolase activity was determined. Results are presented as mean ± SD for three pools o f slices, 
each comprising ten slices. The immunoblot analysis was carried out by exposure o f microsomes 
to antibodies against epoxide hydrolase followed by the appropriate peroxidase-labelled 
secondary antibody. Each lane was loaded with 30 pg of total protein. The blots were stripped 
and re-probed with anti-(3-actin antibody to normalise for differences in protein loading. *, 
P<0.05; **, P<0.01; ***, P<0.001.
Both glucosinolates caused a marked increase in microsomal epoxide hydrolase activity in rat 
liver slices, which was manifested at 1 pM, the lowest concentration employed, and was 
accompanied by a parallel rise in protein levels (Figure 4.14).
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Figure 4.14: Modulation of epoxide hydrolase activity and expression in precision-cut rat 
liver slices by glucoraphanin and glucoerucin. Precision-cut rat liver slices were incubated 
with glucoraphanin or glucoerucin (0-25 pM), for 24 h; slices were pooled and microsomes 
isolated, and epoxide hydrolase was deteimined. Results are presented as mean ± SD for three 
pools o f slices, each comprising ten slices. The immunoblot analysis was carried out by exposure 
of microsomes to antibody against epoxide hydrolase followed by the appropriate peroxidase- 
labelled secondary antibody. Each lane was loaded with 30 pg o f total protein. The blots were 
stripped and re-probed with anti-P-actin antibody to normalise for differences in protein loading. 
*, P<0.05; **, P<0.01; ***, P<0.001.
V. Total glutathione levels
Finally, erucin and R,5*-sulforaphane increased total hepatic glutathione levels, whereas 
glucoraphanin elicited no effect and glucoerucin caused only a slight increase at the 10 pM 
concentration; addition of myrosinase to the glucosinolate incubations, however, led to an 
increase in the glutathione content (Figures 4.15 and 4.16).
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Figure 4.15: Modulation of glutathione levels in 
precision-cut ra t liver slices by sulforaphane 
and glucoraphanin. Precision-cut rat liver slices 
were incubated with R.^-sulforaphane (0-25 pM), 
glucoraphanin (0-25 pM) or glucoraphanin (0-25 
pM) plus myrosinase (0.018 U) for 24 h; slices 
were pooled and cytosol isolated, and glutathione 
levels deteimined. Results are presented as mean ± 
SD for three pools of slices, each comprising ten 
slices.*, P<0.05; **,P<0.01; ***, P<0.001.
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Figure 4.16: M odulation of glutathione levels in 
precision-cut ra t liver slices by erucin and 
glucoerucin. Precision-cut rat liver slices were 
incubated with erucin (0-25 pM), glucoemcin (0-25 
pM) or glucoemcin (0-25 pM) plus myrosinase (0.018 
U) for 24 h; slices were pooled and cytosol isolated, 
and glutathione levels detenuined. Results are 
presented as mean ± SD for three pools of slices, each 
comprising ten slices.*, P<0.05; **, P<0.01: 
P<0.001.
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4.3.4 Effect o f  glucosinolates on CYPl activity and expression in rat lung slices 
In rat lung slices, R,5'-sulforaphane failed to stimulate the 0-deethylation of ethoxyi'esorufm 
whereas its precursor glucosinolate, glucoraphanin, elevated this activity; supplementation of the 
glucosinolate incubation with myrosinase eradicated this increase in activity (Figure 4.17). R,S- 
sulforaphane, however, increased CY PlAl and CYPIBI apoprotein levels (Figure 4.17). Similar 
rise in apoprotein levels was observed in the lung slices exposed to the glucosinolate, but the 
extent of increase was generally more pronounced after supplementation with myrosinase 
(Figure 4.17).
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Figure 4.17: Effect of sulforaphane and glucoraphanin on the 0-dealkylation of 
ethoxyresorufin and CY Pl expression in precision-cut ra t lung slices. Precision-cut rat lung 
slices were incubated with i?,-S'-sulforaphane (0-25 pM), glucoraphanin (0-25 pM) or 
glucoraphanin (0-25 pM) plus myrosinase (0.018 U) for 24 h; slices were pooled and 
microsomes isolated, and the (9-dealkylation of ethoxyresorufin determined. The immunoblot 
analysis was carried out by exposure of the microsome to mouse anti-rat CYPlAl or rabbit anti­
rat CYPIBI primary antibodies followed by the appropriate peroxidase-labelled secondary 
antibody. Each lane was loaded with 30 pg of total protein. The blots were stripped and re­
probed with anti-P-actin antibody to normalise for differences in protein loading. Enzyme 
activity results are presented as mean ± SD for three pools of slices, each comprising ten slices. 
*, P<0.05; **, P<0.01; ***, P<0.001.
Similarly, emcin failed to stimulate the O-deethylation of ethoxyresomfin while its 
glucosinolate, glucoemcin, raised this activity; addition of myrosinase to the glucosinolate 
incubation eliminated this increase in activity (Figure 4.18). On the other hand, emcin, enhanced 
CYPlAl and CYPIBI apoprotein levels (Figure 4.18). Rises in apoprotein levels were evident 
also in the lung slices exposed to the glucosinolate, but the degree of increase was in general 
more marked with the supplementation of myrosinase (Figure 4.18).
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Figure 4.18: Effect of erucin and glucoerucin on the 0-dealkylation of ethoxyresorufin and C Y Pl 
expression in precision-cut rat lung slices. Precision-cut rat lung slices were incubated with erucin (0- 
25 pM), glucoerucin (0-25 pM) or glucoerucin (0-25 pM) plus myrosinase (0.018 U) for 24 h; slices were 
pooled and microsomes isolated, and the (9-dealkylation of ethoxyresomfm determined. The immunoblot 
analysis was carried out by exposure of microsomal proteins to mouse anti-rat CYPl AI or rabbit anti-rat 
CYPIBI primary antibodies followed by the appropriate peroxidase-labelled secondary antibody. Each 
lane was loaded with 30 pg of total protein. The blots were stripped and re-probed with anti-(3-actin 
antibody to normalise for differences in protein loading. Enzyme activity results are presented as mean ± 
SD for three pools of slices, each comprising ten slices. *, P<0.05; **, P<0.01; ***, P<0.001.
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4.3.5 Effect o f  glucosinolates on phase I I  enzyme activity and expression^ and on glutathione 
levels in rat lung slices
i. Quinone reductase
Both isothiocyanates, and especially i?,Y-sulforaphane, stimulated quinone reductase activity 
whereas no such effect was noted with their parent glucosinolates (Figures 4.19 and 4.20); 
addition o f myrosinase to the glucosinolate incubations, however, led to a rise in activity. At the 
protein level, both isothiocyanates elevated quinone reductase levels whereas glucoerucin 
increased the levels more modestly and glueoraphanin had no effect; supplementation with 
myrosinase, however, led to an increase in the expression of this enzyme (Figures 4.19 and 4.20).
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Figure 4.19: Modulation of quinone reductase activity and expression in precision-cut rat 
lung slices by sulforaphane and glueoraphanin. Precision-cut rat lung slices were incubated 
with i^,5'-sulforaphane (0-25 pM), glueoraphanin (0-25 pM) or glueoraphanin (0-25 pM) plus 
myrosinase (0.018 U) for 24 h; slices were pooled and cytosol isolated, and quinone reductase 
activity determined. The immunoblot analysis was earned out by exposure of the cytosol to 
rabbit anti-rat quinone reductase primary antibody followed by the appropriate peroxidase- 
labelled secondaiy antibody. Each lane was loaded with 30 pg of total protein. The blots were 
stripped and re-probed with anti-LDH antibody to normalise for differences in protein loading. 
Results are presented as mean ± SD for three pools of slices, each comprising ten slices. *, 
P<0.05; **, P<0.01; ***, P<0.001.
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Figure 4.20: Modulation of quinone reductase activity and expression in precision-cut rat 
lung slices by erucin and glucoerucin. Precision-cut rat lung slices were incubated with erucin 
(0-25 pM), glucoerucin (0-25 pM) or glucoerucin (0-25 pM) plus myrosinase (0.018 U) for 24 h; 
slices were pooled and cytosol isolated, and quinone reductase activity determined. The 
immunoblot analysis was carried out by exposure of cytosolic proteins to rabbit anti-rat quinone 
reductase primary antibody followed by the appropriate peroxidase-labelled secondary antibody. 
Each lane was loaded with 30 pg of total protein. The blots were stripped and re-probed with 
anti-LDH antibody to normalise for differences in protein loading. Results are presented as mean 
± SD for three pools of slices, each comprising ten slices. *, P<0.05; **, P<0.01; ***, P<0.001.
a. Glutathione S-transferase
Similarly, both isothiocyanates enhanced glutathione ^transferase activity whereas only 
glueoraphanin of the two glucosinolates increased this activity, and only at the higher 
concentrations studied; although the levels were also higher in the glucoerucin-treated slices, no 
statistical significance was attained, but incorporation of myrosinase resulted in a significant rise 
in activity (Figures 4.21 and 4.22). /?,5'-sulforaphane and glueoraphanin increased only 
moderately GSTa expression and no major change was evident when myrosinase was added to 
the glueoraphanin incubations (Figure 4.21). Erucin and, to a much lesser extent, glucoerucin 
enhanced GSTa expression in rat lung slices; a clear increase in expression was observed when 
myrosinase was added to the glucoerucin incubations (Figure 4.22).
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Figure 4.21: Modulation of glutathione ^'-transferase aetivity and expression in preeision-eut rat 
lung sliees by sulforaphane and glueoraphanin. Precision-cut rat lung slices were incubated with R,S- 
sulforaphane (0-25 pM), glueoraphanin (0-25 pM) or glueoraphanin (0-25 pM) plus myrosinase (0.018 
U) for 24 h; slices were pooled and cytosol isolated, and glutathione ^-transferase activity determined. 
The immunoblot analysis was carried out by exposure of the cytosol to rabbit anti-rat GSTAl-1 primary 
antibody followed by the appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 
30 pg of total protein. The blots were stripped and re-probed with anti-LDH antibody to nonualise for 
differences in protein loading. Results are presented as mean ± SD for tliree pools of slices, each 
comprising ten slices. *, P<0.05; **, P<0.01; ***, P<0.001.
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Figure 4.22: Modulation of glutathione ^'-transferase activity and expression in precision-cut rat 
lung slices by erucin and glucoerucin. Precision-cut rat lung slices were incubated with emcin (0-25 
pM), glucoerucin (0-25 pM) or glucoerucin (0-25 pM) plus myrosinase (0.018 U) for 24 h; slices were 
pooled and cytosol isolated, and glutathione S'-transferase activity determined. The immunoblot analysis 
was carried out by exposure of the cytosol to rabbit anti-rat GSTAl-I primaiy antibody followed by the 
appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg of total protein. 
The blots were stripped and re-probed with anti-LDH antibody to normalise for differences in protein 
loading. Results are presented as mean ± SD for three pools of slices, each comprising ten slices. *, 
P<0.05; **, P<0.01; ***, P<O.OOL
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in. Total glutathione levels
Finally, total glutathione levels increased when the lung slices were incubated with the 
isothiocyanates, but a less pronounced effect was noted with the glucosinolates which did not 
always attain statistical significance (Figures 4.23 and 4.24). Supplementation of the 
glucosinolate incubations with myrosinase led to a clear rise in glutathione levels (Figures 4.23 
and 4.24).
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Figure 4.23: Modulation of glutathione levels in 
precision-cut ra t lung slices by sulforaphane and 
glueoraphanin. Precision-cut rat lung slices were 
incubated with i?,5'-sulforaphane (0-25 pM), 
glueoraphanin (0-25 pM) or glueoraphanin (0-25 pM) 
plus myrosinase (0.018 U) for 24 h; slices were 
pooled and cytosol isolated, and glutathione levels 
determined. Results are presented as mean ± SD for 
three pools of slices, each comprising ten slices. *, 
P<0.05; **, P<0.01; ***, P<0.001.
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Figure 4.24: Modulation of glutathione levels in 
precision-cut ra t lung slices by erucin and 
glucoerucin. Precision-cut rat lung slices were 
incubated with emcin (0-25 pM), glucoemcin (0-25 
pM) or glucoemcin (0-25 pM) plus myrosinase 
(0.018 U) for 24 h; slices were pooled and cytosol 
isolated, and glutathione levels determined. Results 
are presented as mean ± SD for three pools of slices, 
each comprising ten slices. *, P<0.05; **, P<0.01; 
***,P<0.001.
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4.3.6 Effect o f  intact glucosinolates and isothiocyanates on carcinogen-metabolising enzymes 
in rat liver slices; importance o f  duration o f  incubation
4.3.6.1 Studies with glucosinolates
The glucosinolates glucoemcin and glueoraphanin, when incubated with precision-cut rat liver 
slices, elevated the O-dealkylations of methoxy- and ethoxyresomfm, but the effect was 
generally manifested following exposure for 6 or 24 hours (Figure 4.25); however, the rise in 
activity tended to be more pronounced after the longer incubation. Both compounds increased 
CYPl A1 and CYP1A2 apoprotein levels but a clear rise in expression was seen only after 24-
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hour incubation in the case of glueoraphanin and 6-hour incubation in the case of glucoerucin 
(Figure 4.26).
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Figure 4.25: Effect of incubation time on the up-regulation of metboxy- and 
ethoxyresorufin 0-deetbyIase activities by glucosinolates. Precision-cut rat liver sliees were 
incubated with either glueoraphanin or glucoerucin (2.5 pM) for 0.5 to 24 h. At the end of the 
incubation slices were pooled and microsomes isolated, and the 0-dealkylation of methoxy- and 
ethoxyresomfm determined. Results are presented as Mean ± SD for three pools of sliees, each 
comprising ten slices.*, P<0.05; **, P<0.01; ***, P<0.001.
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Figure 4.26: Effect of incubation time on up-regulation of C Y PlA l and CYP1A2 
expression by glucosinolates. Precision-cut rat liver slices were incubated with either 
glueoraphanin or glucoemcin (2.5 pM) for 0.5 to 24 hours. At the end of the incubation slices 
were pooled and microsomes isolated. The immunoblot analysis was carried out by exposure of 
the microsome to mouse anti-rat CYPlAl and CYP1A2 followed by the appropriate peroxidase- 
labelled secondary antibody. Each lane was loaded with 30 pg of total protein. The blots were 
stripped and re-probed with anti-p-actin antibody to normalise for differences in protein loading.
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43.6.2 Studies with isothiocyanates
All three isothiocyanates increased quinone reductase activity when incubated for 6-hours or 
longer that was accompanied by a rise in protein expression with maximum increase in 
expression being evident at the 24-hour incubation point (Figure 4.27).
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Figure 4.27: Influence of incubation time on the isothiocyanate-mediated up-regulation of 
quinone reductase activity and expression. Precision-cut rat liver slices were incubated with 
either i?,5'-sulforaphane (10 pM), erucin (10 pM) or phenethyl isothiocyanate (1 pM) for 0.5 to 
24 h. At the end of the incubation slices were pooled, the cytosolic fraction isolated and quinone 
reductase activity determined. The immunoblot analysis was carried out by exposure of the 
cytosol to rabbit anti-rat NQOl primary antibodies followed by the appropriate peroxidase- 
labelled secondary antibody. Each lane was loaded with 30 pg of total protein. The blots were 
stripped and re-probed with anti-LDH antibody to normalise for differences in protein loading. 
Results are presented as Mean ± SD for three pools of slices, each comprising ten slices.*, 
P<0.05; **, P<0.01; ***, P<0.001.
When glutathione ^'-transferase was monitored using CDNB, incubation of rat liver slices with 
phenethyl isothiocyanate a rise in activity was noted following incubation for 6 or 24-hours, but 
in the case of emcin a modest, statistically significant, rise in activity was noted following a 4- 
hour incubation, but the effect was far more pronounced at the 6- and 24-hour incubations 
(Figure 4.28); in the case of i?,5'-sulforaphane, an increase in activity was apparent as early as 2 
hours. When the levels of GSTa were determined immunologically, levels gradually rose in the 
case of emcin and i?,5'-sulforaphane, whereas in the ease of phenethyl isothiocyanate a rise was 
only evident at the 6 and 24 hours (Figure 4.28).
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Figure 4.28: Influence of incubation time on the isothiocyanate-mediated up-regulation of 
glutathione Y-transferase activity and expression. Precision-cut rat liver slices were incubated 
with either i?,5'-sulforaphane (10 pM), erucin (10 pM) or phenethyl isothioeyanate (1 pM) for 
0.5 to 24 h. At the end of the incubation slices were pooled, the cytosolic fraction isolated and 
glutathione S'-transferase activity determined using CDNB as substrate. The immunoblot analysis 
was carried out by exposure of the cytosol to rabbit anti-rat GSTAl-1 primary antibodies 
followed by the appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 
30 pg of total protein. The blots were stripped and re-probed with anti-LDH antibody to 
normalise for differences in protein loading. Results are presented as Mean ± SD for three pools 
of slices, each comprising ten slices.*, P<0.05; **, P<0.01; ***, P<0.001.
4.3.7 Activation o f  the Ah receptor
In studies to find out the ability of glueoraphanin and glucoerucin to activate the Ah receptor, 
glucoerucin was found to be relatively a better ligand than glueoraphanin, attaining 15% and 5% 
of binding, respectively when compared with TCDD. However, when comparing to 
benzo[a]pyrene, both glucosinolates were very weak agonists of the Ah receptor (Figure 4.29).
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Figure 4.29: Activation of the Ah receptor by benzo[a]pyrene, glueoraphanin and 
glucoerucin. H lL l.lc2  cells (7 x 10  ^cells/ml) were incubated in culture medium supplemented 
with benzo[a]pyrene or glueoraphanin or glucoerucin (10‘^  ^ - lO'^M) for 24 h. ■ Benzo(a)pyrene, 
À glueoraphanin, •  glucoerucin. Activation of the receptor is expressed as % of that achieved by 
TCDD (10'^ M). Results are presented as mean ± SD of triplicate determinations.
4.4 Discussion
4.4.1 Modulation o f  rat hepatic carcinogen-metabolising enzyme by intact glucosinolates and 
isothiocyanates
In this study, neither of the glucosinolates influenced liver slice viability at the concentrations 
studied when monitored using the leakage of lactate dehydrogenase as biomarker, in agreement 
with studies which concluded that glueoraphanin was safe when administered to F344 rats at a 
dose range of 30-60 mg/kg (Lai et al., 2008). Similarly, at the same concentrations, the free 
isothiocyanates displayed no toxicity (Hanlon et al., 2009b). Purified glucosinolates from 
vegetable leaf and Brassica seeds showed no significant cytotoxicity in human colon cancer cells 
(Gamet-Payrastre et al., 1998) and human Jurkat T- leukaemia cells (Fimognari et al., 2002).
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In studies to compare sulforaphane absorption from fresh broccoli sprouts and a glucoraphanin- 
rich broccoli powder lacking myrosinase, alone and in combination, in healthy men, the 
appearance of sulforaphane in plasma and urine from the broccoli powder was delayed when 
compared to sulforaphane from myrosinase-rich sprouts (Cramer and Jeffery, 2011). In other 
studies, the same workers found that glueoraphanin powder lacking myrosinase was an 
insufficient dietary source of sulforaphane when compared with broccoli sprouts; moreover, 
intact broccoli sprouts were capable of hydrolysing competently glueoraphanin from powder 
form in contrast to air-dried broccoli sprouts, when the efficacy was correlated to the plasma 
sulforaphane levels (Cramer et al., 2011). These observations indicate the increment in plasma 
levels most likely translates to a superior potential for cancer risk reduction. It has been reported 
that hydrolysis of glueoraphanin occurred both in situ and ex vivo in F344 rat caecal microbiota 
(Lai et al., 2010), indicating that glueoraphanin was converted into the biologically active 
sulforaphane whose absorption took place across the caecal wall. Thus the matrix has major 
influence on the fate of isothiocyanates/glucosinolates.
It was suggested that high doses of glueoraphanin tend to increase cytochrome P450 and 
glutathione ^'-transferase activities in the liver of rats following oral administration (Perocco et 
al., 2006). It is very important to determine whether the rise in these activities is due to the 
glucosinolate per se or as a result of sulforaphane produced by the hydrolysis of its precursor by 
intestinal flora (Getahun and Chung, 1999). To address this matter, studies were conducted using 
precision-cut rat liver slices to assess the ability of glueoraphanin and glucoerucin in modulating 
cytochrome P450 enzymes of the CYPl family, the most significant family in carcinogen 
metabolism (loannides and Lewis, 2004), as well as phase II detoxification systems such as 
quinone reductase, glutathione ^'-transferase, UDP-glucuronosyl transferase, epoxide hydrolase 
as well as total glutathione levels.
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Cytochrome P450 enzymes
In this study, neither i?,6'-sulforaphane nor erucin had any effect on the dealkylation of
ethoxyresorufin or methoxyresorufin but, at the apoprotein level, both isothiocyanates up-
regulated CYPlAl, CYP1A2 and, to a lesser extent, CYPlBl. According to Hanlon et al,,
(2008b), both i^^iS-sulforaphane and erucin enhanced the apoprotein levels of CYPlAl, CYP1A2
and CYPIBI but without any concurrent increase in the 0-deethylation of ethoxyresorufin and
the 0-demethylation of methoxyresorufin, catalysed by CYTlAl and CYP1A2 respectively
(Namkung et al., 1988); the lack of association between the enzyme activity and the expression
is due to the fact that both isothiocyanates are effective mechanism-based inhibitors of CYPl
enzymes (Yoxall et al., 2005; Hanlon et al., 2008a). Expression of CYP1A2 was elevated in
animals treated with sulforaphane for 10 days, without concomitant rise in the dealkylations of
methoxy- and ethoxyresorufin (Yoxall et al. 2005). In primary rat hepatocytes, sulforaphane
inhibited 0-deethylation of ethoxyresorufin at concentrations > 5 pM (Maheo et al. 1997),
whereas it could not modulate significantly the activity of human CYP1A2 in bicictronic
bacterial membranes (Langouet et al. 2000). It has been repeatedly reported that sulforaphane
was a monofunctional inducer that selectively stimulated Phase II detoxifying enzymes without
concomitant induction in the AhR-dependent cytochrome P450 enzymes such as the CYTl
family (Miao et al. 2004; Higdon et al. 2007). For the first time, the current studies reveal that
their precursor glucosinolates glueoraphanin and glucoerucin, can increase both alkoxyresorufin
dealkylations directly, with parallel increases in CYPl apoprotein levels, demonstrating that the
increase in activity is an outcome of the rise in enzyme availability. Once myrosinase was added
to the glucosinolate-containing incubations, the enzyme that hydrolyses glucosinolates to their
corresponding isothiocyanates, the rise in the dealkylation of ethoxy- and methoxyresorufin was
averted indicating the direct role of the glucosinolates. Up-regulation of the CYPl family by
these glucosinolates may involve increased transcription, although mRNA and protein
stabilisation are also feasible. The induction of CYPl enzymes is regulated by the AhR via
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transcriptional activation (Whitlock, 1999; Nebert et al., 2004); although both glucosinolates 
interact with the AhR, they are poor activators, with glucoerucin being a relatively better ligand.
Phase II  enzymes
Quinone reductase is a phase II detoxification enzyme that protects the cells firom quinone redox 
cycling and production of reactive oxygen species generated during the oxidation of endogenous 
quinones and polycyclic aromatic hydrocarbons (Brunmark and Cadenas, 1989). Enhanced 
quinone reductase activity and expression have been demonstrated in rat liver slices treated with 
the two isothiocyanates, sulforaphane and erucin (Hanlon et al., 2009). The current studies 
showed that both of their precursor glucosinolates also increased this activity and expression, but 
required exposure of the slices to high concentrations. These findings concord with published 
studies conducted in vivo in male F344 rats in which quinone reductase was observed to increase 
in a dose-dependent manner after rats were given various doses of semi-purified glueoraphanin 
(Lai et al., 2008); however, these studies do not allow us to discern the individual role of 
glucosinolate/isothiocyanate. It has also been reported that glucosinalbin, one of the 
glucosinolates present in cruciferous vegetables, induced quinone reductase activity in mouse 
hepatoma hepa-lclc7 cells in the absence of myrosinase (Tawfiq et al., 1995). The presence of 
myrosinase in the glucosinolate-containing incubation systems with slices elevated further 
hepatic quinone reductase activity, demonstrating that the isothiocyanates are the principal 
contributors to the increased activity.
Hepatic glutathione 5"-transferase activity, measured using CDNB as an accepting substrate, was
stimulated by both i?,5'-sulforaphane and emcin, concomitant with an increase in the GSTa and
GSTp apoprotein levels, and in agreement with earlier studies conducted by Hanlon et al.
(2009b). The R,&sulfbraphane precursor, glueoraphanin elevated this activity, although only at
the highest concentrations studied, and at these concentrations a modest rise in the apoprotein
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levels of GSTa and GSTp was also seen in the slices exposed to glueoraphanin and, to a lesser 
extent, glucoerucin. Similarly, it was observed that in rat studies hepatic glutathione S- 
transferase was influenced by oral glueoraphanin intake (Perocco et al., 2006). Studies conducted 
in rats using two alkylthio glucosinolates, glucoraphasatin and glucoraphenin, dissimilar in the 
oxidation level of the side chain sulphur, also increased glutathione ^'-transferase activity 
measured using CDNB as substrate (Barillari et al., 2007). In the current studies, 
supplementation of the glucoemcin and glueoraphanin incubation systems with myrosinase 
further enhanced hepatic glutathione ^-transferase activity, which now was apparent also at the 
lower concentrations of glucosinolates. It could be concluded that the isothiocyanates are more 
effective than their glucosinolates in stimulating glutathione ^'-transferase activity, at the 
concentrations employed.
Even though the effects of sulforaphane and emcin on quinone reductase and glutathione S-
transferases have been well shown both in vivo and in vitro, the capability of these
isothiocyanates to modulate other Phase II detoxifying enzyme systems for example
glucuronosyl transferase and epoxide hydrolase, both of which participate in carcinogen
metabolism, has attracted little interest. UDP-glucuronosyl transferases are a very important
phase II conjugation enzyme system involved in the metabolism of major classes of chemical
carcinogens such as polycyclic aromatic hydrocarbons and aromatic amines (Bock, 2006). In the
present studies, a major isoform, UGTIA6, has been monitored immunologically since it is the
most active in the metabolism of carcinogens (Bock, 2006). It was demonstrated in the present
study that isothiocyanates have potential in up-regulating hepatic glucuronosyl transferase;
emcin and phenethyl isothiocyanate were powerful inducers, while sulforaphane was inactive in
this regard. It may be inferred that the increase in activity was the result of increased enzyme
availability, as shown by Western blot analysis. These findings comparable in vivo studies in
which sulforaphane was unsuccessful in enhancing the activity of this enzyme in the rat liver
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(Yoxall et al., 2005); though this may reflect differences in tissue concentration. However, it has 
been shown that sulforaphane elevated UGTlAl expression at the mRNA level in HepG2 cells 
(Bacon et al., 2003). The present studies agree with earlier findings (Walters et al., 2004) where 
it was reported that consumption of cruciferous vegetables in the diet tended to increase 
glucuronidation of the heterocyclic amine PhIP (2-amino-l-methyl-6-phenylimidazo[4,5- 
6]pyridine) in humans, even though other components from these vegetables have probably 
contributed to the modulation of this enzyme. Similarly, supplementation of diets with 
cruciferous vegetables led to reduced serum bilirubin levels, the glucuronidation of which is 
catalysed by UGTlAl (Navarro et al., 2009). In addition, the present studies demonstrated that 
exposure of rat liver slices to phenethyl isothiocyanate caused an increase in the glucuronidation 
of 1-naphthol, in concordance with findings reported following consumption of watercress, a rich 
source of phenethyl isothiocyanate, in which enhanced nicotine glucuronidation among smokers 
was noted (Hecht et al., 1999). In contrast, neither glucosinolate induced glucuronosyl 
transferase activity in rat liver slices as measured using 1-naphthol as substrate. In in vivo 
studies, however, both glucosinolates elevated glucuronosyl transferase activity (Barillari et al., 
2007); similarly, Wortelboer et al. (1992) found that cooked Brussels sprouts enriched with 
glucosinolates enhanced the hepatic glucuronyl transferase 1 activity in male Wistar rats given 
semi-synthetic diets supplemented with 20% cooked Brussels sprouts. These effects are likely 
due to that isothiocyanates generated by the action of intestinal myrosinase (Getahun and Chung, 
1999).
In this study, aromatic phenethyl isothiocyanate was found to be the most potent inducer of
hepatic epoxide hydrolase activity, and resulted in an 8-fold increase in activity, showing that it
is one of the most effective inducers of this enzyme; a rise in protein levels indicates that
increased enzyme concentration is responsible for the rise in activity. Erucin, one of the two
aliphatic isothiocyanates used in this study, was a weak inducer while sulforaphane caused no
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induction, comparable with in vivo studies (Yoxall et al., 2005). It is clear that the nature of the 
side chain is crucial in determining the ability of these isothiocyanates to induce microsomal 
epoxide hydrolase activity. Epoxide hydrolases (EC 3.3.2.7-11) are engaged in the hydrolysis of 
many epoxides to the corresponding diols; epoxides are the reactive intermediates o f many 
structurally diverse chemicals, such mycotoxins, polycyclic aromatic hydrocarbons and 
halogenated aliphatic compounds (Decker et al., 2009).
Finally, total hepatic glutathione levels were elevated at the lower concentrations of the free 
isothiocyanates studied (1, 2.5, and 10 pM), in agreement with previous studies (Kim et al., 
2003; Misiewicz et al., 2004; Hanlon et al., 2008); however, in the case of glucosinolates no 
major effect was observed, whereas supplementation with myrosinase of the glucosinolate- 
containing incubations to liberate the free isothiocyanate caused a rise in concentration.
4,4.2 Modulation o f  rat pulmonary carcinogen-metabolising enzyme by intact glucosinolates 
and isothiocyanates
It has been reported that rats-treated orally with high doses of glueoraphanin slightly modulated
Phase-n conjugation enzymes, while strongly induced Phase-I bioactivation enzymes in the lung
(Paolini et al., 2004). Similarly gluconasturtiin, a glucosinolate originating from cruciferous
vegetables and the precursor of phenethyl isothiocyanate, induced pulmonary CYP450 and Phase
II metabolising enzymes in male Swiss Albino GDI mice (Canistro et al., 2004). Nevertheless,
since the hydrolysis of glucosinolates to isothiocyanates occurred in the intestine by microbial
myrosinase (Getahun and Chung, 1999) it is possible to discern whether these effects are caused
by the isothiocyanates or their parent glucosinolates. As already discussed {vide supra)
glucosinolates can be absorbed intact via the intestinal epithelium, and the mechanism may
involve carrier-mediated transport mechanisms (Holst and Williamson, 2004). Therefore, studies
have been conducted to ascertain whether intact glucosinolates can influence pulmonary enzyme
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activity of enzymes participate in metabolism of carcinogen. To accomplish this objective, 
precision-cut rat lung slices were incubated with a various concentrations of the isothiocyanates, 
corresponding glucosinolates or a mixture of the glucosinolates and myrosinase, the enzyme that 
generates the isothiocyanate.
Cytochrome P450 enzymes
Both glucosinolates in this study raised the dealkylation of ethoxyresorufin, a biomarker of 
CYPlAl activity in the lung, and this was associated with an increase in the apoprotein levels of 
CYPlAl and CYPIBI, demonstrating that the increase in activity is the result of enhanced 
enzyme bioavailability; these observations are in agreement with studies showing a marked 
increase in CYPl A activity in the lung of rats when their diet was supplemented with 
glueoraphanin (Paolini et al., 2004). CYP1A2, is not expressed in the lung (Kimura et al., 1986). 
Even though both isothiocyanates, erucin and i?,5'-sulforaphane, also enhanced CYPl apoprotein 
expression levels, no concomitant rise in the 0-deethylation of ethoxyresorufin activity was 
observed, which is in concordance with studies in rat lung slices where exposure to erucin or 
sulforaphane, did not modulate cytochrome P450 activities but raised CYPIA/Bl apoprotein 
levels (Hanlon et al., 2008a). As previously discussed, isothiocyanates are mechanism-based 
inhibitors so that the induced enzyme is incapable of eliciting metabolic activity (Yoxall et al., 
2005; Hanlon et al., 2008a; Konsue and loannides, 2010c); obviously, lung has adequate 
metabolic capacity to transform isothiocyanates to the metabolite(s) that can cause inhibition. 
The addition of myrosinase into the glucosinolate-containing incubations clearly eliminated the 
effect o f the glucosinolates on the 0-deethylation of ethoxyresorufin activity confirming that the 
increase in activity is mediated by the intact glucosinolate.
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Phase II enzymes
No statistically significant increase was evident in quinone reductase activity in lung slices 
exposed to glucosinolates, which is in contrast to the findings in rat liver slices where an increase 
in activity was noted after exposure to the highest concentrations studied, alluding to a tissue 
difference; but in the case of glucoerucin an increase in pulmonary protein expression was 
evident. In agreement with previous studies (Hanlon et al., 2009a), both isothiocyanates up- 
regulated both activity and protein levels. Furthermore, co-incubation of glucosinolates with 
myrosinase to allow the formation of their corresponding isothiocyanates, further increased 
pulmonary quinone reductase activity and expression, proving that the free isothiocyanates are 
far more potent inducers of this activity as compared with the glucosinolates from previous 
studies. It is pertinent to indicate that the difference between lung and liver in quinone reductase 
activity after exposure to isothiocyanates has been documented where phenethyl isothiocyanate 
modulated this activity in the liver but not in the lung (Konsue and loannides 2008; Guo et al., 
1992)
Glutathione ^'-transferases are one of the most important Phase II detoxification enzymes
favourable in cancer prevention by enhancing the excretion of xenobiotics, via generation of
their conjugates with cellular glutathione. In the current study, pulmonary glutathione S-
transferase activity, measured using CDNB, which is a non-specific substrate whose conjugation
with glutathione is catalysed by a number of glutathione ^'-transferases isoenzymes (Sherratt and
Hayes, 2002), and in consequence offers a general picture of changes in this activity in rat lung,
raised GST activity was in accordance with previous studies (Hanlon et al., 2009a); intact
glueoraphanin also elevated this activity, at high concentrations in concordance with previous
studies where rats treated with glueoraphanin orally displayed higher pulmonary glutathione S-
transferase activity, monitored using j[?-chloronitrobenzene as the substrate, following repeated
exposure (Paolini et al., 2004). The expression of GSTa was examined in lung slices after
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exposure to the isothiocyanates and their glucosinolate precursors, since this isoenzyme is very 
active in the detoxification of epoxides of benzo[a]pyrene (Awasthi et al., 1985), and possibly 
other polycyclic aromatic hydrocarbons. As demonstrated in rat liver, the isothiocyanates 
enhanced expression of GSTa; similarly, an increase in expression was manifested in lung slices 
following exposure to glueoraphanin, although the effect was marginal in the case of 
glucoerucin.
A marked increase in pulmonary total glutathione levels was evident when the lung slices were 
incubated with the isothiocyanates, confirming previous studies (Hanlon et al., 2009a) where a 
dose-dependent effect of erucin and sulforaphane on total glutathione levels in rat lung slices was 
seen; however the effect was less pronounced with the glucosinolates. Supplementation of the 
glucosinolate incubations with myrosinase caused a clear rise in glutathione levels. In fact, a 
relationship between cellular glutathione concentration, accumulation of isothiocyanate and the 
efficacy of isothiocyanates in modulating carcinogen-metabolising enzymes has been reported 
(Kim et al., 2003). It was suggested that a rise in isothiocyanate accumulation was associated 
with high cellular glutathione concentration, which consequently caused induction of ARE 
(antioxidant response element)-mediated phase II enzyme genes (Kim et al., 2003) or resulted in 
cytochrome P450 enzymes inhibition (Conaway et al., 2001); thus, the depletion in cellular 
glutathione levels resembles the induction in Phase II enzymes expression. On the other hand, 
Kim et al. (2003) demonstrated that HepG2-C8 cells exposed to non-toxic levels of sulforaphane, 
displayed a marked fall in glutathione levels during the first 4 hours of incubation, which was 
then reinstated, up to 2.2-fold, following 24 hours incubation, indicating that ARE induction was 
taking place throughout in the early hours of glutathione depletion.
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4.4.3 Importance o f  incubation time on the up-regulation o f  carcinogen-metabolising enzymes 
in rat liver slices by glucosinolates and isothiocyanates
A correlation between biological half-life of a compound and potency of induction of 
cytochrome P450 enzymes was seen in studies carried out four decades ago. Using a series of 
barbiturates, a direct correlation was found between duration of biological half-life and potency 
of induction of cytochrome P450 activities so that phénobarbital, having the longest half-life, 
was found to be the most effective inducer of these enzymes (Valerino et al., 1974; loannides 
and Parke, 1975). Obviously the length of time a compound exists in the body unmetabolised is 
an important determinant of the level of induction.
A most important mechanism of action by chemopreventive isothiocyanates is up-regulation of 
Phase II detoxification enzyme systems, for instance glutathione 5"-transferases and quinone 
reductase (Hanlon et al., 2009). Most work carried out on the chemopreventive mechanism of 
glucosinolates and isothiocyanates was conducted mostly in vitro, and the significance o f such 
studies can only be assessed in relationship with attainable plasma/tissue levels. It is customary 
that the in vitro effects are related to the Cmax, the highest plasma concentration achieved after 
dietary intake. Inherent to such an approach is the hypothesis that even transient tissue exposure 
to the biologically-active concentrations is adequate for a complete response for up-regulation of 
these enzyme systems to be manifested. One of the objectives of the current part of the study was 
to investigate this hypothesis using glucosinolates/isothiocyanates, by incubating them for 
different periods of time with precision-cut rat liver slices, an in vitro system that is appropriate 
in evaluating the potential of xenobiotics to modulate cytochrome P450 and phase II activities in 
the liver and lung (Pushparajah et al., 2007; Hanlon et al., 2009a). The concentrations of 
glucosinolates/isothiocyanates were selected based on previous (Hanlon et al., 2009) and current 
studies in this system illustrating clear induction of the relevant enzyme systems. In order to 
induce significantly the dealkylation of ethoxyresorufin and methoxyresomfin, markers for the
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Ah-regulated CYPlAl/2 (Lum et al., 1986; Namkung et al., 1988), it was necessary for the slices
to be in contact with the glucosinolates for no less than 6 hours. A similar pattern in quinone
reductase activity emerged when precision-cut liver slices were incubated with isothiocyanates;
all three isothiocyanates employed in this study up-regulated this activity in rat liver slices with a
minimum exposure of 6 hours being crucial. At earlier time points of incubation, a very modest
increase in apoprotein level could be seen in the case of aliphatic isothiocyanates. The activity of
glutathione 6"-transferase was monitored using CDNB as the accepting substrate (Ricci et al.,
1994). Previous studies (Hanlon et al., 2009; Konsue and loannides, 2010), reported that the
activity of this enzyme was elevated following incubation of rat liver slices with all three
isothiocyanates. However, the present studies established that the time of incubation necessitated
for the increase in activity to be apparent differ with these isothiocyanate, ranging from 2 hours
in the case of R,6'-sulforaphane to 6 hours in the case of phenethyl isothiocyanate, evidently
indicating that the nature of the side chain is essential in the up-regulation o f this enzyme by
isothiocyanates. In contrast to the other enzymes studied, such as quinone reductase and UDP-
glucuronosyltransferase, which are mediated by the Ah receptor (Bonnesen et al. 2001), the
glutathione iS-transferase subunits are subject to control by other transcription factors, for
example the 90 kDa heat shock proteins (HSP90) that inhibits dimérisation with the Ah receptor
nuclear translocator protein (ARNT), the X-associated protein 2 (XAP2), which is important for
the binding of both HSP90 and Ah receptor, and 23 kDa co-chaperone protein, p23 (Denison et
al., 2002; Petrulis and Perdew, 2002; Denison and Nagy, 2003). Sulforaphane has been shown to
be an efficient antagonist of PXR, a nuclear hormone receptor, which plays a role as a xenobiotic
sensor to monitor metabolism of xenobiotics through transcriptional regulation of several
glutathione *S'-transferase family members (Zhou et al., 2007), and is unlikely that PXR mediates
the observed effects. Nevertheless, the expression of glutathione ^-transferase enzyme is also
controlled by a nuclear factor-E2 p45-related factor (Nrf) 2 transcription factor, which acts as a
sensor of cellular stress that is involved in the regulation of antioxidant and detoxication
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enzymes (McMahon et al., 2001). Therefore, according to Zhang (2000) who studied the 
importance of glutathione in the accumulation of isothiocyanates and their conjugates in Hepa 
lc lc7  cells, it may be hypothesised that the early induction of glutathione ^'-transferase 
expression in this study is regulated by Nrf2, directly via agonism to the receptor itself or 
indirectly via depletion of reduced glutathione because as a consequence of the rapid conjugation 
with sulforaphane. GSTa levels, one of the subunits involved in the CDNB metabolism (Sherratt 
and Hayes, 2002), were also enhanced by the three isothiocyanates indicating that increased in 
enzyme concentration.
The present studies clearly point out that shorter exposure by means a transient attainment of the
biologically-active concentration of glucosinolates or isothiocyanates in a tissue is inadequate to
cause to elevation of enzyme activities, and longer exposure is perhaps necessary. This may be
related to the fact that isothiocyanates reach high intracellular concentrations (Zhang and
Talalay, 1998; Ye and Zhang, 2001; Zhang and Callaway, 2002). It was suggested that peak
intracellular concentrations of isothiocyanates are attained within 0.5-3.0 hours of exposure, and
the concentration may reach 200-fold higher than extracellular concentration, as observed in in
vitro studies involving human and animal cells (Zhang, 2004). Significantly, about 95% of the
intracellular sulforaphane exists as the glutathione conjugate 30 minutes after exposure, while
only 5% is left in this form after a 3-hour with exposure; indicating that the ratio of parent
compound to the glutathione metabolite has changed dramatically during the incubation period
(Zhang, 2000). It is relevant to consider that this ratio may be important in determining the time-
dependent up-regulation of the glutathione ^'-transferase; at the early time points of incubation,
production of glutathione conjugates and depletion of the glutathione pool steers enzyme
induction via the Nrf2 transcription factor, while at later time points the high concentration of
jfree parent compound leads to activation of the AhR to mediate rises in enzyme systems. The
potential of diverse isothiocyanates to provoke quinone reductase and glutathione ^'-transferase
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activities was related to their intracellular concentration and its dithiocarbamate metabolites 
(Zhang and Talalay, 1998; Ye and Zhang, 2001). In contrast to 7^,5'-sulfbraphane and erucin, no 
up-regulation in glutathione ^'-transferase activity was noted after short incubation with 
phenethyl isothiocyanate and required incubation for at least 6 hours. This is due to the fact that 
initially phenethyl isothiocyanate enters the cell more gradually as compared with sulforaphane 
and, more essentially, the levels of the non-metabolised phenethyl isothiocyanate are sustained 
for at least 12 hours (Zhang and P. Talalay, 1998), indicating poor metabolism by glutathione 
conjugation. Secondly, the concentration that caused an induction by phenethyl isothiocyanate, 
via the Ah receptor, is much lower (1 pM) than that of erucin and i?,5'-sulforaphane (10 pM); 
thus no glutathione depletion occurs to steer induction of this enzyme through the Nrf2 
transcription factor. It is pertinent to point out that in pharmacokinetic studies performed 
employing sulforaphane, the intravenous and oral administration in rats and oral dosing of 
human volunteers with broccoli caused a marked drop in the plasma concentrations of 
sulforaphane most likely demonstrating intracellular accumulation of this isothiocyanate (Hanlon 
et al., 2008; 2009), while in the case of phenethyl isothiocyanate, no such effect was evident in 
rat studies (Konsue et al., 2010).
An alternative explanation for the 6-hour requirement to stimulate enzyme activities via the Ah 
receptor, may be that a sustained signalling via this transcription factor is essential for the active 
protein to be synthesised, that would require a prolonged association of the 
glucosinolate/isothiocyanate with the receptor. It is worthwhile to note that, in general the 
enzyme activity or expression increased further when the incubation time was extended from 6 to 
24 hours. Finally, the possibility that small rises in activity occurred at earlier time points of 
incubation that could not be identified due to lack of sensitivity of the enzyme assays cannot be 
ruled out.
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4.5 Conclusions
o Intact glucosinolates can modulate the activity of carcinogen-metabolising enzyme 
systems, which is likely to impact on the chemopreventive activity linked to cruciferous 
vegetable consumption.
® Neither glucosinolate caused a significant increase in quinone reductase activity in lung
slices in contrast to observations in rat liver slices, implying a tissue difference.
® For an effective rise in the activity of GYP and Phase II detoxification enzymes as a
consequence of exposure to glucosinolates/isothiocyanates to be manifested, tissue 
exposure of at least 6 hours to the appropriate concentrations is required.
® Present studies demonstrate for the first time that intact glucosinolates are poor agonists
to the Ah receptor, properties that may contribute significantly to their chemopreventive 
potency.
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CHAPTER 5
Modulation of rat hepatic and pulmonary carcinogen 
metabolising enzymes by Daikon glucosinolates
156
Chapter 5: Modulation o f carcinogen-metabolising enzymes by Daikon glucosinolates
5.1 Introduction
Studies described in Chapter 4 showed that intact glucosinolates, glucoraphanin and glucoerucin, 
have the potential to modulate carcinogen-metabolising enzymes in both liver and lung slices. 
Glucoraphasatin, also known as 4-methylsulfanyl-3-butenyl glucosinolate, glucodehydroenicin 
(CAS number 28463-23-2, Figure 5.1) is another glucosinolate derived from Raphanus sativus 
L. (Kaiware Daikon), a white radish consumed widely in Japan, and increasingly in Europe and 
the United States (Talalay and Fahey, 2001). When it comes into contact with myrosinase (P- 
thioglucoside glucohydrolase, EC.3.2.1.147), glucoraphasatin is converted to 4-methylsulfanyl- 
3-butenyl isothiocyanate (raphasatin). It has been reported that glucoraphasatin has redox 
properties as it reacted with both H2O2 and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic 
acid) (ABTS^ radical cation that eventually resulted in its conversion into glucoraphenin, 
indicating that this glucosinolate may have potential health benefits because of its reducing 
capability (Barillari et al. 2005). The same workers (2006) observed that this glucosinolate has 
also antioxidant properties and extensively stimulated bile flow in rats. In studies conducted in 
male Sprague-Dawley rats, glucoraphasatin administration by oral gavage as a single or repeated 
doses revealed that this glucosinolate could influence carcinogen-metabolising enzymes; 
CYP3A1/2 were the most sensitive enzymes to glucoraphasatin, whilst a repeated administration 
of a higher dose it caused a 2.4-fold increase in CYP3Al/2-linked and 1.6-fold increase in 
CYPlA2-supported monooxygenases (Barillari et al., 2007). In addition, CYPlAl-linked 
activities and the CYP2B 1/2-supported oxidases were also elevated (1.5-fold) after repeated 
administration of high doses (Barillari et al., 2007). With respect to Phase II enzymes, rats 
treated repeatedly with a high dose of glucoraphasatin displayed increased UDP-glucuronosyl 
transferase activity (2-fold) (Barillari et al., 2007). Furthermore, an aqueous extract of Raphanus 
sativus L. significantly elevated mRNA expression of CYPlA l, CYP1A2 and CYPIBI 
enzymes, as well as of Phase II detoxifying enzymes such as quinone reductase, haem oxygenase
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1 and thioredoxin reductase 1 in human hepatoma HepG2 cell line (Hanlon et al., 2007). Similar 
observations were made by Hanlon et al. (2009) who reported that the vegetative part of Spanish 
black radish, another source of glucoraphasatin had superior antioxidant properties than the 
roots, and was able to induce the expression of detoxification enzymes to the same extent as the 
roots. Since the potential of isothiocyanates to modulate Phase II detoxification enzyme systems 
is influenced by the substituent, and taking into account the extensive use of this vegetable in 
human diets, glucoraphasatin has been extracted firom Japanese Daikon sprouts, and an extensive 
study has been carried out in precision-cut rat liver slices to assess the capability of intact 
glucoraphasatin and its isothiocyanate metabolite, 4-methylsulfanyl-3-butenyl isothiocyanate 
(raphasatin), on carcinogen-metabolising enzyme systems.
Myrosinase 
PBS, pH 7.4
— ► S = C = N '
■O3SO
Glucose
Glucoraphasatin + HSO,^ ' 4-methylsulfanyl-3-butenyl isothiocyanate
Figure 5.1: Formation of 4-methyIsuIfanyI-3-butenyl isothiocyanate from glucoraphasatin 
at pH 7.4 by enzymic hydrolysis. Adapted firom Fahey et al. (2001).
An additional study was conducted in in vivo following exposure of rats to three doses of a 
glucosinolate-rich extract firom Daikon sprouts, the lowest representing the human dietary dose 
based on body weight; the principal glucosinolate in this extract is glucroraphasatin (253±9 
pmol/g; 11.6±0.4% w/w) but it also contains substantial amounts of glucoraphenin (116±10 
pmol/g; 5.5±0.5% w/w), when it became apparent that this glucosinolate, as well as its 
corresponding isothiocyanate, namely raphasatin, could modulate carcinogen-metabolising 
enzymes in rat liver slices. The main objective of the present study was to assess in rats the effect
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of intake of glucosinolate-rich Daikon extract, employing dietary levels of exposure, on 
cytochromes P450, epoxide hydrolase, UDP-glucoronosyltransferase, A-acetylase, 
sulphotransferase, NQOl, GSTs, and total glutathione. Even though limited studies on the effects 
of glucoraphasation on such enzyme systems have been previously reported (Barillari et al., 
2007; Hanlon et al., 2007), these employed rather high doses. Furthermore, modulation of these 
enzymes was investigated in two different tissues, e.g. liver and lung, as the liver is the principal 
site of carcinogen metabolism, and the lung is a major target tissue for the chemopreventive 
activity of glucosinolates and isothiocyanates.
5.2 Methods
5.2.1 In vitro modulation o f  rat hepatic carcinogen-metabolising enzymes by glucoraphasatin
Methodology for preparation and incubation of rat liver slices is elaborated in section 2.2.2. In
order to choose a range of concentrations of the glucosinolate/isothiocyanate that do not
compromise the viability of rat liver slices, an initial study was conducted where slices were
exposed for 24 hours to glucoraphasatin (0-25 pM), in the presence and absence of myrosinase,
and toxicity was assessed using the leakage of lactate dehydrogenase as biomarker (see section
2.2.3). Glucoraphasatin displayed no toxicity at the concentrations studied but, in contrast, when
myrosinase was added to generate 4-methylsulfanyl-3-butenyl isothiocyanate, toxicity was
evident at the highest concentrations. Therefore, incubation of precision-cut rat liver slices was
performed by exposure to glucoraphasatin at concentrations of 0-10 pM, either in the presence or
absence of myrosinase to assess the ability of this glucosinolate to modulate the various enzyme
systems. At the end of the incubation period, microsomal and cytosolic fractions were prepared
by differential centrifugation, and used to determine phase I and II enzyme activities, and total
glutathione levels as described in sections 22.6-2.2.7. The changes in protein expression level
were determined by Western blot analysis (section 2.2.9).
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5.2.2 In vivo modulation o f  rat hepatic and pulmonary carcinogen-metabolising enzymes by 
glucosinolate-rich Daikon extract
5.2.2.1 Animal treatment
After one week of acclimatisation, 20 male Wistar Albino rats (180 ± 20 g), purchased from 
Charles River UK Ltd (Manston Road, Margate, Kent, U.K), were randomly assigned to 4 
groups of 5 rats each. Since the human intake of glucoraphasatin and glucoraphenin, to my 
knowledge, has not been reported, the doses employed in the present study were based on the 
average human consumption of total glucosinolates in the United Kingdom, which is 14 
mg/person/day (Sones et al., 1984); assuming an average body weight of 70kg, this is equivalent 
to 0.2 mg/kg/day. Diets were supplemented with the glucosinolate extract so that the daily doses 
of total glucosinolate were approximately 0.5 (Low), 5.0 (Medium) and 50 (High) mg/kg/day, 
whereas one group served as control. The animals were maintained on these diets for 14 days, 
and body weights were recorded daily. At the end of the treatment period, rats were killed by 
cervical dislocation; livers and lungs were removed and weighed. The tissues were immediately 
frozen in liquid nitrogen and stored at -80°C until use. Both rat liver and lung S9 fractions were 
processed and prepared as described in section 2.2.4.
5.2.2.2 Determination o f carcinogen-metabolising enzyme activities
The dealkylations of ethoxy-, methoxy-, pentoxyresorufrn and 7-benzyloxyquinoline (section 
2.2.6), epoxide hydrolase and UDP-glucuronosyltransferase (sections 1.2.1.2> and 2.2.7.4) were 
determined in the microsomal fractions. In the cytosolic fractions, the following assays were 
carried out: QR using menadione as substrate, glutathione ^'-transferases activities using CDNB, 
DCNB and NBD-Cl as accepting substrates, sulphotransferase using 2-naphthol as substrate, N- 
acetyltransferase using PABA as substrate, and total glutathione (see section 2.2.7). Lastly, total 
protein concentration using the Bradford method, and changes in expression levels of enzymes
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using Western blot analysis was determined as described in sections 2.2.8 and 2,2.9, 
respectively.
5.3 Results
5.3.1 Toxicity o f glucoraphasatin to tissue slices
No toxicity was found after slices were exposed to glucoraphasatin for 24 hours at concentrations 
of 0-25 pM. However, when myrosinase was added to generate 4-methylsulfanyl-3-butenyl 
isothiocyanate, toxicity was evident at the highest concentrations (Figure 5.2).
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Figure 5.2: Leakage of LDH following incubation of precision-cut rat liver slices with 
glucoraphasatin in the absence and presence of myrosinase. LDH leakage was measured in 
rat liver slices incubated with glucoraphasatin alone (0-25 pM) and in the presence of 
myrosinase (0.018 U) for 24 h. Results are presented as mean ± SD of three slices, each analysed 
in duplicate. *, P<0.05; **, P<0.01; ***, P<0.001.
5.3.2 In vitro modulation o f rat hepatic xenobiotic-metabolising enzymes by glucoraphasatin
5.3.2.1 Phase I enzymes
Incubation of precision-cut rat liver slices with glucoraphasatin (0-10 pM), either in the presence 
or absence of myrosinase, failed to influence the dealkylations of methoxy- and ethoxyresorufm 
(Figure 5.3).
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Figure 5.3: Effect of glucoraphasatin on CYPl activities in precision-cut rat liver slices.
Precision-cut rat liver slices were incubated with glucoraphasatin (0-10 pM) or glucoraphasatin 
(0-10 pM) plus myrosinase (0.018 U) for 24 h; slices were pooled and microsomes isolated, and 
the O-dealkylations of methoxy- and ethoxyresorufm determined. Results are presented as mean 
± SD for three pools of slices, each comprising ten slices. *, P<0.05; **, P<0.01; ***, P<0.001.
Similarly, the intact glucosinolate did not modulate the protein expression of the two enzymes 
belonging to the CYPl family, namely CYPlAl and CYPIBI, except CYP1A2 with a modest 
increase. When, however, the incubation medium was supplemented with myrosinase, a clear 
rise in the expression of CYP1B1/A2 was evident (Figure 5.4). Moreover, a statistically 
significant increase in the 0-demethylation of methoxyresorufm was observed, but only at the 
highest dose (Figure 5.3).
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Figure 5.4: Effect of glucoraphasatin on CYP expression in precision-cut rat liver slices.
Precision-cut rat liver slices were incubated with glucoraphasatin (0-10 pM) or glucoraphasatin 
(0-10 pM) plus myrosinase (0.018 U) for 24 h; slices were pooled and microsomes isolated. The 
immunoblot analysis was carried out by exposure of microsomal proteins to mouse anti-rat 
CY PlA l, mouse anti-rat CYP1A2 or rabbit anti-rat CYPIBI primary antibodies followed by the 
appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg o f total 
microsomal protein from pooled slices. The blots were stripped and re-probed with anti-)3-actin 
antibody to normalise for differences in protein loading.
5.3.2.2 Phase II  detoxification enzymes 
i. Quinone reductase
Exposure of the rat liver slices to glucoraphasatin suppressed quinone reductase activity at the 
highest concentrations studied, but addition of myrosinase to the incubation medium led to more 
than doubling of the activity; comparable changes were observed at the protein level (Figure 
5.5).
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Figure 5.5: Effect of glucoraphasatin on quinone reductase activity and expression in 
precision-cut rat liver slices. Precision-cut rat liver slices were incubated with glucoraphasatin 
(0-10 pM) or glucoraphasatin (0-10 pM) plus myrosinase (0.018 U) for 24 h; slices were pooled 
and cytosol isolated, and quinone reductase activity determined. Results are presented as mean ± 
SD for three pools of slices, each comprising ten slices. The immunoblot analysis was carried out 
by exposure of cytosolic proteins to rabbit anti-rat NQOl primary antibody followed by the 
appropriate peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg of total 
cytosolic protein from pooled slices. The blots were stripped and re-probed with anti-LDH 
antibody to normalise for differences in protein loading. *, P<0.05; **, P<0.01; ***, P<0.001.
a. Glutathione S-transferase
When glutathione ^'-transferase activity was monitored, as in the case of quinone reductase,
activity was impaired at the higher doses of the glucosinolate but doubled following
supplementation of the incubation medium with myrosinase; a similar picture emerged at the
protein level when GSTa levels were determined (Figure 5.6).
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Figure 5.6: Effect of glucoraphasatin on glutathione Y-transferase activity and expression 
in precision-cut rat liver slices. Precision-cut rat liver slices were incubated with 
glucoraphasatin (0-10 pM) or glucoraphasatin (0-10 pM) plus myrosinase (0.018 U) for 24 h; 
slices were pooled and cytosol isolated, and glutathione ^'-transferase activity determined. 
Results are presented as mean ± SD for three pools of slices, each comprising ten slices. The 
immunoblot analysis was carried out by exposure of cytosolic proteins to rabbit anti-rat GSTAl- 
1 primary antibody followed by the appropriate peroxidase-labelled secondary antibody. Each 
lane was loaded with 30 pg of total cytosolic protein from pooled slices. The blots were stripped 
and re-probed with anti-LDH antibody to normalise for differences in protein loading. *, P<0.05; 
**, P<0.01; ***,P<0.001.
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in. UDP-glucuronosyl transferase
Microsomal glucuronosyl transferase activity was elevated only at the highest concentration of 
glucoraphasatin, but addition of myrosinase led to significant increases in activity at lower 
concentrations, and in both cases the rise in activity was paralleled by increased expression of the 
protein determined immunologically (Figure 5.7).
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Figure 5.7: Modulation of UDP-glucuronosyl transferase activity and expression in precision-cut 
rat liver slices by glucoraphasatin. Precision-cut rat liver slices were incubated with glcucoraphasatin 
(0-10 pM) or glucoraphasatin (0-10 pM) plus myrosinase (0.018 U) for 24 h; slices were pooled and 
microsomes isolated and UDP-glucuronosyl activity determined. Results are presented as mean ± SD for 
three pools of slices, each comprising ten slices. The immunoblot analysis was carried out by exposure of 
microsomal proteins to antibody against glucuronosyl transferase (UGT1A6) followed by the appropriate 
peroxidase-labelled secondary antibody. Each lane was loaded with 30 pg of total microsomal protein 
from pooled slices. The blots were stripped and re-probed with anti-^-actin antibody to normalise for 
differences in protein loading. *, P<0.05; **, P<0.01; ***, P<0.001.
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iv. Epoxide hydrolase
Both the glucosinolate and, in particular, the generated isothiocyanate markedly induced the 
epoxidation of benzo[a]pyrene 4,5-epoxide; protein expression was similarly enhanced (Figure 
5.8).
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Figure 5.8: Modulation of epoxide hydrolase activity and expression in precision-cut rat 
liver slices by glucoraphasatin. Precision-cut rat liver slices were incubated with 
glcucoraphasatin (0-10 pM) or glucoraphasatin (0-10 pM) plus myrosinase (0.018 U) for 24 h; 
slices were pooled and microsomes isolated and epoxide hydrolase activity determined. Results 
are presented as mean ± SD for three pools of slices, each comprising ten slices. The immunoblot 
analysis was carried out by exposure of microsomal proteins to antibody against epoxide 
hydrolase followed by the appropriate peroxidase-labelled secondary antibody. Each lane was 
loaded with 30 pg of total microsomal protein from pooled slices. The blots were stripped and 
re-probed with anti-(3-actin antibody to normalise for differences in protein loading. *, P<0.05; 
**, P<0.01; ***,P<0.001.
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V. Total glutathione levels
Finally, total glutathione levels were not altered by exposure of the liver slices to 
glucoraphasatin, but following addition of myrosinase to the incubation mixture a significant 
increase was observed (Figure 5.9).
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Figure 5.9: Effect of glucoraphasatin on glutathione levels in precision-cut rat liver slices.
Precision-cut rat liver slices were incubated with glucoraphasatin (0-10 pM) or glucoraphasatin 
(0-10 pM) plus myrosinase (0.018 U) for 24 h; slices were pooled and cytosol isolated, and 
glutathione levels determined. Results are presented as mean ± SD for three pools of slices, each 
comprising ten slices. *, P<0.05; **, P<0.01; ***, P<0.001.
5.3.3 Effect o f treatment o f  rats with a glucosinolate-rich Daikon extract on hepatic and 
pulmonary carcinogen-metabolising enzyme
5.3.3.1 Effect o f glucosinolate-rich Daikon extract on animal body weight growth 
Body weight of animals was recorded daily during the treatment phase. All animals gained 
weight progressively (Figure 5.10), without any clinical or behavioral signs of toxicity being 
observed in the treatment groups.
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Figure 5.10: Body weight changes in rats exposed to glucosinolate-rich Daikon extract. Rats 
were given diets supplemented with a glucosinolate-rich Daikon extract at a total glucosinolate 
dose of 0.5 (Low dose), 5.0 (Medium dose) and 50 (High dose) mg/day diet for 14 days, whereas 
one group served as control. Results are presented as mean ± SD for five rats.
5.33.2 In vivo modulation o f  cytochrome P450 enzymes in the liver and lung o f rats treated with 
a glucosinolate-rich Daikon extract
5.3.3.2.1 Modulation o f hepatic cytochrome P450 enzyme activities by glucosinolate-rich Daikon 
extract treatment o f  rats
Administration of the Daikon extract at the Low dose significantly elevated the dealkylations of 
ethoxy-, methoxy-, pentoxyresorufin and 7-benzyloxyquinoline, markers for C Y PlA l, CYP1A2, 
CYP2B, and CYP3A2 respectively (Table 5.1). In contrast, a modest drop in activity was 
observed in CYPlAl, as exemplified by the (9-deethylation of ethoxyresorufm, at the two higher 
doses of the Daikon extract (Table 5.1). Immunoblot analysis revealed a small increase in 
CY PlA l, CYP1A2, CYPIBI and, to a lesser extent, CYP3A2 apoprotein levels at the Low dose 
relative to control, but the effect decreased at the higher doses of the Daikon extract (Figure 
5.11).
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Table 5.1: Effect of glucosinolate-rich Daikon extract administration on CYP enzymes
activity in rat liver
Groups of five rats were fed diets supplemented with a glucosinolate-rich Daikon extract at a 
total glucosinolate dose of 0.5 (Low dose), 5.0 (Medium dose) and 50 (High dose) mg/day for 14 
days, whereas one group served as control. At the end of the treatment period, rats were killed 
and livers were removed. Hepatic S9 was prepared from which microsomes were isolated and 
used to determine enzyme activities. Results are presented as mean ± SD of five rats. *, P<0.05; 
**, P<0.01: ***, P<0.001 versus control.
Enzyme
activity
Daikon extract (Dose)
Control Low Medium High
EROD 42.13± 56.38± 34.57± 26.34±
(praol/min/mg protein) 4.94 7.50** 1.24* 4.97***
MROD 32.75± 50.84± 31.26± 28.86±
(pmol/min/mg protein) 4.80 3.09*** 7.40 5.57
PROD 11.37± 14.23± 11.40± 9.27±
(pmol/min/mg protein) 1.89 1.87* 1.73 0.96
BOD 159.65± 266.26± 155.89± 125.46±
(pmol/min/mg protein) 28.78 72.31* 33.42 43.19
OC 0.4
C Y PlA l
Actin
CYP1A2
Actin
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Figure 5.11: Effect of glucosinolate-rich Daikon extract administration on cytochrome 
P450 apoprotein levels in rat liver. Rats were maintained on diets supplemented with a 
glucosinolate-rich Daikon extract at a total glucosinolate dose of 0.5 (Low dose), 5.0 (Medium 
dose) and 50 (High dose) mg/day for 14 days, whereas one group served as control. Hepatic 
microsomal proteins from pooled animals were solubilised and resolved in 10% (w/v) SDS- 
PAGE before being transferred electrophoretically to polyvinylidene difluoride membrane. The 
immunoblot analysis was carried out by exposure of microsomal proteins to mouse anti-rat 
CYPlAl, mouse anti-rat CYP1A2, or rabbit anti-rat CYPIBI and CYP3A2 primary antibodies 
followed by the appropriate peroxidase-labelled secondary antibody. Lanes 1, 2, 3 and 4 refer to 
Control, Low, Medium, and High doses of the glucosinolate-rich Daikon extract, respectively. 
Each lane was loaded with 30 pg of total protein. The blots were stripped and re-probed with 
anti-p-actin antibody to normalise for differences in protein loading.
53.3.2.2 Modulation o f lung cytochrome P450 enzyme activities by glucosinolate-rich Daikon 
extract treatment in rats
In lung, EROD activity (Table 5.2) and CYPlAl apoprotein levels (Figure 5.12) were not 
influenced by the Daikon extract; on the other hand, the Low dose of the Daikon extract led to a 
marked rise in the dealkylation of pentoxyresorufin, a marker for CYP2B (Table 5.2). A modest 
increase in CYPIBI and CYP3A2 apoprotein levels was also evident in the Low dose group 
(Figure 5.12).
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Table 5.2: Effect of glucosinolate-rich Daikon extract administration on CYP enzymes
activity in rat lung
Groups of five rats were fed diets supplemented with a glucosinolate-rich Daikon extract at a 
total glucosinolate dose of 0.5 (Low dose), 5.0 (Medium dose) and 50 (High dose) mg/day for 14 
days, whereas one group served as control. At the end of the treatment period, rats were killed 
and lungs were removed. Pulmonary S9 was prepared from which microsomes were isolated and 
used to determine enzyme activities. Results are presented as mean ± SD of five rats. *, P<0.05 
versus control.
Enzyme
activity
D aikon  extract (Dose)
Control Low Medium High
EROD 30.59± 28.40± 29.12± 24.13±
(pmol/min/mg protein) 6.12 3.44 4.79 2.99
PROD 8.44± 12.45± 9.00± 8.03±
(pmol/min/mg protein) 1.05 2.89* 1.64 1.57
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CYPlAl
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Figure 5.12: Effect of glucosinolate-rich Daikon extract 
administration on CYP apoprotein levels in rat lung. Rats 
were maintained on diets supplemented with a glucosinolate-rich 
Daikon extract at a total glucosinolate dose of 0.5 (Low dose), 5.0 
(Medium dose) and 50 (High dose) mg/day for 14 days, whereas 
one group served as control. Pulmonary microsomal proteins 
from pooled animals were solubilised and resolved in 10% (w/v) 
SDS-PAGE before being transferred electrophoretically to 
polyvinylidene difluoride membrane. The immunoblot analysis 
was carried out by exposure of microsomal proteins to mouse 
anti-rat CYPlAl, or rabbit anti-rat CYPIBI and CYP3A2 
primary antibodies followed by the appropriate peroxidase- 
labelled secondary antibody. Lanes 1, 2, 3 and 4 refer to Control, 
Low, Medium, and High doses of the glucosinolate-rich Daikon 
extract, respectively. Each lane was loaded with 30 pg of total 
protein. The blots were stripped and re-probed with anti-[3-actin 
antibody to normalise for differences in protein loading.
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S3.3.3 In vivo modulation o f phase II enzymes in the liver and lung o f rats treated with a 
glucosinolate-rich Daikon extract
5 3 3 3 .1  Modulation o f hepatic phase II enzyme activities by glucosinolate-rich Daikon extract 
treatment in rats
A modest, but statistically significant increase was observed in NQOl activity at the Low and 
Medium doses. At all doses studied, a pronounced rise in GST activity was observed when 
assessed by using CDNB, DCNB and NBD-Cl as accepting substrates. Sulphotransferase and N- 
acetylase activities, determined using 2-naphthol and PABA as substrates respectively, decreased 
at the Medium dose only while epoxide hydrolase and UDP-glucuronosyl transferase activities 
were markedly elevated at the High dose. Finally, total glutathione levels were unaffected by the 
treatment with the Daikon extract (Table 5.3).
Western blot analysis employing antibodies to NQOl and GSTa revealed an increase in protein 
levels at the Low and Medium doses. On the other hand, expression levels of GSTp rose at the 
two higher doses, and a more modest apparently dose-dependent increase was seen in the case of 
GST%. No increase was observed in SULT and NAT enzyme expression, except a rise in EH and 
UDP-GT at the High dose (Figure 5.13).
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Table 5.3: Effect of glucosinolate-rich Daikon extract administration on phase II enzymes
activity in rat liver
Groups of five rats were fed diets supplemented with a glucosinolate-rich Daikon extract at a 
total glucosinolate dose of 0.5 (Low dose), 5.0 (Medium dose) and 50 (High dose) mg/day for 14 
days, whereas one group served as control. At the end of the treatment period, rats were killed 
and livers were removed. Hepatic S9 was prepared from which cytosol and microsomes were 
isolated and used to determine enzyme activities and total glutathione content. Results are 
presented as mean ± SD of five rats. *, P<0.05; **, P<0.01; ***, P<0.001 versus control.
Enzyme
activity
D a ik o n  ex tr a c t  (Dose)
Control L ow Medium H igh
QR 94.59± 135.924: 123.494= 98.684=
(nmol/min/mg protein) 6.68 21.48** 22.24* 9.23
GST 0.18± 1.83± 1.994= 0.244=
(CDNB) 0.01 0.10*** 0.14*** 0.02***
(pmol/min/mg protein)
GST 0.15± 0.204: 0.204= 0.20±
(DCNB) 0.02 0.03** 0.02** 0.03**
(pmol/min/mg protein)
GST 0.23± 0.274= 0.294= 0.344=
(NBD-Cl) 0.04 0.06 0.02* 0.02***
(pmol/min/mg protein)
SULT 8.21± 8.334: 6.114= 7.154=
(pmol/min/mg protein) 1.92 1.97 0.61* 1.21
NAT 15.22± 14.354= 11.024= 12.494=
(nmol/min/mg protein) 3.06 3.85 0.89* 2.17
EH 1.25± 1.224= 1.334= 2.064=
(nmol/min/mg protein) 0.18 0.19 0.30 0.14***
UDP-GT 107.96± 115.84± 125.204= 229.584=
(nmol/min/mg protein) 13.24 12.80 19.42 25.66***
Total glutathione 3.69± 3.544= 3.174= 3.174:
(mM) 0.95 0.41 0.59 0.37
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Figure 5.13: Effect of glueosinolate-rich Daikon extract on phase II enzyme protein levels 
in rat liver. Rats were maintained on diets supplemented with a glueosinolate-rich Daikon 
extract at a total glucosinolate dose of 0.5 (Low dose), 5.0 (Medium dose) and 50 (High dose) 
mg/day for 14 days, whereas one group served as control. Hepatic cytosolic or microsomal 
proteins from pooled animals were solubilised and resolved in 10% (w/v) SDS-PAGE before 
being transferred electrophoretically to polyvinylidene difluoride membrane. The immunoblot 
analysis was carried out by exposure of cytosolic or microsomal proteins to rabbit anti-rat 
NQOl, GSTAl-1, GSTMl-1, GSTPl-1 and epoxide hydrolase or goat anti-mouse SULTl, 
NAT-1/2 and UGT1A6 primary antibodies followed by the appropriate peroxidase-labelled 
secondary antibody. Lanes 1 , 2 ,3  and 4 refer to Control, Low, Medium, and High doses of the 
glucosinolate-rich Daikon extract, respectively. Each lane was loaded with 30 pg of total protein. 
The blots were stripped and re-probed with anti-LDH antibody or anti-P-actin antibody to 
normalise for differences in protein loading of cytosolic and microsomal proteins, respectively.
5.3.33.2 Modulation o f phase II enzyme activities by glucosinolate-rich Daikon extract in rat 
lung
At all doses studied, the Daikon extract failed to modulate activities of NQOl, sulphotransferase, 
N- acetyltransferase, epoxide hydrolase, GST and UDP-glucuronosyl transferase in the lung 
(Table 5.4). At the protein level, no increase was evident in any of the enzymes studied (Figure 
5.14).
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Table 5.4: Effect of glucosinolate-rich Daikon extract on Phase II enzymes activity in rat
lung
Groups of five rats were fed diets supplemented with a glucosinolate-rich Daikon extract at a 
total glucosinolate dose of 0.5 (Low dose), 5.0 (Medium dose) and 50 (High dose) mg/day for 14 
days, whereas one group served as control. At the end of the treatment period, rats were killed 
and lungs were removed. Pulmonary S9 was prepared from which cytosol and microsomes were 
isolated and used to determine enzyme activities and total glutathione content. Results are 
presented as mean ± SD of five rats.
Enzyme
activity
Daikon extract (Dose)
Control Low Medium High
QR 71.04± 79.14± 80.694= 74.644=
(nmol/min/mg protein) 8.52 7.72 5.22 8.03
GST 0.18± 0.17± 0.16± 0.164:
(CDNB) 0.04 0.02 0.03 0.04
(pmol/mln/mg protein)
GST 0.24± 0.22± 0.254= 0.194=
(NBD-Cl) 0.03 0.04 0.04 0.04
(pmol/min/mg protein)
SULT 6.51± 6.32± 5.744= 5.984=
(pmol/min/mg protein) 1.02 1.07 0.98 1.61
NAT 11.59± 11.13± 10.60± 9.91±
(nmol/min/mg protein) 1.40 1.53 2.21 2.51
EH 66.52± 68.03± 63.374= 62.234=
(pmol/min/mg protein) 7.30 8.75 5.56 2.92
UDP-GT 93.91± 102.794: 105.714= 107.894=
(nmol/min/mg protein) 7.95 7.34 11.91 15.72
Total glutathione 0.81± 0.724= 0.744= 0.734=
(mM) 0.20 0.22 0.31 0.25
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Figure 5.14: Effect of glucosinolate-rich Daikon extract on phase II enzyme expression in 
rat lung. Rats were maintained on diets supplemented with a glucosinolate-rich Daikon extract 
at a total glucosinolate dose of 0.5 (Low dose), 5.0 (Medium dose) and 50 (High dose) mg/day 
for 14 days, whereas one group served as control. Pulmonary cytosolic or microsomal proteins 
from pooled animals were solubilised and resolved in 10% (w/v) SDS-PAGE before being 
transferred electrophoretically to polyvinylidene difluoride membrane. The immunoblot analysis 
was carried out by exposure of cytosolic or microsomal proteins to rabbit anti-rat NQOl, 
GSTAl-1, GSTMl-1, GSTPl-1 and epoxide hydrolase or goat anti-mouse SULTl, NAT-1/2 and 
UGT1A6 primary antibodies followed by the appropriate peroxidase-labelled secondary 
antibody. Lanes 1, 2, 3 and 4 refer to Control, Low, Medium, and High doses of the 
glucosinolate-rich Daikon extract, respectively. Each lane was loaded with 30 pg of total protein. 
The blots were stripped and re-probed with anti-LDH antibody or anti-p-actin antibody to 
normalise for differences in protein loading of cytosolic and microsomal proteins, respectively.
5.4 Discussion
5.4.1 In vitro modulation o f  rat hepatic carcinogen-metabolising enzymes by glucoraphasatin
Chemical agents like glucosinolates or their breakdown products, isothiocyanates, exhibit their 
chemopreventive potential by preventing the interaction of chemical carcinogens with DNA. 
This can be achieved by means of facilitating the detoxification of the reactive, genotoxic 
metabolites of carcinogenic compounds, following the induction of the relevant Phase II 
detoxification enzyme systems. Several studies have reported that chemopreventive 
glucosinolates and/or isothiocyanates are very potent inducers of such enzymes in both liver and 
lung of rats, as well as in vitro studies conducted in rat and human slices (Hanlon et al., 2008a; 
Hanlon et al., 2008b; Konsue and loannides, 2008; Hanlon et al., 2009; Chapter 4). The
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impairment of cytochrome P450 activity is also a feasible alternative mechanism that may be an 
important contributor through the suppression of the bioactivation of chemical carcinogens to 
their reactive intermediates. In the present study, the potential of glucoraphasatin, the major 
glucosinolate in Daikon, to modulate the activity of both cytochromes P450 and Phase II enzyme 
systems in rat liver slices was evaluated, and thus its function as a potential dietary 
chemopreventive phytochemical. The glucoraphasatin used in this study was kindly supplied by 
Dr Renato lori (Agricultural Research Council, Industrial Crop Research Center (CRA-CIN), 
Bologna, Italy), and was derived from Daikon sprouts, a major source of this glucosinolate. 
Precision-cut tissue slices allow us to differentiate between the effects of glucoraphasatin per se 
from those of the isothiocyanate, produced by the supplementation of myrosinase into the 
glucosinolate-containing incubations. In this study no toxicity was found following exposure of 
the slices to glucoraphasatin for 24 hours (0-25 pM). Nonetheless, when myrosinase was added 
to generate 4-methylsulfanyl-3-butenyl isothiocyanate, toxicity was manifested at the highest 
concentrations; these studies concord with previous studies (Hanlon et al., 2007) where it was 
found that glucoraphasatin, up to a 30 pM concentration, did not significantly influence cell 
viability in HepG2 human hepatoma cell line. The same workers, (Hanlon et al., 2009) observed 
reduced viability when HepG2 human hepatoma cells were exposed to an aqueous extract (5 
mg/ml) from the vegetative part of Spanish black radish, which contains high amount of 
glucoraphasatin; however, this toxicity may not be mediated by this glucosinolate.
5.4.1.1 In vitro modulation o f hepatic cytochrome P450 enzymes by glucoraphasatin
Intact glucoraphasatin caused no significant effect on the 0-deethylation of ethoxyresorufm and
G-demethylation of methoxyresorufin, substrate markers of the CYPlAl and CYP1A2 enzymes
respectively, that are strongly related to the bioactivation of chemical carcinogens (loannides and
Lewis, 2004; Zhou et al., 2009). Similarly, apoprotein levels of CYPlA l, CYP1A2 and CYPIBI
remained unchanged by the treatment with glucoraphasatin, contradicting previous studies
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(Hanlon et al., 2007; Scholl et al., 2011) where it was reported that aqueous extracts of Spanish 
Black Radish containing glucoraphasatin significantly up-regulated the mRNA expression of 
CYPlAl, CYP1A2, and CYPIBI in human hepatoma HepG2 cell line. It is conceivable that 
other compounds present in the extract may have been responsible, at least partly for these 
effects. The behaviour of glucoraphasatin appears to be different than that of glucoraphanin and 
glucoerucin which raised the activity and apoprotein expression of these enzymes, in both rat 
liver and lung slices, demonstrating that individual glucosinolates vary in their potential to 
modulate cytochrome P450 enzymes. Other workers (Lee and Lee, 2006) has reported that radish 
extracts containing glucoraphasatin acted as a monofunctional inducers having no effect on GYP 
450 levels, but modulating Phase II enzyme activities in cultured H epalclc? murine hepatoma 
cells.
Co-incubation of glucoraphasatin with myrosinase to form 4-methylsulfanyl-3-butenyl 
isothiocyanate did not affect the dééthylation of ethoxyresorufm while the déméthylation of 
methoxyresorufin was enhanced by 30%, only at the highest dose studied; so as to determine 
whether the rise in activity represents increased enzyme availability, Western immunoblotting 
was carried out on pooled slices, which demonstrated that the CYP1A2 and CYPIBI apoprotein 
levels also increased. It is important to point out that exposure of glucoraphasatin to myrosinase 
at pH 7.4 allows the complete conversion of this glucosinolate to 4-methylsulfanyl-3-butenyl 
isothiocyanate (Papi et al., 2008). Thus like erucin and sulforaphane (Hanlon et ah, 2008b), 4- 
methylsulfanyl-3-butenyl isothiocyanate up regulates CYPl enzyme expression. However, in the 
case of erucin and sulforaphane no increase in activity was observed because of the ability of 
these isothiocyanates to act as mechanism-based inhibitors. Whether 4-methylsulfanyl-3-butenyl 
isothiocyanate also acts as a mechanism-based inhibitor remains to be established.
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5.4.1.2 In vitro modulation o f  hepatic Phase I I  enzymes by glucoraphasatin
Hanlon and Barnes (2011) showed that radish sprouts have higher a amount of glucoraphasatin
compared with the roots, and are consequently more effective inducers of the antioxidant
response element (ARE), a molecular mechanism involved in the up-regulation of Phase II
detoxifying enzymes, and thus the chemopreventative potential of cruciferous vegetables
(Talalay and Fahey, 2001). Epoxides are involved in the carcinogenesis of several chemical
carcinogens including polycyclic aromatic hydrocarbons, mycotoxins such as aflatoxin Bi, and
halogenated aliphatic compounds such as vinyl chloride (Decker et al., 2009). There are two
enzymes effective in the detoxification of such epoxides, namely the microsomal epoxide
hydrolase and the cytosolic glutathione ^'-transferases. Glucoraphasatin was found not to
influence glutathione ^'-transferase activity, but it was an effective inducer of epoxide hydrolase
activity and expression. In fact, the activity of epoxide hydrolase increased 3-fold at a
concentration of only 1 pM of glucoraphasatin, the lowest concentration used in the present
studies; the effect of glucoraphasatin is more potent than that of glucoerucin and glucoraphanin
under identical conditions (Chapter 4). The current observations lend support to previous studies
where feeding mice a diet containing 20% freeze dried radishes enriched in glucoraphasatin for 2
weeks, significantly elevated expression of hepatic microsomal epoxide hydrolase and
glutathione ^'-transferase a2 (Scholl et al., 2011). However, these effects may be at least partly
due to the isothiocyanates generated by the action of intestinal myrosinase (Getahun and Chung,
1999) rather than the parent glucosinolate. Generation of 4-methylsulfanyl-3-butenyl
isothiocyanate by supplementation of myrosinase to the slice incubation medium sustained the
rise in epoxide hydrolase activity and expression, demonstrating that the isothiocyanate
modulates this enzyme similar to the parent glucosinolate. Furthermore, production of 4-
methylsulfanyl-3-butenyl isothiocyanate fi"om glucoraphasatin resulted in a doubling of
glutathione ^'-transferase activity, measured using CDNB as substrate, in which conjugation with
glutathione is catalysed by a number of glutathione ^'-transferase isoenzymes (Sherratt and
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Hayes, 2002) and therefore provides a general indication of changes in this activity. 
Supplementation of glucoraphasatin with myrosinase caused an increase in GSTa protein levels 
in slices exposed to the glucosinolate, demonstrating that increased enzyme levels are at least 
partly responsible for the increase in activity. Lastly, a rise of 50% was also evident in the total 
glutathione levels in the slices treated with a mixture of glucoraphasatin and myrosinase, 
comparable to the effect shown by glucoraphanin and glucoerucin following exposure under the 
same conditions (Chapter 4). Thus increased glutathione ^'-transferase activity is unlikely to be 
compromised by limiting glutathione levels.
Quinone reductase is an enzyme engaged in the detoxification of quinones via catalysing the 
two-electron reduction to hydroquinones, so preventing them from going through redox cycling 
generating reactive oxygen species that may cause oxidative stress. Exposure of rat liver slices to 
glucoraphasatin does not stimulate this enzyme, indeed activity dropped at the highest 
concentrations studied, in contrast to the effect displayed by glucoraphanin and glucoerucin 
studied under the same conditions (Chapter 4). It has been reported that some glucosinolates 
provoked an increase in quinone reductase activity whereas others had no effect; for example 
glucoiberin enhanced quinone reductase activity in Hepa-lclc7 cells whereas gluconapin and 
sinalbin had no effects suggesting that the response is dependent on the side-chain substituent of 
the glucosinolate (Zhu and Loft, 2003). On the other hand, addition of myrosinase to the 
glucoraphasatin-containing incubation system resulted in doubling of this enzyme activity and 
increased enzyme expression, indicating that the increase in activity was the result of increased 
enzyme availability. These findings contradict the work of Scholl et al. (2011) who demonstrated 
that in the HepG2 cells glucoraphasatin induced quinone reductase activity and mRNA 
expression of significantly higher than its degradation products that were generated by addition 
of myrosinase into the cell culture media prior to the addition to the cells; however, in their 
studies much higher concentrations (50-200 pM) of the glucosinolate were employed. In another
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study, the methanol extract of radish sprouts containing glucoraphasatin demonstrated high 
potency in inducing quinone reductase activity in H epalclc? cells (Lee and Lee, 2006), although 
it is possible that other compounds in the extract were responsible for this effect.
In the present study, glucoraphasatin at the concentrations studied, failed to up-regulate 
glucuronosyl transferase activity, comparable with previous findings with other glucosinolates as 
reported in Chapter 4. Supplementation, however, of the incubation mixture with myrosinase 
resulted in significant rise in activity; an increase in UGT1A6 expression, the most important 
isoform in carcinogen metabolism (Bock, 2006), was also observed.
5.4.2 In vivo modulation o f  cytochrome P450 enzymes in the liver and lung o f  rats treated with 
a glucosinolate-rich Daikon extract
Following exposure of animals to the Daikon extract through the diet, dealkylations of ethoxy-,
methoxy-, pentoxyresorufin and benzyloxyquinoline, markers for CY PlA l, CYP1A2, CYP2B,
and CYP3A2 respectively (Burke and Mayer, 1974; Nerurkar et al., 1993; Lubet et al., 1985;
Stresser et al., 2002), were modulated by treatment with the Daikon extract at the Low dose in rat
liver. Similarly, Barillari et al. (2007) reported that administration of single or repeated doses of
glucoraphasatin resulted in the induction of CYPlAl, CYP1A2, CYP2B1/2 and CYP3A1/2
activities in rat liver. In the lung, however, the Low dose of the Daikon extract stimulated only
the dealkylation of pentoxyresorufin, a marker for CYP2B, but had no effect on the other CYP
enzymes studied, clearly indicating that there exists a tissue difference in the up-regulation o f
these enzymes by Daikon extract. It has already been reported that glucoraphanin, differing from
glucoraphasatin only in the oxidation degree of the side-chain sulphur atom (Barillari et al.,
2005), induced pulmonary CYPlAl and CYP2B1 enzyme activities after oral administration to
rats (Paolini et al., 2004). Since CYP1A2 is not expressed in extrahepatic tissues (Kimura et al.,
1986), only CYPIAI/Bl and CYP3A2 expression levels were investigated in the lung. CYPIBI
apoprotein levels are expressed in a tissue-specific manner (McFadyen and Murray, 2008) with
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comparatively high levels in the lung but low levels in the liver (Walker et ah, 1995; Pushparajah 
et ah, 2007). At the Medium and High doses, hepatic dealkylation of ethoxyresorufin decreased 
concomitantly with a decrease in CYPlAl apoprotein levels, indicating that a higher dose is 
required to suppress this enzyme activity in rat liver. It has been reported that suppression of 
CYPlAl activity may be important in eliminating reactive oxygen species (ROS) via the 
suppression of nuclear factor 1 (NFl) gene promoter (Morel and Barouki, 1998), and may be 
responsible to the CYP450 inhibition at the High dose. It has been reported that ROS are over­
generated in rats following a single or repeated administration of glucoraphanin (Paolini et al., 
2004). It is clear that the Daikon extract may impair the formation of DNA adducts by decreasing 
their cytochrome P450-mediated generation. Indeed, an aqueous extracts of Brussels sprouts 
diminished DNA damage induced by 2-nitropropane (Deng et al., 1998), while diet 
supplemented with freeze-dried Brussels sprouts impaired IQ-induced DNA damage in rat liver 
(Humblot et al., 2004). In the lung, no significant change in the dealkylation of ethoxyresorufin 
was noted after rats dosed with High dose of the Daikon extract along with no effect on CYPl A 
apoprotein levels, indicating both concentration- and tissue-differences in the modulation of 
cytochrome P450 enzymes by Daikon extract in the rat.
5.4.3 In vivo modulation o f  Phase II enzymes in the liver and lung o f  rats treated with a 
glucosinolate-rich Daikon extract
At the dietary Low dose administration, the Daikon extract enhanced hepatic glutathione S-
transferase, when evaluated using CDNB and DCNB as accepting substrates, accompanied with
a rise in GSTa and a modest rise in GSTtt protein expression; quinone reductase was similarly
increased in activity and enzyme expression. In concordance, it has already been reported that
oral administration of glucoraphasatin elevated glutathione ^'-transferase activity in rat liver
(Barillari et al., 2007). Clearly, following exposure even at dietary levels of the Daikon extract,
detoxification enzymes are up-regulated as a result of elevated enzyme levels, in contrast to
erucin and sulforaphane where a rise in quinone reductase, but not glutathione ^'-transferase was
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observed (Hanlon et al., 2008). In the lung, phase II enzymes were not affected at this Low dose. 
At the Medium dose, a marked increase was noted in hepatic glutathione ^'-transferase activity 
measured using CDNB, DCNB and NBD-Cl as substrates, being the outcome of a rise in protein 
expression. A modest rise in GSTp and GSTte protein levels was once again observed but to a 
lesser extent compared with the Low dose. Hepatic sulphotransferase and A-acetylase activities 
diminished at the Medium dose of the Daikon extract concomitantly with decreased protein 
levels, indicating that Phase II detoxification enzymes differ in their sensitivity to this 
glucosinolate. In lung, no activity was detectable when GST was assessed using DCNB as 
substrate, most probably due to poor expression of GSTp compared with the liver (Sherratt et al., 
2002). On the other hand, GST activity in lung was not affected by Daikon extract treatment 
when either CDNB or NBD-Cl served as substrates, demonstrating that the effects of the Daikon 
extract are tissue- and isoform-specific, in agreement to previous findings (van Lieshout et al., 
1996). At the High dose, hepatic glutathione ^'-transferase activities determined using DCNB and 
NBD-Cl as substrates were elevated by treatment with the Daikon extract, while impaired when 
CDNB used as substrate.
Epoxide hydrolase and UDP-glucuronosyl transferase activities in the liver were also enhanced
at High dose, while lung enzymes were resistant to this treatment, indicating that the Daikon
extract exhibits tissue specificity in the modulation of these enzymes. Similarly, rats fed a diet
supplemented with phenethyl isothiocyanate caused a rise in quinone reductase and glutathione
^'-transferase activities in the liver but not in the lung (Konsue and loannides, 2008). Similarly, in
vitro studies employing precision-cut rat tissue slices, glucoraphanin and glucoerucin failed to
modulate quinone reductase in the lung but in the liver an increase in activity was evident
(Chapter 4). In studies conducted in mice, hepatic quinone reductase, microsomal epoxide
hydrolase, and glutathione ^'-transferase «2 expression were induced following treatment with
glucoraphasatin (Scholl et al. 2011). Lastly, the Daikon extract failed to influence total
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glutathione concentration in both rat liver and lung, consistent with the results observed in in 
vitro studies utilising precision-cut rat tissue slices (Chapter 4).
It is impossible to determine whether the observed changes are caused by the glucosinolate per 
se and/or the generated isothiocyanate. It was demonstrated that, at least in rats or dogs, 
glucosinolates may survive passage via the intestine to get into the systemic circulation 
(Bheemreddy and Jeffery, 2007; Cwik et al., 2010). Even though the Daikon extract was given in 
the absence of myrosinase, microbial myrosinase present inside the intestine can catalyse the 
generation of the isothiocyanate (Ren-Hau et al., 2010). It is important to point out that 
glucoraphasatin is an exceptional substrate of myrosinase, so that exposure to this enzyme at pH
7.4 allows to its complete hydrolysis (Papi et al., 2008). The fact that a good biological response 
was observed even at the lowest level of exposure indicates that the 
glucosinolates/isothiocyanates are well-absorbed and can attain sufficiently-high intracellular 
concentrations to modulate carcinogen-metabolising enzyme systems.
5.5 Conclusions
The present studies in precision-cut liver slices have established that glucoraphasatin, at 
concentrations as low as 1 pM, either intact and/or through its degradation product 4- 
methylsulfanyl-3-butenyl isothiocyanate, is a potent inducer of hepatic enzymes involved in the 
detoxification of ubiquitous chemical carcinogens such as polycyclic aromatic hydrocarbons, 
heterocyclic amines and mycotoxins, whereas it does not influence cytochrome P450 enzymes 
such as the CYPl family. Meanwhile, in in vivo studies at Low dose, equivalent to human 
dietary intake, a glucosinolate-rich Daikon extract up-regulated modestly hepatic CYP and 
markedly stimulated Phase II enzymes involved in carcinogen-metabolism. Bearing in mind the 
ability of this glucosinolate to elevate markedly glutathione ^'-transferase activity, in my view, it
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Figure 6.1: Evaluation of the toxicity of isothiocyanates in the absence and presence 
of benzo[a]pyrene in H lL l . lc l  cells. Cytotoxicity in H lL l.lc2  cells was evaluated 
using the MTT assay. H lL l.lc2  cells, at a density of 7 x 10'^  cells/ml, were seeded into 
96-well plates and cultured for 24 h. These cells were then incubated in culture medium 
supplemented with benzo[a]pyrene (lO'^^-lO'^M) (A), isothiocyanates; m erucin, ♦ R,S- 
sulforaphane, © phenethyl isothiocyanate (10'^°-10'^M) (B), and benzo[a]pyrene 
(lO'^^-lO'^M) with each isothiocyanate; □ erucin, 4 7^ ,^ '-sulforaphane, o phenethyl 
isothiocyanate (10‘^ M) (C) for 24 h. An aliquot (10 pi) of 3-(4,5-dimethylthiazol-2-yl)- 
2,5-diphenyltetrazolium bromide (MTT) (5 mg/ml) in PBS, was added into the wells
2.3 hours before completion of the incubation. At the end of the incubation, DMSO 
(100 pi) was added into the wells, and absorbance was read at 540 nm. Results are 
expressed in percentage, as mean ± SD of triplicate determinations. For Figure 6.IB; *, 
P<0.05 as eompared to control for erucin, for Figure 6.1C; *, P<0.05 as compared to 
control for phenethyl isothiocyanate and \  P<0.05 as compared to control for R,S- 
sulforaphane.
6.3.2 Validation o f  the Ah receptor procedure
Maximum activation was noted at a concentration of 10'  ^M when the CALUX assay was 
authenticated with TCDD, the highest affinity ligand loiown for the aryl hydrocarbon 
(Ah) receptor (Figure 6.2A) as well as benzo[a]pyrene, with maximum activation 
occurring at a concentration o f 10'  ^M (Figure 6.2B).
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Figure 6.2: Activation of the Ah receptor by TCDD and benzo[a]pyrene. H lL l.lc 2  
cells (7 X  10“^ cells/ml) were incubated with TCDD (lO'^^-lO'^M) (A), benzo[a]pyrene 
(lO'^^-lO’^ M) (B) for 24 h. The aetivation of the reeeptor is expressed as % of that 
achieved by TCDD (10‘^ M). Results are expressed as mean ± SD o f triplicate 
determinations.
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6.3.3 Activation o f  the Ah receptor by glucosinolates and isothiocyanates 
Glucosinolates were poor ligands in comparison with benzo[a]pyrene, but glucoerucin 
was found to be a relatively a better ligand than glucoraphanin, achieving 15% and 5% of 
activation of the receptor, respectively (Chapter 4). In the case of sulforaphane, the 
i?-isomer was found to be comparatively a better ligand than the 5"-isomer, attaining 10% 
and 4% of activation, respectively (Chapter 3).
Phenethyl isothiocyanate was a weak agonist of the Ah receptor, attaining only 8% 
activation compared to benzo[a]pyrene (Figure 6.3). Similarly, both erucin and R,S- 
sulforaphane were poor ligands to the Ah receptor, displaying a <10 % activation of the 
receptor as compared with TCDD, with no concentration-dependent effect being evident; 
in contrast, benzo[a]pyrene was a very good ligand (Figure 6.3).
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Figure 6.3: Isothiocyanates as ligands for the Ah receptor. H lL l.lc2  cells 
(7 X  lO'^  cells/ml) were incubated in culture medium supplemented with benzo[a]pyrene, 
phenethyl isothiocyanate, jR,5'-sulfbraphane or erucin (lO'^^-lO'^M) for 24 h. o 
Benzo[a]pyrene, © Phenethyl isothiocyanate, A Erucin, 4 i?,5'-sulforaphane. The 
activation of the receptor is expressed as % of that achieved by TCDD (10'^ M). Results 
are presented as mean ± SD of triplicate determinations.
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6.3.4 Effect o f  glucosinolates and isothiocyanates on the benzo[a]pyrene-mediated 
activation o f  the Ah receptor
Glucosinolates
Studies were undertaken to evaluate whether the activation of the Ah receptor by 
benzo[a]pyrene was modulated in the presence of the glucosinolates glucoraphanin and 
glucoerucin, the precursors of sulforaphane and erucin respectively, to ascertain whether 
these glucosinolates displayed any antagonistic activity. Glucoraphanin at either 
concentrations of lO’^ M or lO'^M, effectively antagonised the benzo[a]pyrene activation 
to the Ah receptor, with the effect being more marked at the higher concentrations of 
benzo[a]pyrene (lO'^-lO'^M) (Figure 6.4).
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Figure 6.4: Modulation of the benzo[a]pyrene activation of the Ah receptor by 
glucoraphanin. H lL l.lc2  cells (7 x 10  ^ cells/ml) were incubated in culture medium 
supplemented with benzo[a]pyrene (lO'^^-lO'^M) alone or in combination with 
glucoraphanin (lO’^ M or lO'^M) for 24 h. 0  Benzo[a]pyrene alone, o Benzo[a]pyrene 
with glucoraphanin (lO’^ M), ABenzo[a]pyrene with glucoraphanin (lO'^M). The 
activation of the receptor is expressed as % of that achieved by TCDD (10’^  M). Results 
are expressed as mean ± SD of triplicate determinations.
Similarly, Figure 6.5 illustrates that benzo[a]pyrene activation of the Ah receptor 
appeared to be suppressed at the higher concentrations (lO'^-lO'^M) when H lL l.lc 2  cells
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incubated with benzo[a]pyrene (lO'^^-lO'^M) in the presence of glucoerucin (lO’^ M or 10' 
^M) for 24 hours. When comparing the antagonistic effects between glucoraphanin and 
glucoerucin at lO'^M on the activation of the Ah receptor by benzo[a]pyrene, 
glucoraphanin was found comparatively a better antagonist than glucoerucin (Figure 6.6).
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Figure 6.5: Modulation of the benzo[a]pyrene activation of the Ah receptor by 
glucoerucin. H lL l.lc2  cells (7 x 10"^  cells/ml) were incubated in culture medium 
supplemented with benzo[a]pyrene (lO'^^-lO'^M) alone or in combination with 
glucoerucin (lO'^M or lO'^M) for 24 h. m Benzo[a]pyrene alone, o Benzo[a]pyrene with 
glucoerucin (lO'^M), ABenzo[a]pyrene with glucoerucin (lO'^M). The activation of the 
receptor is expressed as % of that achieved by TCDD (lO'^M). Results are expressed as
mean ± SD of triplicate determinations.
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Figure 6.6: M odulation of the benzo[a]pyrene activation of the Ah receptor by 
glucoraphanin and/or glucoerucin. H lL l.lc2  cells (7 x 10"^  cells/ml) were incubated in 
culture medium supplemented with benzo[a]pyrene (lO’^^-lO'^M) alone or in combination 
with either glucoraphanin or glucoerucin (lO'^M) for 24 h. n Benzo[a]pyrene alone, 
© Benzo[a]pyrene with glucoraphanin (lO'^M), ABenzo[a]pyrene with glucoerucin 
(lO'^M). The activation of the receptor is expressed as % of that achieved by TCDD 
(10'^ M). Results are expressed as mean ± SD of triplicate determinations.
Phenethyl isothiocyanate
Benzo[a]pyrene as expected was a very good ligand for the receptor, but in the presence 
of phenethyl isothiocyanate the receptor activation was markedly suppressed, especially 
at the lower concentrations of the hydrocarbon (Figure 6.1 K). When the H lL l.lc2  cells 
were initially incubated with this isothiocyanate, with the unbound fraction being washed 
off subsequently and a further incubation with benzo[a]pyrene carried out, the activation 
of the receptor by benzo[a]pyrene was prevented, but no concentration-dependent effect 
was apparent (Figure 6.7B). If the cells were initially exposed to benzo[a]pyrene with the 
unbound fraction being washed off subsequently and a further incubation conducted for 2 
hours in the presence of phenethyl isothiocyanate carried out, the activation of the 
receptor by benzo[a]pyrene was impaired, especially at the highest concentrations of the 
hydrocarbon, but the effect did not appear to be concentration-dependent (Figure 6.7C).
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Figure 6.7: Modulation of the benzo[a]pyrene activation of the Ah receptor by 
phenethyl isothiocyanate. (A) H lL L lc2  cells (7 x 10"^  cells/ml) were incubated in 
culture medium supplemented with benzo[a]pyrene (lO'^^-lO'^M) and either phenethyl 
isothiocyanate (lO'^M or lO'^M) for 24 h. m Benzo[a]pyrene, 4 Benzo[a]pyrene with 
phenethyl isothiocyanate at lO'^M, A Benzo[a]pyrene with phenethyl isothiocyanate at 
lO'^M; (B) H lL l.lc2  cells (7 x 10"^  cells/ml) were incubated in culture medium 
supplemented with phenethyl isothiocyanate (lO'^M, 10‘^ M, lO'^M) for 24 h, washed with 
PBS to remove the free isothiocyanate followed by incubation with benzo[a]pyrene 
(10‘^ ^-10'^M) for a further 24 h. m Benzo[a]pyrene, A Phenethyl isothiocyanate at lO'^M 
with benzo[a]pyrene, 4 Phenethyl isothiocyanate at lO'^M with benzo[a]pyrene, © 
Phenethyl isothiocyanate at lO'^M with benzo[a]pyrene; (C) H lL l.lc 2  cells 
(7 X  10"^  cells/ml) were incubated in culture medium supplemented with benzo[a]pyrene 
(lO'^^-lO'^M) for 24 h, washed with PBS to remove the free aromatic hydrocarbon 
followed by incubation with phenethyl isothiocyanate (lO'^M, lO’^ M and lO'^M) for a 
further 2 h. ®Benzo[a]pyrene with phenethyl isothiocyanate at lO'^M, A Benzo[a]pyrene 
with phenethyl isothiocyanate at lO'^M, ♦ Benzo[a]pyrene with phenethyl isothiocyanate 
at lO'^M, m Benzo[a]pyrene. In all studies, the activation of the receptor is expressed as 
% of that achieved by TCDD (10'^ M). Results are presented as mean ± SD of triplicate 
determinations.
Erucin and R,S~sulforaphane
Both i?,5'-sulforaphane and erucin when incubated with benzo[a]pyrene impaired the 
latter's activation of the receptor at concentrations of the hydrocarbon >10’^^M, but no 
concentration-dependent effect could be discerned (Figures 6.8A & B).
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Figure 6.8: Modulation of the benzo[a]pyrene activation of the Ah receptor by the 
aliphatic isothiocyanates erucin and i^^iS-sulforaphane. (A) H lL l.lc2  cells 
(7 X 10"^  cells/ml) were incubated in culture medium supplemented with benzo[a]pyrene
(lO'^^-lO’^ M) alone or in combination with i?,5'-sulforaphane (10‘^ M or lO'^M) for 24 h. 
□ Benzo[a]pyrene alone, A Benzo[a]pyrene with i?,5'-sulforaphane (10‘^ M), 
o Benzo[a]pyrene with i?,.S-sulforaphane (lO'^M); (B) H lL l.lc2  cells (7 x 10"^  cells/ml) 
were incubated in culture medium supplemented with benzo[a]pyrene (lO'^^-lO'^M) alone 
or in combination with erucin (10' M or lO'^M) for 24 h. □ Benzo[a]pyrene alone, 
A Benzo[a]pyrene with erucin (lO'^M), © Benzo[a]pyrene with erucin (lO'^M). In all 
studies, the activation of the receptor is expressed as % of that achieved by TCDD (10'^ 
M). Results are presented as mean ± SD of triplicate determinations.
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Of the two sulforaphane isomers, i?-sulforaphane was clearly the more effective 
antagonist, with the activation of the receptor by benzo[a]pyrene being almost completely 
suppressed at the highest concentrations of the hydrocarbon (Figures 6.9A & B).
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Figure 6.9: Modulation of the benzo[a]pyrene activation of the Ah receptor by sulforaphane 
isomers. (A) HlLl.lc2 cells (7 x 10"^  cells/ml) were incubated in culture medium supplemented 
with benzo[a]pyrene (10‘"-10‘^ M) alone or in combination with i?-sulforaphane (lO'^M or lO'^M) 
for 24 h. n Benzo[a]pyrene alone, A Benzo[a]pyrene with i?-sulforaphane (lO'^M), 
o Benzo[a]pyrene with i?-sulforaphane (lO'^M); (B) HlLl.lc2 cells (7 x 10“^ cells/ml) were 
incubated in culture medium supplemented with benzo[a]pyrene (10’"-10'^M) alone or in 
combination with ^sulforaphane (lO'^M or lO'^M) for 24 h. a Benzo[a]pyrene alone, 
ABenzo[a]pyrene with '^-sulforaphane (lO'^M), o Benzo[a]pyrene with ^'-sulforaphane (lO'^M). 
In all studies, the activation of the receptor is expressed as % of that achieved by TCDD (10‘^ M). 
Results are presented as mean ± SD of triplicate determinations.
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In order to further clarify the antagonistic effects of the aliphatic isothiocyanates with the 
Ah receptor, additional studies were conducted using i?,5'-sulforaphane and 
benzo[a]pyrene. When the cells were incubated either in the absence or presence of three 
concentrations of i?,5'-sulforaphane (10'^, 10'^, or 10'^ M) alone for 24 hours, and the &ee 
isothiocyanate was removed, a further 24-hour incubation with benzo[a]pyrene (10'^^-10’^  
M) revealed that the activation of the receptor by the hydrocarbon was markedly 
suppressed in the cells initially exposed to the isothiocyanate; however, the effect was not 
concentration dependent (Figure 6.10A). In order to establish whether i?,5'-sulforaphane 
could displace benzo[a]pyrene from its binding site on the Ah receptor, cells were 
initially incubated with benzo[a]pyrene (lO'^^-lO'^M) for 24 hours, with the free 
hydrocarbon being removed at the end of the incubation; a further 2-hour incubation was 
carried out in the absence and presence of i?,5'-sulforaphane (10'^, 10' ,^ or lO'^M). R,S- 
sulforaphane was effective in displacing benzo[a]pyrene but the effect was, once again, 
not concentration-dependent (Figure 6.1 OB).
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Figure 6.10: M odulation of the benzo[a]pvrene activation of the Ah receptor by R,S- 
sulforaphane. (A) H lL l.lc2  cells (7 x 10 cells/ml) were incubated in culture medium 
supplemented with i?,5'-sulforaphane (10‘^ M, lO'^M and lO'^M) or vehicle for 24 h, 
washed with PBS to remove the free isothiocyanate followed by incubation with
benzo[a]pyrene (10' -10' M) for a further 24 h. ♦ Benzo[a]pyrene with 7?,6'-sulforaphane 
(lO'^M), •  Benzo[a]pyrene with 7?,5'-sulforaphane (lO'^M), A Benzo[a]pyrene with 7?,«5- 
sulforaphane (lO'^M), m Benzo[a]pyrene alone. (B) H lL l.lc2  cells (7 x lO^^cells/ml) were 
incubated in culture medium supplemented with benzo[a]pyrene (lO'^^-lO'^M) or vehicle 
for 24 h, washed with PBS to remove the free aromatic hydrocarbon followed by 
incubation with i?,6'-sulforaphane (lO'^M, lO'^M, lO'^M) for a further 2 h. m 
Benzo[a]pyrene alone, 4 i?,5'-sulforaphane (lO'^M) with benzo[a]pyrene, © R,S- 
sulforaphane (lO'^M) with benzo[a]pyrene, A jR^iS'-sulforaphane (lO'^M) with 
benzo[a]pyrene. In all studies, the activation of the receptor is expressed as % of that 
achieved by TCDD (10'^ M). Results are presented as mean ± SD of triplicate 
determinations.
6.3.5 Ah receptor andA rnt expression in H lL l . l c l  cells exposed to isothiocyanates 
and/or henzo[a]pyrene
i. Phenethyl isothiocyanate
Exposure of the H lL l.lc2  cells to either phenethyl isothiocyanate or benzo[a]pyrene 
elevated the levels of the Ah receptor and Amt levels at the higher concentrations. The 
increase was less pronounced when the cells were incubated in the presence of both 
compounds (Figure 6.11).
210
6 ;  z^'o/AzocyoMore^ wzf/z Z /ze^/z r e c ^ r o r
AhR expression Arnt expression
0.5 -,
d
Benzo[a]pyrene (M)
*Q-Q
<©
1
2.5 I
I
2 j
1.5 
1
0.5 
0
*
X
Benzo[a]pyrene (M)
3 -
2.5 
2
1.5 
1
0.5
0
T 3* Q
T J
a
# <
S
'a
o
3
2.5 
2
1.5
1 '
[
0.5 I
0
T 1 T
m
JL __ L_^  j I— 'L_-J
■X.
d
Phenethyl isothiocyanate (M)
f
Phenethyl isothiocyanate (M)
(continued)
211
Chapter 6: Interactions o f glucosinolates and isothiocyanates with the Ah receptor
AhR expression Arnt expression
a  0.8
K 0.6
Benzo[a]pyrene (M) + Phenethyl 
isothiocyanate (10'® M)
BC
ieu
<
©ts£3
(A
^
Benzo[a]pyrene (M) + Phenethyl 
isothiocyanate (10‘^  M)
Figure 6.11: Expression of Ah receptor (AhR) and aryl hydrocarbon receptor 
nuclear translocator (Arnt) in H lL l.lc 2  cells exposed to benzo[a]pyrene and 
phenethyl isothiocyanate. H lL l.lc2  cells (7 x 10"* cells/ml) were incubated with 
benzo[a]pyrene (IO’'^-10'^M), phenethyl isothiocyanate (lO'^^-lO'^M) or a combination of 
benzo[a]pyrene (lO'^^-lO’^ M) with phenethyl isothiocyanate at lO'^M for 24 h. The cell 
lysates were harvested and the cytosolic fraction isolated. Immunoblot analysis was 
earned out by exposure of the cytosolic proteins to goat polyclonal antibody against AhR 
or Arnt antibodies followed by the appropriate peroxidase-labelled secondary antibody. 
Each lane was loaded with 30 pg of total protein. The blots were stripped and re-probed 
with anti-LDH antibody to normalise for differences in protein loading. Results are 
expressed as mean ± SD of triplicate determinations.*, P<0.05 as compared to control.
a. Erucin and R,S-sulforaphane
Exposure of the cells to either 7?,/S-sulforaphane or erucin resulted in a modest increase in 
Ah receptor and Arnt expression, but only at the highest concentration employed (lO'^M); 
no statistically-significant change was observed when benzo[a]pyrene (10"’'- lO'^M) and 
either isothiocyanate (10'^ M) were incubated together (Figure 6.12).
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6.3.6 Up-regulation o f  CYPlAl mRNA in liver slices incubated with isothiocyanates
Phenethyl isothiocyanate
A concentration-dependent study revealed that following incubation of rat liver slices 
with phenethyl isothiocyanate for 24 hours, a significant increase in CYPlAl mRNA 
levels was achieved only at 1 pM, and a decrease was evident at the highest 
concentrations studied (Figure 6.13).
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Figure 6.13: C Y PlA l mRNA levels in ra t liver slices exposed to phenethyl 
isothiocyanate. CY PlAl mRNA levels were determined in precision-cut rat liver slices 
incubated with phenethyl isothiocyanate (0-25 pM) for 24 h. Total RNA was extracted 
from tissue slices and the mRNA levels were quantified by quantitative RT-PCR 
methodology (Taqman); mRNA levels were normalised with respect to 185" rRNA. 
Values are expressed as mean ± SD of three replicates, each containing 3 slices. *, 
P<0.05; **, P<0.01; ***, P<0.001 as compared to 0 concentration.
Erucin and R,S-sulforaphane
Both erucin and i?,5'-sulforaphane elevated CY PlA l mRNA levels in precision-cut rat 
liver slices following a 24-hour exposure, in concentration-dependent fashion, maximal 
rise being achieved at a concentration of 10 pM with both isothiocyanates (Figure 6.14).
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Figure 6,14: C Y PlA l mRNA levels in ra t liver slices exposed to aliphatic 
isothiocyanates. CY PlAl mRNA levels were determined in precision-cut rat liver slices 
incubated with R,iS-sulforaphane or erucin (0-25 pM) for 24 h. Total RNA was extracted 
from tissue slices and the mRNA levels were quantified by quantitative RT-PCR 
methodology (Taqman); mRNA levels were normalised with respect to 185" rRNA. 
Values are expressed as mean ± SD of three replicates, each containing 3 slices. *, 
P<0.05; **, P<0.01; ***, P<0.001 as compared to 0 concentration.
When phenethyl isothiocyanate (1 pM) was incubated with precision-cut rat liver slices, a 
modest but statistically significant increase in CYPlAl mRNA levels was evident 
following incubation for 8 hours or longer (Figure 6.15). Incubation of slices with both 
erucin and 7?,5'-sulforaphane (10 pM) for various time periods elevated CYPlAl mRNA 
levels; in both cases a significant increase was achieved at incubations longer than 6 
hours (Figure 6.16).
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Figure 6.15: C Y PlA l mRNA levels in ra t liver slices exposed to phenethyl 
isothiocyanate for various periods of time. CYPlAl mRNA levels were deteiinined in 
precision-cut rat liver slices incubated in culture medium containing phenethyl 
isothiocyanate (1 pM) for various time periods (0-24 h). Total RNA was extracted from 
tissue slices and the mRNA levels were quantified by quantitative RT-PCR methodology 
(Taqman); mRNA levels were normalised with respect to 186" rRNA. Values are 
expressed as mean ± SD of three replicates, each containing 3 slices. *, P<0.05; 
P<0.01; ***, P<0.001 as compared to 0 time.
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Figure 6.16: C Y PlA l mRNA levels in ra t liver slices exposed to aliphatic 
isothiocyanates for various periods of time. CYPlAl mRNA levels were detennined in 
precision-cut rat liver slices incubated in culture medium containing R,Nsulforaphane or 
erucin (10 pM) for various time periods (0-24 h). Total RNA was extracted from tissue 
slices and the mRNA levels were quantified by quantitative RT-PCR methodology 
(Taqman); mRNA levels were normalised with respect to 185' rRNA. Values are 
expressed as mean ± SD of three replicates, each containing 3 slices. *, P<0.05; **, 
P<0.01; ***, P<0.001 as compared to 0 time.
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6.3.7 Vp-regulation o f  CYPlAl mRNA in liver slices incubated with benzo[a]pyrene 
In order to identify the optimum concentration and incubation time for CYPlAl mRNA 
induction by benzo[a]pyrene, rat liver slices were incubated with various concentrations 
of benzo[a]pyrene (0-10 pM) at two incubation periods namely 4 and 8 hours. Figures 
6.17A and 6.17B show that CYPlAl mRNA levels were increased in a concentration 
dependent manner at both time periods, the effect being clearly more pronounced after 
the 4-hour incubation.
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Figure 6.17: CYPlAl mRNA levels in rat liver slices exposed to benzo[a]pyrene. CYPlAl 
mRNA levels were determined in precision-cut rat liver slices incubated in culture medium 
containing benzo[a]pyrene (0-10 pM) for 4 h (A) or 8 h (B). Total RNA was extracted from 
tissue slices and the mRNA levels were quantified by quantitative RT-PCR methodology 
(Taqman); mRNA levels were normalised with respect to 185 rRNA. Values are expressed as 
mean ± SD of three replicates, each containing 3 slices. *, P<0.05; **, P<0.01; ***, P<0.001 as 
compared to 0 concentration.
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6.3.8 Antagonism by isothiocyanates o f  the benzo[a]pyrene-mediated rise in CYPlAl 
mRNA levels
i. Phenethyl isothiocyanate
Incubation of precision-cut rat liver slices with benzo[a]pyrene (2 pM) alone for 4 hours 
caused a huge rise in CYPlAl mRNA levels; this effect was antagonised by phenethyl 
isothiocyanate in a concentration-dependent manner (Figure 6.18).
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Figure 6.18: CYPlAl mRNA levels in rat liver slices exposed to phenethyl 
isothiocyanate in combination with benzo[a]pyrene. Precision-cut rat liver slices were 
incubated with benzo[a]pyrene (2 pM) in the presence of phenethyl isothiocyanate 
(0-25 pM) for 4 h. Total RNA was extracted from tissue slices and the mRNA levels of 
CYPlAl were quantified by quantitative RT-PCR methodology (Taqman); mRNA levels 
were normalised with respect to 185 rRNA. Values are expressed as mean ± SD of three 
replicates, each containing 3 slices, f , P<0.05; t f ,  P<0.01; t t t ,  P<0.001 as compared to 
control; *, P<0.05; **, P<0.01; ***, P<0.001 as compared to 0 pM phenethyl 
isothiocyanate.
ii. Erucin and R,S-sulforaphane
Similarly, benzo[ajpyrene-mediated rise in CY PlAl mRNA levels was antagonised by 
R,5-sulforaphane and erucin, the former being more effective (Figure 6.19).
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Figure 6.19: C Y PlA l mRNA levels in ra t liver slices exposed to aliphatic 
isothiocyanates in combination with benzo[a]pyrene. Precision-cut rat liver slices were 
incubated with benzo[ajpyrene (2 pM) in the presence of either i?,5-sulforaphane or 
erucin (0-25 pM) for 4 h. Total RNA was extracted from tissue slices and the mRNA 
levels of CYPlAl were quantified by quantitative RT-PCR methodology (Taqman); 
mRNA levels were normalised with respect to 185 rRNA. Values are expressed as mean 
± SD of three replicates, each containing 3 slices. P<0.05; t t ,  P<0.01; P<0.001 as
compared to control; *, P<0.05; **, P<0.01; ***, P<0.001 as compared to 0 pM 
isothiocyanate.
6.3.9 Effect o f  isothiocyanates on the benzo [ajpyrene-mediated up-regulation ofERO D  
activity
Phenethyl isothiocyanate
This work was conducted by Dr N. Konsue at the University of Surrey (Konsue, 2010). 
Exposure of rat liver slices to benzo[ajpyi'ene resulted in a marked increase in the O- 
deethylation of ethoxyresomfm; this rise in activity was antagonised by phenethyl 
isothiocyanate (Figure 6.20). When precision-cut liver slices from 2 donors (Donor A: 
Female, 67 years; Donor B: Male, 64 years) were incubated with benzo[a]pyrene alone, 
ethoxyi'esorafm 0-deethylase activity rose, but the effect was markedly more pronounced
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in Donor A; in both cases, however, the rise in activity was antagonised by phenethyl 
isothiocyanate (Figure 6.20).
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Figure 6.20; Effect of phenethyl isothiocyanate on the benzo [ajpyrene-mediated up- 
regulation of ethoxyresorufin 0-deethylase (EROD) activity in rat and human precision-cut 
liver slices. Liver slices were incubated in culture medium containing benzo[ajpyrene (0.1 pM) 
alone or in combination with phenethyl isothiocyanate (1-50 pM) for 24 h. At the end of the 
incubation, microsomes were isolated and EROD activity determined. Values are presented as 
mean ± SD of three replicates, each containing 10 slices/ml. f, P<0.05; ft? P<0.01; t t t?  P<0.001 
as compared to control; *, P<0.05; **, P<0.01; ***, P<0.001 as compared to 0 pM phenethyl 
isothiocyanate.
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Erucin and R,S-sulforaphane
This study was performed by Dr N. Hanlon at the University of Surrey (Hanlon, 2009).
A marked increase in the (9-deethylation of ethoxyresorufin was observed following 
exposure of the slices to two concentrations of benzo[a]pyrene, namely 1 and 5 pM; this 
increase in activity stimulated by benzo [ajpyrene was antagonised by both 
isothiocyanates, but no dose-dependency was apparent (Figure 6.21). Erucin and R,S- 
sulforaphane failed to elevate this enzyme activity when incubated alone with the slices, 
under the same conditions.
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Figure 6.21: Effect of aliphatic isothiocyanates on the benzo [a] pyrene-mediated up- 
regulation of ethoxyresorufin O-deethylase (EROD) activity in ra t liver precision- 
cut slices. Rat liver slices were incubated in culture medium containing benzo [ajpyrene 
(1 or 5 pM) alone or in combination with (A) erucin or (B) R,5-sulforaphane (1-50 pM) 
for 24 h. At the end of the incubation, microsomes were isolated and EROD activity 
detennined. Control EROD activity was 1 pmol/min/mg protein. Values are presented as 
mean ± SD of three replicates, each containing 6-10 slices/ml. *, P<0.05; **, P<0.01; 
***,P<0.001.
6.4 Discussion
Many studies, utilising TCDD, have ascertained that ligand binding to the Ah receptor 
unleashes a plethora incidents that are harmful to the cell and organism (Beischlag et al., 
2008; Barouki et al., 2007). This receptor has been linked to different types of toxicity 
including developmental toxicity, inflammation, immunotoxicity and tumourigenesis. It 
is also clear that the Ah receptor plays an important role in human cancer through 
interaction with signalling pathways in a cell-specific manner, suggesting that this 
receptor may be a helpful device in the early detection and healing of cancer (Barouki et 
a l, 2007). As a result, the role of antagonists to block ligand-mediated activation of the 
Ah receptor may be beneficial, particularly if these are widely-consumed phytochemicals 
with proven safety. The breakdown product of glucosinolates, isothiocyanates have been 
shown in epidemiology studies to lower cancer incidence, and their anti-carcinogenic
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properties have been confirmed in laboratory studies (Hecht, 2000). As electrophiles, 
they are likely to manipulate cellular processes through binding covalently to nucleic 
acids, proteins, or small molecules and may be indirectly reducing pools of cellular 
reductants (Nakamura and Miyoshi, 2010). A mechanistic study to determine the effect o f 
isothiocyanates on CY PlA l and CYP1A2 activity and expression, and Ah receptor 
translocation in Mcf7 cells demonstrated that both enzymes were significantly stimulated 
by benzo [ajpyrene, and isothiocyanates were able to inhibit the rise in activity 
(Skupinska et ah, 2009). A view has been expressed that the inhibition of CYPlAl and 
CYP1A2 enzymes may serve as a useful strategy for cancer chemoprevention (Kleiner et 
al., 2003). A likely causative mechanism of action of chemopreventive phytochemicals 
may be to avert the activation of Ah receptor by carcinogenic ligands such as 
benzo [ajpyrene.
Neither benzo [ajpyrene nor isothiocyanates caused any toxicity in the H lL l.lc 2  cells, 
comparable with the studies where benzo [ajpyrene and sulforaphane isomers were 
exposed to HepG2 and FAO cells, respectively (Kassie et al., 2003; Chapter 3). Similarly, 
recent studies employing the MTT assay revealed that sulforaphane (1-10 pM) does not 
influence cell viability of murine hepatoma Hepa lc lc7  cells (Anwar-Mohamed and El- 
Kadi, 2009). The CALUX assay was validated utilising the well-known Ah receptor 
ligands TCDD and benzo [ajpyrene. The activation characteristics were similar to what 
was previously demonstrated by other workers, employing the same method (Machala et 
al., 2001; Pushparajah et al., 2007; Pushparajah et al., 2008).
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6.4.1 Activation o f the Ah receptor by benzo [ajpyrene and its modulation by 
isothiocyanates and glucosinolates
i. Aromatic isothiocyanate
Phenethyl isothiocyanate, the most comprehensively studied aromatic isothiocyanate, was 
a poor ligand of the Ah receptor, in agreement with the studies in rat hepatoma cell line 
H4IIE where it was found that this isothiocyanate had no agonist activity (Miao et ah, 
2004). Similarly, in the current studies, exposure of rat liver slices to phenethyl 
isothiocyanate led to a very modest rise in CY PlAl mRNA levels in contrast to the avid 
ligand benzo[a]pyrene. Similarly in primary human hepatocytes both sulforaphane and 
phenethyl isothiocyanate raised CYPlAl mRNA levels (Gross-Steinmeyer, 2004). When 
rats were administered diets containing phenethyl isothiocyanate, up-regulation in hepatic 
CYPlAl apoprotein levels was noted at high doses but with no concomitant increase in 
CYPlAl activity, most probably due to the fact that phenethyl isothiocyanate is a 
mechanism-based inhibitor (Konsue and loannides, 2008; 2010).
In contrast to phenethyl isothiocyanate and comparables with other studies (Pushparajah 
et al., 2008), benzo [ajpyrene was a very good ligand for the Ah receptor. It was reported 
that among six PAHs, benzo [ajpyrene was one of the best ligands to the receptor with a 
binding affinity (EC50) value of 5 x 10'^ M (Pushparajah et al., 2008). In this study, 
however, the activation of the receptor by benzo [ajpyrene was clearly diminished in the 
presence of phenethyl isothiocyanate, but no concentration-dependent outcome was 
evident. Since phenethyl isothiocyanate is such a weak ligand, its effect on the binding of 
benzo [ajpyrene is not likely to involve competitive mechanisms. So as to assess this 
further, the H lL l.lc2  cells were initially incubated with the isothiocyanate which was 
washed off prior to exposure to benzo [ajpyrene. Again the activation of the hydrocarbon 
was efficiently prevented; however as in the earlier study no concentration-dependent
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effect was evident. Ultimately, in order to assess whether phenethyl isothiocyanate could 
possibly displace benzo [ajpyrene from the receptor, the cells were initially incubated 
with the hydrocarbon which was subsequently washed off, before the cells were 
incubated with the isothiocyanate; the benzo [ajpyrene-mediated activation of the receptor 
was attenuated by the isothiocyanate. Prolonging the second incubation from 2 hours to 
24 hours did not bring about a more prominent effect. Clearly, phenethyl isothiocyanate 
can prevent the activation of the Ah receptor by benzo [ajpyrene, even when the two 
compounds were not present together in the incubation system, arguing against a 
competitive mechanism. It is relevant to point out that phenethyl isothiocyanate 
significantly inhibited forestomach tumourigenesis induced by benzo [ajpyrene in mice 
(Lin et al., 1993).
ii. Aliphatic isothiocyanates
The naturally-occurring aliphatic isothiocyanates, erucin and i<!,»S'-sulforaphane were also 
found to be weak agonists but strong antagonists of the Ah receptor similar to phenethyl 
isothiocyanate. In rat liver slices they enhanced moderately CYPlAl mRNA levels, in 
agreement with observations made in murine hepatoma H epalclc? and human HepG2 
cells exposed to sulforaphane, where this isothiocyanate elevated CY PlA l mRNA levels 
in a concentration- and time-dependent manner, and activated transformation of Ah 
receptor and its binding to the xenobiotic responsive element (XRE) (Anwar-Mohamed 
and El-Kadi, 2009). This is in accordance with studies where these isothiocyanates, both 
in vitro and in vivo, up-regulated the expression of CYP1A2 and CYPIBI in rat liver, as 
well as CYPlAl and CYPIBI in rat lung (Yoxall et al., 2005; Hanlon et al., 2008a; 
2008b, Hanlon et al., 2009). Evidently, the rise in the expression of these enzymes 
involves, at least partly, increased transcription. Nevertheless, there was no parallel rise
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in CYPl activity in rats exposed to these isothiocyanates since these compounds are 
efficient mechanism-based inhibitors (Yoxall et ah, 2005; Hanlon et ah, 2008a).
The activation of the Ah receptor by the potent agonist benzo [ajpyrene was attenuated in 
the presence of either of the two isothiocyanates in the incubation system. Furthermore, 
initial exposure of the cells to i?,5'-sulforaphane followed by removal of the un-reacted 
isothiocyanate prevented the activation of the receptor by benzo [ajpyrene. Finally, R,S- 
sulforaphane could displace bound benzo [ajpyrene from the receptor, as initial exposure 
of the cells to the hydrocarbon with subsequent removal of the un-reacted fraction, 
followed by exposure to i?,5'-sulforaphane led to a clearly suppressed activation of the 
receptor. It is pertinent to highlight that the antagonistic action of the isothiocyanates 
against the agonist benzo [ajpyrene did not exhibit dose-dependency with respect to the 
isothiocyanate concentration alluding to a non-competitive mechanism that may be due to 
conformational alteration in a functionally important site(s) of the Ah receptor.
Hi. Comparison o f  the antagonistic potential o f  the sulforaphane isomers
It was demonstrated that in both precision-cut rat liver slices and rat hepatoma FAO cells, 
R-sulfbraphane was more efficient than the 5-isomer in modulating Phase II 
detoxification enzymes (Chapter 3). These findings prompted a study to investigate 
whether isomer-dependent differences in the interactions of the isomer with the Ah 
receptor could exist. Indeed, R-sulforaphane was a relatively superior agonist and a far 
better antagonist of the Ah receptor, indicating once again the better biological activity of 
the i?-isomer. In a study that involved the naturally occurring i?-sulforaphane, and its two 
synthetic analogues namely isothiocyanate-2-oxohexyl and alyssin, it was demonstrated 
that all three isothiocyanates inhibited the B[ajP-induced CYPlAl and CYP1A2 enzyme 
activity, protein expression, as well as Ah receptor translocation in Mcf7 cells, with
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sulforaphane displaying feeble inhibitory characteristics compared to the analogues 
(Skupinska et ah, 2009).
iv. Glucosinolates
In studies to assess whether the glucosinolate precursors of sulforaphane and erucin 
displayed any antagonistic effect on the activation of the Ah receptor by benzo [ajpyrene, 
both glucosinolates revealed a clear antagonistic effect, with glucoraphanin being 
relatively a better antagonist than glucoerucin. It has already been demonstrated that both 
glucosinolates induced the (9-deethylation of ethoxyresorufin (Chapter 3), a biomarker of 
CYPl activity that is regulated by the Ah receptor through transcriptional activation 
(Whitlock, 1999). In other studies, glucosinolates such as sinigrin, glucoiberin, progoitrin 
and glucosinalbin were capable of inhibiting the level of yff-naphthoflavone-induced 
CYPlAl expression in Ah receptor-replete cells, and the inhibition effect was found to 
be dependent on the side chain of the glucosinolate (Wang et al., 1997). Meanwhile, a 
pronounced induction in CYPlAl mRNA expression has been reported following 
exposure of HepG2 cells to another glucosinolate, glucoraphasatin (Scholl et al., 2011), 
that could reflect activation of the Ah receptor by glucoraphasatin.
6.4.2 Putative mechanisms for the AhR antagonistic action o f  isothiocyanates 
In line with the ligand-binding studies, a benzo[a]pyrene-mediated rise in hepatic 
CYPlAl mRNA levels was antagonised by phenethyl isothiocyanate, erucin and R,S- 
sulforaphane. Besides, a comparable antagonism was seen at the activity level, when the 
(9-deethylation of ethoxyresorufin was employed as biomarker for CYPl activity. 
Phenethyl isothiocyanate prevented the benzo [ajpyrene-mediated rise in activity at a 
concentration as low as 1 pM, the lowest concentration used in these studies, and a 
concentration attainable after exposure to dietary levels of the isothiocyanate. It has been
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reported that hydrolysis products of glucosinolates, such as prop-2-enyl, 3- 
methylsulphinylpropyl and 2-hydroxybut-3-enyl isothiocyanates, even at low 
concentrations such as 1 pM markedly decreased ^-naphthoflavone-induced CYPlAl 
transcription in HepG2 cells (Wang et ak, 1997). Similarly, both erucin and R,S- 
sulforaphane antagonised the benzo[a]pyrene-mediated increase in this activity, but no 
dose-dependency could be discerned in the concentration range studied. In agreement, it 
has been demonstrated that oral administration of sulforaphane to mice resulted in the 
inhibition of benzo[ajpyrene-induced aryl hydrocarbon receptor activation that 
consequently decreased cytochrome P450 enzyme activities (Priya and Sakthisekaran, 
2011). Studies conducted in Mcf7 mammary tumour cells indicated that sulforaphane 
prevented the induction of ethoxyresorufin and methoxyresorufin (9-dealkylase activities 
by benzo[a]pyrene, although without concentration-dependency being evident (Skupinska 
et al., 2009). It is possible that this inhibiting effect of the isothiocyanates on the O- 
deethylation of ethoxyresorufin, to some point represents mechanism-based inhibition 
associated with these compounds (Yoxall et ah, 2005; Hanlon et al., 2008a). 
Nevertheless, it is considered that this is not likely to be a major mechanism as in studies 
utilising isolated rat liver microsomes from animals exposed to y^-naphthoflavone, a 
selective CYPl inducer, mechanism-based inhibition by sulforaphane was detected only 
at concentrations of at least 50 pM (Yoxall et al., 2005), where in the present studies 
CYPl activity induced by benzo [ajpyrene was clearly repressed at a concentration of 
only 10 pM. In studies performed in Mcf7 cells, the activity of CYPl A after induction by 
benzo [ajpyrene, was inhibited by sulforaphane at concentrations as low as 0.5 pM, but 
exposure to higher concentrations of this isothiocyanate caused a further reduction in 
CYPl A activity (Skupinska et al., 2009).
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In order to assess that the observations of phenethyl isothiocyanate inhibiting the 
benzo [ajpyrene-mediated rise in CYPlAl activity made in rat are also maintained in 
humans, precision-cut liver slices from two donors were exposed to benzo [ajpyrene alone 
or in the presence of phenethyl isothiocyanate. As in rat, the increase in the O- 
deethylation of ethoxyresorufin brought about by benzo [ajpyrene was antagonised by the 
isothiocyanate. Once again the fall in activity may represent, at least partly, the potential 
of this isothiocyanate to cause mechanism-based inhibition (Konsue and loannides, 
2010). Nevertheless, it is important to point out that it is the phenobarbital-inducible 
CYP2B enzymes that catalyse the metabolism of phenethyl isothiocyanate to the 
metabolite(s) liable for mechanism-based inhibition, rather than the benzo [ajpyrene 
inducible CYPl enzymes, suggesting that mechanism-based inhibition is unlikely to be 
the dominant mechanism (Konsue and loannides, 2010; Goosen et al., 2000; Nakajima et 
al., 2001; Lee, 1996).
The existing experimental findings does not allow for the mechanisms through which 
phenethyl isothiocyanate, emcin and i?,5-sulforaphane act as Ah receptor antagonists to 
be defined, whether they prevent the binding of the ligand or manipulate subsequent 
transcriptional and/or post-transcriptional occurrences. However, it cannot be attributed 
to lower Ah receptor and Arnt levels, since these isothiocyanates did not diminish their 
concentration in the H ILLlc2 cells, and indeed even enhanced the levels at the higher 
concentrations. Isothiocyanates are electrophiles so they readily interact with sulfhydryl 
groups (Nakamura and Miyoshi, 2010) and can therefore interact with intracellular 
proteins, such as the Ah receptor, in a non-competitive manner. In comparison to the 
isothiocyanates, the flavones that are antagonists of the Ah receptor seem to act 
competitively as they compete with TCDD, an avid ligand for the receptor, and appear 
not to cause a conformational alteration that would prevent translocation of the receptor
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into the nucleus or subsequent interaction with Arnt (Gasiewicz et al., 1996; Murray et 
al., 2010).
It is rational to implicate the isothiocyanate group as the critical structural moiety 
responsible for the Ah receptor antagonism. In fact, isothiocyanates act non-specifically 
with thiol groups of proteins (Thomalley, 2003) and interact with cysteine residues of 
Keapl, which lead to activation of the transcription factor NrG followed by an induction 
of the antioxidant response element, this being an essential protective mechanism in 
response to reactive oxygen species (Hu et al., 2011). In addition, the main metabolic 
pathway of isothiocyanates is conjugation with glutathione, the conjugate being further 
processed and secreted as a mercapturic acid. This simplistic interaction with -SH  groups 
is considered to be also liable for the extensive plasma protein binding of isothiocyanates 
(Ji et al., 2005). Because of the Ah receptor has 18 cysteine residues, it is possible that 
isothiocyanates interact with one or more of these residues, leading to conformational 
alterations that either diminish the binding of agonists such as benzo [ajpyrene to the Ah 
receptor and/or its translocation into the nucleus, heterodimerisation with Arnt or 
interaction of the heterodimer with DNA-responsive elements; the available data do not 
permit for the specific mechanism(s) to be determined. The importance of lysine and 
cysteine residues has been emphasised in site-directed mutagenesis studies which 
specified that lysine (Lys350) does not influence Ah receptor-TCDD binding and Ah 
receptor transformation, while cysteine (Cys327) plays a significant role in ligand- 
binding to the Ah receptor (Pandini et al., 2007). Nevertheless, isothiocyanates may also 
interact with amino groups such as lysine to form stable conjugates at physiological 
conditions when allyl isothiocyanate (AITC) was incubated with bovine serum albumin 
in a phosphate buffer (pH 7.4), a stable allyl isothiocyanate-lysine conjugate was 
produced as detected using high performance liquid chromatography (HPLC) (Nakamura
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et al., 2009). Even though AITC readily interacts with thiol instead of with Lys, this 
isothiocyanate can be released from thiols and then may interact with amino groups 
(Nakamura et al., 2009), which consequently provide a suitable marker for isothiocyanate 
target molecules.
6.5 Conclusions
In summary, the present studies demonstrate for the first time that phenethyl 
isothiocyanate and the aliphatic isothiocyanates, erucin and sulforaphane are poor 
agonists but potent non-competitive antagonists of the Ah receptor, properties that may 
contribute significantly to their established chemopreventive potency. As isothiocyanates 
are extensively consumed from cruciferous vegetables, are quickly absorbed following 
oral intake attaining good bioavailability, they are among the most potent dietary 
chemopreventive phytochemicals, and their function as antagonists of the Ah receptor 
may contribute to their anti-carcinogenic activity.
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Prevention and/or protection against chemical carcinogens by phytochemicals present in 
extensively consumed glucosinolate-containing cruciferous vegetables is of great of interest, 
as they provide a safe and cost effective means of combating cancer. Extensive 
epidemiological studies revealed repeatedly an inverse relationship between cruciferous 
vegetable consumption and the incidence of cancer at a number of sites (Ambrosone et al., 
2004; Joseph et al., 2004; Zhao et al., 2007; Lam et al., 2009; Bhattacharya et al., 2010). 
Isothiocyanates, derived from the hydrolysis of glucosinolates, are believed to mediate the 
chemopreventive effect of these vegetables.
Chemopreventive mechanisms of isothiocyanates influence all stages of carcinogenesis; 
nevertheless, impairment of the formation of DNA adducts with chemical carcinogens by 
limiting the generation of their reactive intermediates via modulation of carcinogen- 
metabolising enzyme systems is considered to be one of the most important; decreased 
bioavailability of genotoxic intermediates can be achieved by inhibition of cytochrome P450 
bioactivation and/or induction of phase II detoxification enzymes (Robbins et al., 2005; 
loannides et al., 2010).
7.1 Possible role of intact glucosinolates in the chemopreventive effect of cruciferous 
vegetables
It is generally believed that the chemopreventive activity of cruciferous vegetables is 
exclusively the result of exposure to degradation products of glucosinolates, such as the 
aforementioned isothiocyanates, and that the parent glucosinolates make no contribution. It 
has also been assumed that intact glucosinolates would be unable to reach the blood
234
Chapter 7; General Discussion
circulation following oral intake. However, at least in rats and dogs, glucosinolates such as 
glucoraphanin, could be absorbed intact following oral intake (Bheemreddy and Jeffery, 
2007; Cwik et al., 2010). Administration of purified glucoraphanin to male F344 rats at 150 
pmol/kg led to 5% of the oral dose being found intact in urine but not in the faeces 
(Bheemreddy and Jeffery, 2007). In addition, glucoraphanin in plasma was detectable in dog 
and rat treated with glucoraphanin as compared to controls; in dog, plasma levels were in the 
range of 7.0-34.0 pM after receiving a single oral dose of 500 pmol/kg/day for 3 days, while 
in rats the mean concentrations determined after 13 days dosing at 30, 115, 230, and 1150 
pmol/kg/day were 0.1, 0.5, 1.0 and 4.0 pM, respectively (Cwik et al., 2010); however, these 
studies employed high doses of glucosinolates in comparison with the average human intake 
(0.5 pmol/kg/day). Nowadays humans are exposed, however, to higher level of 
glucosinolates since there are available as supplement pills that are believed to provide a 
health benefit. In this situation, the glucosinolates are taken in the absence of myrosinase, 
and only microbial myrosinase in the intestine may catalyse the formation of the 
isothiocyanate, so that high levels of glucosinolates may be attained sufficient to modulate 
carcinogen-metabolising enzyme systems. Therefore, the present study was performed to 
assess whether intact glucosinolates have potential chemopreventive activity. Studies were 
undertaken in vitro, employing precision-cut tissue slices of rat liver and lung.
Table 7.1 summarises the effects of three glucosinolates, glucoraphanin, glucoerucin and 
glucoraphasatin on carcinogen-metabolising enzyme systems in precision-cut rat liver and 
lung slices. These studies clearly show, for the first time, that in the both tissues, glucoerucin 
and glucoraphanin increased CYPl activity as exemplified by the (9-dealkylations of
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methoxy- and ethoxyresorufin (Namkung et ak, 1988). However, although this may be 
considered detrimental in carcinogen bioactivation, the effect is very modest compared with 
environmental contaminants such as benzo [ajpyrene, a strong inducer of CYPl enzymes. 
Similar effects were observed in lung slices incubated with the same glucosinolates. In 
contrast, glucoraphasatin failed to show an effect, suggesting that the response may be 
dependent on the side-chain substituent of the glucosinolate (Zhu and Loft, 2003).
Table 7.1: Modulation of carcinogen-metabolising enzyme by intact glucosinolates in
precision-cut rat tissue slices
System Glucosinolate Tissue Enzyme activity^’*
CYP
enzymes Glucoraphanin Liver EROD ÎÎ, MROD #T
Lung EROD ÎÎÎ
Glucoerucin Liver EROD î î t ,  MROD f t
Lung EROD t t t
Glucoraphasatin Liver EROD MROD ->
Phase II Glucoraphanin Liver Q Rt, GST t, EH t, UDP-GT
enzymes
Lung QR->, GSTt
Glucoemcin Liver QR t, GST t, EH t, UDP-GT
Lung Q R ^ , GST->
Glucoraphasatin Liver QR GST EH t, UDP-GT t
small increase; ff, modest increase; fff, marked increase; f, small decrease; f | ,  modest 
decrease; f j j ,  marked decrease; no effect.
'^EROD, Ethoxyresomfin (9-deethylase; MROD, methoxyresorufin 0-dealkylase; QR, quinone 
reductase; GST, glutathione 5-transferase; EH, epoxide hydrolase; UDP-GT, glucuronyltransferase.
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Intact glucosinolates could also stimulate phase II detoxification enzymes. These studies 
provide strong evidence that glucosinolates have the potential to modulate enzyme systems 
involved both in the bioactivation and detoxification of chemical carcinogens, and may play 
a role in the chemopreventive activity of glucosinolates. However, before such conclusions 
are reached, it is imperative that the pharmacokinetic behaviour of glucosinolates in humans 
is investigated so that the in vitro data may be extrapolated to the in vivo situation.
Most studies carried out on the chemopreventive mechanism of glucosinolates and 
isothiocyanates were conducted mostly in vitro, and the significance of such studies can 
only be assessed in relationship with attainable plasma/tissue levels. It is customary that the 
in vitro effects are related to the Cmax, the highest plasma concentration achieved after 
dietary intake. Inherent to such an approach is the hypothesis that even transient tissue 
exposure to the biologically-active concentrations is adequate for a complete response in the 
up-regulation of enzyme systems to be manifested. In precision-cut rat liver slices exposed 
to glucoraphanin and glucoemcin, for various periods of time up to 24 hours, increase in the 
0-dealkylation of methoxy- and ethoxyresorufin emerged only at incubation periods longer 
than 6 hours, indicating that for an effective rise in activity of these enzymes, as a result of 
exposure to glucosinolates, to be manifested, tissue exposure of at least 6 hours to the 
appropriate concentrations is required.
7.2 Modulation of carcinogen-metabolising enzyme systems by isothiocyanates
The ability of isothiocyanates to modulate cytochrome P450 enzymes and phase II enzymes 
such as quinone reductase and glutathione 5-transferase has been widely established (Yoxall
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et al., 2005; Hanlon et al., 2008a; Hanlon et al., 2008b; Konsue and loannides, 2010); 
however, their effects on other enzyme systems, such as glucuronosyltransferase and 
epoxide hydrolase, which are also important in carcinogen metabolism, have not attracted 
much interest, and therefore were addressed in this study. As illustrated in table 7.2, 
exposure of rat liver slices to the isothiocyanates, erucin and phenethyl isothiocyanate, 
elevated glucuronosyltransferase and epoxide hydrolase activities, but not in the case of i?,5- 
sulforaphane, commensurate with in vivo studies where exposure of rats to sulforaphane 
failed to increase the activity of this enzyme in the liver (Yoxall et al., 2005). At the mRNA 
level, however, sulforaphane increased UGTlAl expression in HepG2 cells (Bacon et al., 
2003). On the other hand, consumption of watercress, a major source of phenethyl 
isothiocyanate, increased the metabolism of nicotine in smokers as a result of increased 
glucuronidation (Hecht et al., 1999), in concordance with the present studies where exposure 
of rat liver slices to phenethyl isothiocyanate led to an increase in the glucuronidation of 1- 
naphthol.
Previous in vitro studies demonstrated significant differences in the induction potential of 
phase II enzymes among individual isothiocyanates that was believed to be associated 
strongly with the intracellular accumulation of the isothiocyanate, which is influenced by the 
isothiocyanate structure. The oxidation state of the sulphur has a marked effect on the 
induction potential (Zhang and Talalay, 1998). In the present studies, sulforaphane had no 
effect whereas erucin elevated epoxide hydrolase and glucuronosyltransferase activities. It is 
relevant to point out that emcin is extensively metabolised to form sulforaphane as a result 
of the oxidation of its sulphide group and, furthermore, sulforaphane is reduced to form
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erucin in vivo. Such an inter-conversion of sulforaphane and erucin may occur in vitro 
during tissue incubation, and in humans consuming broccoli sprouts or broccoli supplements 
(Kassahun et ah, 1997; Clarke et ah, 2011).
Table 7.2; Modulation of Phase II detoxification enzymes by isothiocyanates in
precision-cut rat tissue slices
Isothiocyanate Tissue Enzyme activity^’*’
Erucin Liver QR HT, GST ÎÎ, EH T, UDP-GT HÎ
Lung Q R ÎÎÎ, GST TH
Sulforaphane Liver Q R ÎÎÎ, GST H, E H ^ , UDP-GT
Lung QR TH, GST TT
Phenethyl isothiocyanate Liver EH TTT, UDP-GT T
small increase; # ,  modest increase; H t, marked increase; t, small decrease; modest 
decrease; # 1 , marked decrease; no effect.
’’QR, quinone reductase; GST, glutathione 5-transferase; EH, epoxide hydrolase; UDP-GT, 
glucuronyltransferase.
There have been a few studies concerned with the concentrations of isothiocyanates in 
plasma and/or their pharmacokinetic behaviour so as to allow the in vitro effects of these 
compounds to be extrapolated in in vivo situation. In a human study (Cramer et ah, 2011), 
participants consumed meals supplemented with broccoli sprouts equivalent to 70 pmol 
sulforaphane or glucoraphanin powder equivalent to 120 pmol sulforaphane, achieved 
plasma levels of about 0.22 pM and 0.25 pM, respectively 3 hours after consumption. In 
another study, subjects consumed 40 g of broccoli sprouts (150 and 71 pmol glucoraphanin 
and glucoemcin, respectively) or 6 supplement pills (121 and 40 pmol glucoraphanin and
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glucoemcin, respectively) achieved maximum plasma concentrations of sulforaphane and 
emcin metabolites at 3 h post consumption (Clarke et ah, 2011). Nevertheless, intracellular 
concentrations of isothiocyanates may be higher than those in the plasma; it has already 
been demonstrated that intracellular concentration may reach 200-fold higher than 
extracellular concentration within a 3 h of exposure (Ye and Zhang, 2001; Zhang and 
Callaway, 2002). Exposure of mouse skin papilloma cells to allyl-, benzyl- and phenethyl 
isothiocyanates and sulforaphane showed that elevation in glutathione levels and, 
glutathione 5-transferase and quinone reductase activities was closely dependent on their 
intracellular accumulation levels, with sulforaphane being the superior inducer (Ye and 
Zhang, 2001), similar data were presented in the present study. It should be emphasised that 
marked differences have been reported in modulation of carcinogen-metabolising enzymes 
by isothiocyanates when human liver slices from various donors were employed, 
demonstrating that inter-individual variation may be a factor influencing the 
chemopreventive potency of isothiocyanates (Moore et al., 2007; Hanlon; 2009; Konsue, 
2010).
Studies on the temporal induction of carcinogen-metabolising enzyme systems by 
isothiocyanates in precision-cut rat liver slices established that the time of incubation 
necessitated for the increase in activity to be apparent differs among isothiocyanates, 
ranging from 2 hours in the case of sulforaphane to 6 hours in the case of phenethyl 
isothiocyanate, clearly indicating that the nature of the side chain is essential in the up- 
regulation of this enzyme by isothiocyanates.
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7.3 Comparison of sulforaphane isomers as modulators of carcinogen-metabolising 
enzyme systems
The chemopreventive activity of sulforaphane was established in animal models of cancer 
using the commercially available racemate, despite the fact that humans are exposed only to 
the i?-enantiomer through the diet. Since a principal mechanism of the chemopreventive 
activity of sulforaphane is modulation of the carcinogen-metabolising enzyme systems, a 
study was conducted in precision-cut rat liver and lung slices, and in FAO cells comparing 
the ability of R- and 5-sulforaphane to modulate these enzyme systems.
In both in vitro systems the naturally-occurring i?-sulforaphane was more effective than the 
5-isomer in modulating the various enzyme systems studied. These observations imply that 
the chemopreventive activity of sulforaphane may have been underestimated as the racemate 
was employed. However, in making such conclusions the assumption is made that the two 
isomers do not differ in their pharmacokinetic behaviour and metabolism, and such studies 
are essential before conclusions are drawn. Moreover, it would be informative to compare in 
in vitro studies the intracellular accumulation of the two isomers.
7.4 Potential of Daikon glucosinolates to act as chemopreventive agents through 
modulation of carcinogen metabolisms
An in vivo study was undertaken in rats using a glucosinolate-rich Daikon extract containing 
glucoraphasatin and substantial amounts of glucoraphenin. A major finding was that the 
lung was refractive to the effect of the Daikon glucosinolates in comparison with the liver. 
Similarly, supplementation of the diet of rats with phenethyl isothiocyanate caused a rise in
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glutathione 5-transferase and quinone reductase activities in the liver whereas the lung was 
refractive (Konsue and loannides, 2008; Guo et al., 1992).
In the liver, especially at the Low dose simulating human intake, there was a rise in CYPl 
activity, a consequence of increased enzyme availability, suggesting that the up-regulation 
of this enzyme by the Daikon extract may involve increased gene transcription, mRNA, 
and/or protein stabilisation. The rise in CYPl activity implies increased production of toxic 
metabolites or that may be detrimental; however, the rise in CYPl activity is modest 
compared with others CYPl inducers to which humans are frequently exposed. Moreover, a 
number of detoxification enzymes was also up-regulated, although in some cases higher 
doses were required. Thus, despite a rise in CYPl activity the balance of 
bioactivation/detoxification may become more favourable.
In order to better evaluate the potential of Daikon glucosinolates as chemopreventive agents, 
additional in vitro studies were conducted in precision-cut rat liver slices employing 
glucoraphasatin, the principal glucosinolate in Daikon. These studies showed a different 
picture between in vitro and in vivo studies in which glucosinolate elevated hepatic 
dealkylations of methoxy-, ethoxy-, pentoxyresorufin and benzyloxyquinoline, as well as 
marked induction of glutathione 5-transferase, quinone reductase and glucuronosyl 
transferase activities in in vivo, in contrast to in vitro studies; both systems showed a marked 
increase in epoxide hydrolase activity. However, supplementation of the incubation system 
with myrosinase to generate the isothiocynate led to a marked rise in glutathione 5- 
transferase, quinone reductase and epoxide hydrolase activities and expression as in the in
242
Chapter 7: General Discussion
vivo studies suggesting that the intact glucosinolate was hydrolysed by myrosinase to 
isothiocyanate.
7.5 Interaction of isothiocyanates and glucosinolates with the Ah receptor
The aryl hydrocarbon (Ah) receptor is a cytosolic transcription factor involved increasingly 
in many patho-physiological processes, so that antagonists of the Ah receptor imply 
chemopreventive potency. It regulates carcinogen-metabolising enzymes, for example the 
CYPl family of cytochromes P450 and quinone reductase, which play an essential role in 
the biotransformation of many chemical carcinogens.
Using the CALUX assay it was established that phenethyl isothiocyanate, erucin and 
sulforaphane, are such antagonists. These isothiocyanates were poor ligands to the Ah 
receptor and weak inducers of CYPlAl mRNA levels when incubated in precision-cut rat 
liver slices. They effectively antagonised, however, in a non-competitive manner, the 
activation of the receptor by the avid ligand benzo[a]pyrene. Among the two isomers of 
sulforaphane, the naturally-occurring R-isomer was the more efficient. In studies involving 
intact glucosinolates, glucoraphanin was more potent antagonist of the Ah receptor than 
glucoemcin. Furthermore, phenethyl isothiocyanate, emcin and sulforaphane suppressed, in 
concentration-dependent manner, the benzo[ajpyrene-mediated rise in rat hepatic CY PlA l 
mRNA levels in rat slices, in concordance with studies reporting that these isothiocyanates 
antagonise the benzo[a]pyrene-mediated increase in the (9-deethylation of ethoxyresorufin in 
both rat and human precision-cut liver slices (Konsue, 2010; Hanlon, 2009), as well as in 
human mammary tumour cell line Mcf7, where sulforaphane inhibited benzo[ajpyrene-
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mediated CYP1A2 induction (Skupinska et al., 2009). It is possible that the effect of 
isothiocyanates on the 0-deethylation of ethoxyresorufin is due, to some extent, mechanism- 
based inhibition associated with these compounds (Yoxall et al., 2005; Hanlon et al., 2008a). 
However, it is important to point out that it is the phenobarbital-inducible CYP2B enzymes 
that catalyse the metabolism of phenethyl isothiocyanate to the metabolite(s) liable for 
mechanism-based inhibition, in contrast to benzo[a]pyrene inducible CYPl enzymes, 
suggesting that mechanism-based inhibition is unlikely to be the dominant mechanism 
(Konsue and loannides, 2010; Goosen et al., 2000; Nakajima et al., 2001; Lee, 1996). Thus, 
it can be inferred that isothiocyanates are effective antagonist of the Ah receptor in rat and 
human liver, and this potential may contribute to their established chemopreventive activity.
7.6 Precision-cut tissue slices as an in vitro system to investigate induction of 
xenobiotic-metabolising enzyme systems
Tissue slicing was established in 1923, and 57 years later the Krumdieck tissue sheer was 
developed, facilitating the use of this procedure for diverse purposes such as study on 
xenobiotic-metabolism, unraveling toxicity mechanisms and organ specificity (reviewed by 
loannides and Lake, 2012). The precision-cut tissue slice is a well-developed in vitro system 
that mimics features of the whole tissue and has great advantages over other in vitro 
systems, particularly isolated cell culture, in maintaining tissue architecture and functional 
heterogeneity as well as cellular communication. It also allows the use of a wide range of 
concentrations that would necessitate large number of animals for commensurate studies in 
vivo (Lerche-Langrand and Toutain, 2000).
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This in vitro system is in particularly appropriate to studies in soft tissues such as the lung, a 
heterogeneous tissue comprised of many different cell types that vary markedly in their 
xenobiotic-metabolising enzyme profile (Hukkanen et al., 2002). Moreover, it has been 
reported that this system is suitable model for use in investigating the potential of 
xenobiotics to modulate cytochrome P450 and phase II enzyme activities in the rat liver and 
lung (Pushparajah et al., 2007). This technique has been successfully employed to establish 
the modulation of cytochrome P450 and phase II enzymes by aliphatic and aromatic 
isothiocyanates, in rat liver and lung as well as in human liver (Hanlon et al., 2008b; Hanlon 
et al., 2009a; Konsue and loannides, 2010).
7.7 Future work
• Conduct studies in vivo to assess whether carcinogen-metabolising enzyme systems 
are perturbed in humans by individual glucosinolates/isothiocyanates. Establish the doses 
required to effectively modulate detoxification enzymes.
• Investigate the metabolism of a model carcinogen, such as a heterocyclic amine or a 
polycyclic aromatic hydrocarbon, in volunteers before and after intake o f cruciferous 
vegetables, individual glucosinolates or isothiocyanates.
• Establish whether R- and 5-sulforaphane, and the racemate differ in their 
pharmacokinetic behaviour and metabolism in volunteers.
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• Evaluate whether R- and 5-sulforaphane as well as the racemate differ in their ability
to mediate chemoprevention through other mechanisms such as cell proliferation and 
apoptosis.
® Clarify the mechanism through which isothiocyanates function as antagonists of the
Ah receptor.
e Daikon glucosinolates appear to be very effective inducers of detoxification 
pathways, and work is merited through epidemiology and laboratory studies in animal 
cancer models to establish whether it displays effective chemopreventive activity.
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